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ABSTRACT 
 
It is well established that adenoviruses inactivate the host cell DNA damage response to 
enhance viral DNA replication. This is achieved, in part, by the ability of viral E1B55K and 
E4ORF6 proteins to hijack host cell cullin-containing E3 ubiquitin ligase complexes and 
target key cellular proteins such as Mre11, p53 and DNA ligase IV for degradation via the 
ubiquitin-proteasome pathway. To assess the generality of this viral response, studies were 
undertaken using a panel of representative serotypes from adenovirus species A to E to 
determine how they interact with the host cell DNA damage response. Notably, serotypes 
from species B and D were unable to promote the degradation and/or relocalization of Mre11 
and p53, although DNA ligase IV degradation was fundamentally conserved. Furthermore, 
species B and D serotypes induced the sustained overexpression of transcriptionally inactive 
p53, and induced both ATM and ATR kinase activity. As these events would typically be 
viewed as detrimental to virus survival, these data suggest that different adenovirus serotypes 
have evolved novel strategies in order to subvert the cellular DNA damage response during 
infection. 
Adenoviruses have long been utilised as useful tools for identifying, and characterizing, the 
function of fundamental cellular proteins such as tumour suppressors and those involved in 
the DNA damage response. Therefore, studies were also carried out to identify novel 
Ad12E1B54K-interacting proteins through mass spectrometric analysis, and subsequently to 
examine the functional significance of these interactions. Several putative novel 
Ad12E1B54K-interacting proteins were identified using this approach, one being the 
transcriptional intermediary factor 1γ (TIF1γ), a transcriptional regulator that has recently 
been identified as a tumour suppressor. Further studies determined that TIF1γ was relocalized 
to nuclear tracks in an E4ORF3-dependent manner early during adenovirus infection, and 
was subsequently degraded in a ubiquitin-mediated proteasome-dependent manner. Uniquely, 
TIF1γ degradation was shown to be E1B55K/E4ORF6-independent and E4ORF3-dependent. 
Data presented in this thesis also suggest that E4ORF3 does not utilise host cell cullin-based 
E3 ubiquitin ligases in order to promote TIF1γ degradation. The ability of E4ORF3 to target 
cellular substrates for degradation represents a novel way in which adenoviruses are able to 
target cellular substrates. Significantly, TIF1γ degradation was conserved during infection 
with Ad serotypes from species A to C which may highlight its importance for productive 
viral infection. It also appears that TIF1γ may have an as yet unidentified role in the DNA 
damage response since it was also found to interact with components of the ATR kinase 
pathway. 
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 INTRODUCTION 
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1.1 ADENOVIRUS 
1.1.1 DNA tumour viruses 
Tumours arise when cells proliferate in an uncontrolled manner and eventually present 
malignant characteristics, such as their ability to invade surrounding tissues and metastasis. It 
has been a century since pioneering studies were carried out that discovered an avian 
retrovirus, Rous sarcoma virus (RSV), which was capable of inducing sarcomas in chickens; 
however it took many years to comprehend the significance of this discovery (Rous, 1911). 
Since this time, a plethora of DNA viruses from the families Adenoviridae, Herpesviridae, 
Papillomaviridae and Polyomaviridae have also been shown to induce tumourigenesis in 
humans or other animals, and in doing so have proven to be invaluable tools in the 
understanding of tumour biology (Javier and Butel, 2008). Although only a small proportion 
of virally-infected humans develop cancer, current estimates indicate that approximately 20% 
of human cancers worldwide (1.9 million new cases in the year 2002) are attributable to 
infectious agents; including the human immunodeficiency virus type 1 (HIV-1), human 
papillomavirus (HPV), human T-cell lymphotrophic virus 1 (HTLV-1), hepatitis B and C 
viruses, the Epstein-Barr virus (EBV) and the Kaposi’s sarcoma-associated herpesvirus 
(KSHV). Of this 20%, a small proportion is also estimated to be caused by persistent 
infections of bacteria or parasites (Parkin, 2006).  
Neoplastic transformation of cells by DNA viruses is a multistep process that can occur many 
years after the initial viral infection. The resulting cells display characteristic morphological 
and growth changes such as loss of contact inhibition, reduced adhesion, reduced serum 
requirements, disruption of the cytoskeleton and immortalization (Hanahan and Weinberg, 
2000). These modifications are transmitted in a heritable manner, from parental cells to 
daughter cells, to form a transformed population which eventually develops into a tumour. 
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The basic mechanism for transformation often involves viral DNA integration into the 
cellular genome where it either permanently expresses early oncogenic viral genes, or causes 
the activation of adjacent cellular oncogenes to disrupt the normal cellular gene expression 
and signal transduction pathways. This is assisted by genetic, immunological and 
environmental factors, and the ability of most DNA tumour viruses to suppress the negative 
control on cell replication caused by cellular tumour suppressors such as p53 and the 
retinoblastoma gene product, pRB (Ludlow and Skuse, 1995, Hanahan and Weinberg, 2000). 
Indeed, as p53 and pRB are the most frequently altered regulatory pathways in human cancer, 
it is no surprise that DNA tumour viruses have been utilised experimentally to delineate the 
critical molecular events that occur during tumourigenesis (Berk, 2005). 
Over the past 40 years tumour virologists have utilised DNA tumour viruses to study the 
molecular basis of cell growth. These studies have lead to revolutionary breakthroughs in our 
understanding of cancer, cell cycle regulation, transcription and DNA replication (Javier and 
Butel, 2008). Perhaps two of the most landmark discoveries have been the identification of 
p53 from simian virus 40 (SV40)-transformed murine cells, and the function of pRb through 
association with the adenovirus (Ad) early region 1A (E1A) gene product (Lane and 
Crawford, 1979, Linzer and Levine, 1979, Whyte et al., 1988). 
 
1.1.2 Identification and classification 
Adenoviruses were first discovered in 1953 by a postdoctoral fellow, and his colleagues, 
while working on a project at the National Institutes of Health (Bethesda, Maryland) hoping 
to isolate the “virus of the common cold” (Rowe et al., 1953). These researchers cultured 
cells isolated from the adenoid and tonsil tissue of infected children, and noted that the cells 
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were rounded and clumped suggesting that they were infected by a virus; hence the family 
name Adenoviridae (“adeno” comes from the Greek word for gland). The next important 
finding came in 1962 when researchers discovered, for the first time, a human virus capable 
of inducing oncogenesis, albeit under experimental conditions (Trentin et al., 1962). This was 
Ad serotype 12 (Ad12) and it was capable of inducing “fast-growing malignant tumours at 
the site of intrapulmonary injection into newborn hamsters” (Trentin et al., 1962).  
The Adenoviridae family is comprised of five serologically distinct genera depending on the 
host species: Mastadenoviridae, Atadenovirus, Aviadenoviridae, Siadenoviridae and the 
recently proposed Ichtadenovirus which infects certain species of fish (Carstens, 2010). 
Mammalian species of Ad fall into the Mastadenovirus genus, with at least 55 known human 
serotypes classified and subdivided into seven species (A to G) largely based on their ability 
to agglutinate erythrocytes (Eiz and Pring-Akerblom, 1997). Patterns of other viral properties 
are also observed within, and between, species including their oncogenic potential in rodents, 
the percentage of DNA homology and G+C content, and their cellular tropism (Table 1.1).  
Since their discovery, adenoviruses have been isolated from every species of mammal, bird 
and amphibian studied, and appear to be highly host specific. Their oncogenic potential, 
however, is limited to mammals such as hamsters and rats, and in vitro all Ad serotypes 
tested to date have the capacity to transform human and rodent primary cells (McBride and 
Wiener, 1964, Russell, 2009). Indeed, sheared non-oncogenic Ad5E1 DNA and oncogenic 
Ad12E1 cDNA have the ability to transform human embryonic kidney (HEK), and human 
embryonic retinoblast (HER) cells, respectively (Graham et al., 1977, Byrd et al., 1982). In 
Ad-induced tumour cells and Ad-transformed cells, partial fragments of viral DNA 
occasionally become integrated into the host’s cellular genome supposedly via a haphazard  
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Species Serotype
Oncogenicity
in rodents
Transformation 
in tissue culture
% of G-C 
in DNA
A 12, 18, 31 High + 48-49
B1 3, 7 , 16, 21, 50 Moderate +
50-52
B2 11, 14, 34, 35, 55 Moderate +
C 1, 2, 5, 6 Low or none + 57-59
D
8, 9, 10, 13, 15, 17, 19, 
20, 22-30, 32, 33, 36-
39, 42-49, 51, 53, 54
Low or none + 57-61
E 4 Low or none + 57-59
F 40, 41 Not reported + 51
G 52 Not reported ? 55
 
 
 
 
 
 
 
 
 
 
 
Table 1.1. Classification of human adenoviruses. Serotypes used in this study are 
highlighted in red. 
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process at a random site; however there are also many claims in the literature that contest this 
view (Sambrook et al., 1980, Hilger-Eversheim and Doerfler, 1997, Doerfler, 2009). 
Approximately one-third of human Ad serotypes are also known to cause a broad spectrum of 
diseases relating to respiratory, gastrointestinal and conjunctival syndromes in the young, 
elderly and immunocompromised (Hierholzer, 1992). Fewer serotypes have also been 
increasingly implicated in severe disorders such as hepatitis, viral meningitis, pneumonia and 
disseminated infection in AIDS and other immunocompromised patients (Hierholzer, 1992, 
Sarantis et al., 2004).  
 
1.1.3 Structure and genome 
Ad virions are composed of icosahedral capsids which are approximately 70 nm in diameter, 
comprised of 87% protein and 13% DNA, and have no membrane or lipid layer (Rux and 
Burnett, 2004). The unique structure of this capsid is formed of 240 homotrimeric hexons and 
12 penton bases, each with a protruding fibre (Russell, 2009). Variation among fibre proteins 
accounts for the differing haemagglutinating properties of serotypes, and also mediates 
binding to cell surface receptors such as the coxsackie and adenovirus receptor (CAR; Zhang 
and Bergelson, 2005). Several minor capsid (IIIa, VI, VIII and IX) and core proteins (V, VII, 
X and the terminal protein; TP) are also expressed to provide stability for the mature virion 
and viral DNA (Russell, 2000, Vellinga et al., 2005).  
Adenoviruses have linear genomes of double-stranded DNA (dsDNA) between 26 and 45 
kilobase (kb) pairs making it the largest known non-enveloped virus. Sequence analysis has 
revealed that within Ad species genome homology ranges from 70-95%, while across species 
sequence homology is only 5-20% which reflects their distinct biology (Green et al. 1979). 
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Ad4 (species E) shows strong homology to several serotypes from species B, while serotypes 
from species A and F are highly related and the most divergent from those of other species 
(Bailey and Mautner, 1994, Davison et al., 2003). All adenoviruses also contain serotype-
specific inverted terminal repeats (ITRs) of 100-140 base pairs (bp) which flank the 5’ and 3’ 
genome ends and encode origins of replication (Rauschhuber et al., 2011). A 55 kilodalton 
(kDa) TP is also covalently joined to the 5’ end of each ITR to act as a primer for DNA 
replication.  
 
1.1.4 Ad replication cycle 
Once Ad DNA enters human cells it becomes uncoated and released into the nucleus where it 
may cause non-replicative latent infection, for example in the T-lymphocyte population of 
tonsils, or lytic infection (Neumann et al., 1987, Zhang et al., 2010). Lytic infectious cycles 
can occur in permissive human epithelial cells, such as those used throughout this study, 
which permit viral replication, progeny virus production, virion release and cell death (Zhang 
et al., 2010). The entire cycle takes approximately 20-24 hours in cultured HeLa cells but 
proceeds much slower in host organisms, and is divided into early and late stages of gene 
transcription, separated by the onset of viral DNA replication (Russell, 2000, Russell, 2009). 
Gene transcription is a tightly orchestrated process with the genome divided into eight 
transcriptional units which are similarly organized in all serotypes: five early (E1A, E1B, E2, 
E3 and E4), two intermediate (IX and IVa2), and one major late which produces five families 
of mRNA transcripts (L1-L5; Fig 1.1). A basic summary of the functions of these Ad gene 
products can be found in Table 1.2, but in brief, early region 2 (E2) is essential for viral DNA 
replication, and early region 3 (E3) encodes the adenovirus death protein (ADP) to facilitate 
cytolysis and virion release late in the infectious cycle, and is required for immune evasion by  
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Fig 1.1. Diagrammatic representation of the adenoviral transcription map.  
The location and direction of the major early and late transcription units are 
shown. The early transcripts are outlined in green, and the late transcripts are 
outlined in blue. Arrows indicate the direction of transcription (adapted from 
Russell, 2000). 
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Transcription unit Function of gene product 
E1A transcription, transformation, induces S-phase entry 
E1B transformation, blocks apoptosis 
E2A encodes DNA binding protein (DBP) 
E2B DNA polymerase 
E3 immune modulation 
E4 
transcriptional regulation, mRNA transport, DNA replication, 
host cell shut off 
IX & IVa2 
transcriptional activation of the major late promoter (MLP) to 
regulate the early to late switch,  synthesis of structural 
proteins 
late synthesis of structural proteins 
Table 1.2. Basic functions of adenovirus gene products.  
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affecting cell surface receptor signalling (Tollefson et al., 1996, Liu et al., 2003, Fessler et 
al., 2004). More recently a 24 kDa late protein has also been identified as the U exon protein 
(UXP) which is predicted to have a function relevant to Ad DNA replication or RNA 
transcription (Tollefson et al., 2007). E1A, early region 1B (E1B) and early region 4 (E4) are 
the only early proteins expressed by all genera of Adenoviridae and their specific roles are 
discussed further below. 
The expression of early viral genes relies on E1A which is a powerful transcriptional 
activator capable of amplifying its own expression, and that of other early proteins which 
drive viral DNA replication and late gene expression. Typically 6-8 hours post-infection, 
once the host cell is primed, Ad DNA replication proceeds from either end of the linear 
genome using viral proteins transcribed from the E2 region. These include the DNA binding 
protein (DBP) and DNA polymerase (AdPol) which are encoded by the E2A and E2B 
proteins, respectively, and pTP which is the TP precursor (van der Vliet and Levine 1973, de 
Jong et al., 2003, Liu et al., 2003). 
In short, DNA replication is initiated by a novel protein-priming mechanism in which AdPol 
catalyzes a covalent linkage between the 5’-terminal nucleotide dCMP (deoxycytidine 
monophosphate) and a pTP serine residue. This dCMP/pTP complex then acts as a primer for 
nascent strand DNA synthesis via a strand displacement mechanism in the presence of AdPol 
and DBP. The cellular transcription factors, nuclear factor I (NF-I) and nuclear factor III (NF-
III) promote replication by binding to AdPol and pTP, respectively, enhancing their affinity 
for viral DNA sequences (Nagata et al., 1982, de Jong et al., 2003, Liu et al., 2003). 
Although DBP acts to promote ATP-independent elongation, a further cellular protein 
nuclear factor II (NF-II) which is type I DNA topoisomerase, is also required for complete 
elongation by relaxing supercoiled DNA (Nagata et al., 1983). Finally, during virion 
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maturation pTP is cleaved via an intermediate TP (iTP) at two sites by a virally encoded 23 
kDa protease. This yields a stable TP which is important for DNA-nuclear matrix association 
and protection from DNA unwinding and exonuclease activity (Dunsworth-Browne et al., 
1980, Stillman et al., 1981, Schaack et al., 1990). Succeeding viral DNA replication, 
transcription of the intermediate and late genes is initiated from the major late promoter 
(MLP) to generate structural proteins required for the synthesis and assembly of mature 
virion particles. 
In order to preserve viral DNA replication and obtain the maximal production of virions, 
adenoviruses must alter the host’s cellular environment to control gene expression, the cell 
cycle and apoptosis. The approaches used to accomplish this are detailed later in this Chapter 
with particular attention on the circumvention of the cellular DNA damage response (DDR). 
 
1.1.5 E1A 
E1A is the first Ad mRNA to be transcribed and is detected approximately 1 hour post-
infection. The E1A region encodes two major RNA products, 12S and 13S which in Ad5 
correspond to 243 and 289 amino acid residue products, respectively (Boulanger and Blair, 
1991). These gene products contain three highly conserved regions (CR1, CR2 and CR4), and 
due to alternative RNA splicing the 13S protein also contains an extra conserved region CR3 
(Gallimore and Turnell, 2001). 12S and 13S have the capacity to interact with in excess of 30 
cellular proteins, and in doing so both sabotages normal cell cycle control and induces viral 
DNA synthesis. Some of these proteins are illustrated in the linear representation of 13S E1A 
seen in Figure 1.2. 
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Crucially, E1A regulates the transcriptional activation and repression of several early viral 
and cellular genes. And although this protein is not a DNA-binding transcription factor itself, 
it instead acts indirectly to transactivate gene expression by interacting with a number of 
cellular proteins that function as transcription factors, co-activators, co-repressors, 
nucleosomal remodelling factors and general transcriptional machinery (Gallimore and 
Turnell, 2001). The best characterized mechanism by which E1A transactivates gene 
expression is through the E2F family of transcription factors. In this instance, CR1 and CR2 
regions act together to bind and deregulate the transcriptional repressor functions of the pRB 
tumour suppressor gene product (and the related pocket proteins p107 and p130), displacing 
it from E2F responsive promoters. Along with remodelling of the surrounding chromatin, this 
“freeing” of E2F activates transcription from a variety of genes containing E2F-binding sites 
in their promoters, such as the Ad E2 early promoter (Bagchi et al., 1990, Ikeda and Nevins, 
1993, Ghosh and Harter, 2003). Transcription of the cellular genes CDK2, cyclin E and 
cyclin A are also activated in this manner which leads to quiescent cells being driven into S-
phase, circumvention of normal cell growth restrictions and priming of the cell for viral DNA 
replication (Grand et al., 1998).  
E1A CR1 also directs cell cycle progression through simultaneously binding to the 
homologous histone acetyltransferases (HATs) CBP (CREB binding protein) and p300 
(Howe et al., 1990, Pelka et al., 2009). CBP and p300 are transcriptional co-activators 
important for the transcriptional regulation of cell cycle mediators, such as p53 and nuclear 
factor-kappa B (NF-κB), through the acetylation of core histone proteins (Turnell and 
Mymryk, 2006). E1A has also recently been shown to inhibit the E3 ubiquitin ligase SCF
Fbw7
 
(a Skp/cullin/F-box complex that contains Fbw7 [F-box and WD repeat domain-containing 7] 
as the F-box protein) which is likely to induce unregulated proliferation during Ad infection,  
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Fig 1.2. Linear representation of Ad5 13S E1A and its biological functions 
 
The four conserved regions of E1A (CR1-CR4) are represented by the coloured 
oblongs, above which are listed their principle cellular binding partners. The 
cellular roles of these distinct regions are also illustrated (adapted from Zheng, 
2010). 
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since the ubiquitin ligase properties of this complex are involved in cell growth, survival and 
differentiation (Isobe et al., 2009). 
The E1A domains responsible for binding to pRB and CBP/p300 have also been implicated 
in stabilizing the tumour suppressor protein p53 and promoting p53-dependent apoptosis 
(Dabbas and White, 1993, Querido et al., 1997, Samuelson and Lowe, 1997). Furthermore, 
E1A can stabilize p53 indirectly through the tumour suppressor protein p19
ARF
, in a manner 
distinct from its DNA damage-induced regulation (de Stanchina et al., 1998). Even though 
stabilizing an important pro-apoptotic protein such as p53 may appear deleterious for a 
replicating virus, the expression of other downstream viral proteins such as E1B and E4 
counteract this action, and one study suggests that functional p53 can even promote virus 
replication and late virus protein expression (Royds et al., 2006). 
Interestingly, the same activities of E1A that deregulate cell cycle progression are also 
required for oncogenic transformation by the virus. Indeed, the ability of E1A to immortalize 
primary cells in vitro is through the binding of cellular proteins such as pRB, p53 and 
p300/CBP. However the cooperation of other oncogenes, such as E1B or activated mutant 
p21
ras
 expression, are required for full transformation and tumourigenesis in rodents (Sarnow 
et al., 1982a, Frisch and Mymryk., 2002). E4ORF6 (early region 4, open reading frame 6) has 
also been shown to interact with, and regulate, the transcriptional functions of p53 in an 
E1B55K-independent manner to enhance E1A-mediated transformation of primary baby rat 
kidney cells (Dobner et al., 1996, Nevels et al., 1997). 
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1.1.6 E1B 
The E1B gene encodes at least five different polypeptides, including E1B19K and E1B55K 
(compared to the Ad5 protein, the Ad12 protein lacks several amino acid residues and is 
referred to as E1B54K), which are made from the same transcript but use alternative reading 
frames and hence have no identical regions (Takayesu et al., 1994, Sieber and Dobner, 2007). 
The principle roles for these proteins are the inhibition of apoptosis and cooperation with 
E1A to promote transformation. A linear representation of Ad5E1B55K can be found in 
Figure 1.3. 
To divert cells away from the pro-apoptotic pathway induced by E1A, E1B55K has evolved a 
number of mechanisms which, along with E4 proteins, act to counteract p53 stabilization in 
the early stages of viral infection. In transformed cells E1B55K actively binds to p53-
responsive promoters in order to represses its transcriptional activity, while during active Ad 
infection p53 activity is additionally counteracted by E1B55K E3 SUMO1 ligase activity 
which stimulates the conjugation of the small ubiquitin-like modifier (SUMO) to p53 (Yew 
and Berk, 1994, Muller and Dobner, 2008, Pennella et al., 2010). This SUMO modification 
maximally inhibits p53 function by initially tethering it into discrete nuclear tracks to 
decrease its mobility, and then by facilitating its nuclear export and ultimately its degradation 
(Pennella et al., 2010). The proteasomal degradation of p53 is regulated by interactions 
between E1B55K and E4ORF6 which associate with cellular proteins to form an E3 ubiquitin 
ligase complex. This is achieved by E4ORF6 acting as an adapter protein via two BC boxes 
which hijack cellular cullin-based E3 ubiquitin ligase complexes to ubiquitylate p53, 
targeting it to the 26S proteasome for proteolytic degradation (Steegenga et al., 1998, 
Querido et al., 2001, Blanchette et al., 2004, Luo et al., 2007). While E4ORF6 can bind p53 
independently, in this instance substrate specificity is managed through E1B55K which 
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directly interacts with p53 and ensures its recruitment to the ligase complex (Blanchette et al., 
2004). The establishment of virally-mediated E3 ubiquitin ligase complexes and their 
importance during Ad infection will be discussed in more detail below. 
Work carried out using Ad5E1B55K-deleted viruses also discovered that E1B55K has 
important roles during the late stages of Ad infection. Indeed, E1B55K is required for the 
nucleocytoplasmic transport and translocation of late viral mRNAs via the CRM1 
(chromosome region maintenance 1) export pathway, and for the inhibition of host cell 
mRNA transport and translation (Babiss et al., 1985, Kindsmüller et al., 2007, Woo and 
Berk, 2007). These functions are associated with E1B55K’s RNA-transporter functions such 
as an N-terminal nuclear export signal (NES), a carboxy-terminal (C-terminal) nuclear 
localization signal (NLS) and a ribonucleoprotein (RNP) RNA-binding motif (Horridge and 
Leppard 1998, Krätzer et al., 2000). 
E1B19K is a functional homolog of the cellular BCL-2 (pro-apoptotic B-cell lymphoma-2) 
family anti-apoptotic MCL-1 (myeloid cell leukaemia-1) protein, and acts to inhibit p53-
independent apoptosis. E1B19K achieves this by mimicking MCL-1 and inhibiting the co-
oligomerization of two other BCL-2 family members, BAX (BCL-2-associated X) and BAK 
(BCL-2-antagonist killer). This inhibition prevents the formation of pores in the 
mitochondrial membrane, cytochrome c release, caspase activation and consequently 
apoptosis (Cuconati et al., 2002).  
 
1.1.7 E4 region 
Alternatively spliced E4 mRNAs potentially encode seven open reading frames (ORFs) of 
leftward-oriented genes (ORF1, ORF2, ORF3, ORF3/4, ORF4, ORF6 and ORF6/7) all of 
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Fig 1.3. Linear representation of Ad5E1B55K and its biological functions 
 
Five different Ad5E1B55K motifs are represented by the coloured oblongs, below 
which can be found their principle biological functions. CKI/II, casein kinase I/II 
phosphorylation site; NES, nuclear export signal; NLS, nuclear localization 
signal; RNP, ribonucleoprotein motif; Zn finger, putative C2H2 zinc finger 
(adapted from Zheng, 2010). 
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which, bar E4ORF3/4, have been demonstrated to be present in infected cells (Cutt et al., 
1987, Thomas et al., 2001). The E4 region encompasses a diverse range of vital functions 
including transcriptional regulation, mRNA transport, DNA replication, virus particle 
assembly and host cell shutoff, all of which are reflected by the defective phenotype of 
viruses where the entire E4 region is deleted (Halbert et al., 1985, Weiden and Ginsberg, 
1994, Tauber and Dobner, 2001). Mutational analysis has discovered that alterations within 
individual ORFs only have nominal effects suggesting that they are dispensable for lytic 
growth, however, mutants lacking both E4ORF3 and E4ORF6 were seriously restricted for 
DNA replication and growth suggesting a functional redundancy between these proteins 
(Halbert et al., 1985). Indeed, E4ORF3 and E4ORF6 have now been shown to be functionally 
redundant during lytic growth, in that they can compensate at varying degrees for each 
other’s defects (Bridge and Ketner, 1989, Huang and Hearing, 1989). Despite this functional 
redundancy, E4ORF3 and E4ORF6 act by very distinct mechanisms to aid viral growth and 
replication. 
The E4ORF6 gene encodes a highly conserved protein which contains a NLS and NES, along 
with an amphipathic arginine-rich α-helical nuclear retention signal (NRS) that is believed to 
target E1B55K/E4ORF6 complexes to the nucleus (Orlando and Ornelles, 1999). In addition, 
it also contains two BC boxes which indirectly interact with E1B55K via cellular E3 
ubiquitin ligase complexes, and a central cysteine-rich region which forms a functional zinc-
binding domain that has also been found to mediate E1B55K interactions (Boyer and Ketner, 
2000, Blanchette et al., 2008). E4ORF6 is also known to directly bind to the C-terminal 
regulatory domain of p53 and block p53-mediated transcriptional activation. This is achieved 
by inhibiting the interaction between the N-terminal activation domain of p53, and the 
transcriptional initiation complex of certain transcriptional targets (Dobner et al., 2006). 
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As discussed above, E4ORF6 cooperates with E1B55K to provoke the degradation of p53 
(Steegenga et al., 1998, Querido et al., 2001, Blanchette et al., 2004). However, parallel to 
this inactivation another highly conserved E4 gene product, E4ORF3, which is tightly 
associated with the nuclear matrix, also acts to restructure both the nucleus and the cytoplasm 
of infected cells by redistributing specific cellular proteins. Markedly is the promyelocytic 
leukemia (PML) protein which forms discrete elongated tracks that eventually surround sites 
of viral replication (Carvalho et al., 1995, Konig et al., 1999). Disruption of these nuclear 
PML oncogenic domains (PODs) has been attributed to a direct interaction between E4ORF3 
and a 40 amino acid residue sequence within the specific PML isoform PMLII (Hoppe et al., 
2006, Leppard et al., 2009). The function of this reorganization is undefined, however, 
evidence suggests that it facilitates the immobilization of cellular proteins and the ability of 
E4ORF3 to epigenetically silence target genes (Pennella et al., 2010, Soria et al., 2010). 
The relocalization and inactivation of p53 into these nuclear tracks is also promoted by 
E4ORF3. Indeed, E4ORF3 has recently been found to induce heterochromatin formation 
through trimethylation of histone H3 at lysine residue 9 (H3K9me3) at p53 target promoters 
to prevent p53-DNA binding (Soria et al., 2010). This silencing of p53-activated transcription 
is independent of E1B55K/E4ORF6-mediated degradation, and synonymous with p53 
stabilization in response to DNA damage (Lakin and Jackson, 1999, Soria et al., 2010). The 
role of E4ORF3 in reorganizing other cellular and viral proteins will be discussed in more 
detail below. 
Besides targeting cellular substrates during infection E4ORF6, and possibly E4ORF3, also 
cooperate with E1B55K to increase late viral protein production by facilitating the nuclear 
export and cytoplasmic accumulation of late viral mRNAs, and blocking cellular mRNA 
nuclear export (Halbert et al., 1985, Shepard and Ornelles 2004, Woo and Berk, 2007). The 
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ability of E4ORF6 to interact with cellular E3 ubiquitin ligase complexes is necessary for 
these late functions since mutant viruses lacking E4ORF6 BC boxes are defective for viral 
growth and viral mRNA nuclear export (Corbin-Lickfett and Bridge 2003, Blanchette et al., 
2008). This suggests the E3 ubiquitin ligase activity of E4ORF6 may have an as yet 
unidentified role in mRNA transport and stability. Furthermore, a recent study has 
demonstrated that E4ORF3 also inactivates components of cytoplasmic mRNA processing 
bodies by relocalizing them into cytoplasmic aggresomes, presumably to aid late viral mRNA 
accumulation (Greer et al., 2011). 
E4ORF4 is a non-essential protein for Ad infection, although it has been shown to negatively 
regulate E1A transactivation of the viral E4 and E2 promoters and have an inhibitory role 
during Ad replication (Bridge et al., 1993, Bondesson et al., 1996, Mannervik et al., 1999). 
Interestingly, when expressed alone E4ORF4 has the capacity to induce p53-independent 
apoptosis in human cancer cells, but not in normal cells, via an interaction with the Bα 
subunit of the protein phosphatase 2A (PP2A) complex (Marcellus et al., 2000, Shtrichman et 
al., 2000). PP2A regulates the CDC25A (cell division cycle 25A) protein in G2/M cell cycle 
checkpoint activation, therefore its interaction with E4ORF4 is proposed to initiate G2 arrest 
(Li et al., 2009). Consequently, E4ORF4 has great therapeutic potential as a high frequency 
of human tumours are p53-deficient and resistant to conventional treatments which are reliant 
on p53-dependent apoptosis (Shtrichman et al., 2000, Branton and Roopchand, 2001). 
The E4ORF6/7 fusion protein is also involved in apoptosis and the transactivation of the E2F 
family of transcription factors alongside E1A, while E4ORF1 and E4ORF2 have unknown 
functions in the late stages of the lytic life cycle and show oncogenic properties (O'Connor 
and Hearing, 2000, Tauber and Dobner, 2001, Thomas et al., 2001, Weitzman, 2005, Seandel 
et al., 2008, Thomas et al., 2009). Indeed, E4ORF1 is the primary oncogenic determinant for 
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the Ad9-mediated development of mammary tumours in rats (Thomas et al., 2001, 
Glaunsinger et al., 2001). 
 
1.1.8 Clinical importance of studying adenoviruses 
Since their discovery nearly 60 years ago, adenoviruses have been, and continue to be, 
utilised as model systems to study fundamental aspects of molecular and cellular biology 
such as tumourigenesis, cell cycle control and the cellular response to DNA damage (Berk, 
2005, Weitzman and Ornelles, 2005). Indeed, due to its broad range of properties and 
transformation potential, E1A is the most widely studied viral oncogene and is responsible 
for the identification and/or characterization of numerous cellular proteins including pRB, 
E2F, CtBP (C-terminal-binding protein) and p300 (Yee and Branton et al., 1985, Kovesdi et 
al., 1986, Whyte et al., 1988, Boyd et al., 1993). The fundamental nature and function of the 
infamous tumour suppressor p53 was also revealed via studies on DNA tumour viruses such 
as Ad (Russell, 2000). Historically, alternative splicing was also first described by scientists 
studying Ad2 where one pre-mRNA molecule was shown to be spliced and processed to 
result in a variety of mature mRNA molecules with different arrangements of exons (Berget 
et al., 1977, Chow et al., 1977).  
As discussed above adenoviruses represent the first known family of human viruses capable 
of causing cancer, and have widely been shown to induce tumours in rodents, yet despite its 
abundance in other human diseases, adenoviruses are rarely associated with human cancer 
(Trentin et al., 1962, Hierholzer, 1992, Sarantis et al., 2004). Recent data does indicate 
however, that Ad serotypes from species B and D may possess transforming potential 
towards humans, as real-time quantitative PCR (RQ-PCR) and in situ hybridization assays 
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have detected Ad DNA at a high frequency in paediatric brain tumours (Kosulin et al., 2007). 
During tumour development in rodents it is widely accepted that early Ad gene products, 
E1A and E1B, cooperate to mediate cellular transformation via a “hit-and-run” mechanism 
since viral DNA sequences are undetectable in the resulting tumour cell (Nevels et al., 2001). 
While the majority of Ad infections are self-limited by the normal immune response and 
there is currently no specific therapy or treatment, several drugs including cidofovir and 
ribavirin are being developed which may have the potential to treat infected patients 
(Miyamura et al., 2000, Neofytos et al., 2007). 
Oncolytic viruses such as Ad also have the potential to be exploited as therapeutic tools. One 
such example is the Ad5E1B55K-deficient dl1520 virus which has been shown to 
preferentially infect and lyse cancer cells; however its efficacy in clinical trials of cancer 
patients has been conflicting (Heise et al., 1999, Khuri et al., 2000, Cherubini et al., 2006). 
The majority of clinical Ad research however has been concerned with its implication as an 
experimental vector for gene therapy, cancer therapy and recombinant vaccine development. 
Indeed, adenoviruses have been utilised as a vehicle for gene delivery since the early 1990s 
due to their ability to infect a wide variety of cells, remain relatively stable in vitro and be 
easily genetically manipulated. Currently, adenoviruses are the most commonly used gene-
delivery vehicle representing nearly 25% of all vectors used in gene therapy clinical trials, 
however their effectiveness is yet to be established (Robinson et al., 2011). 
There are undoubtedly more lessons to be derived from studying the natural biology of Ad 
infection that will contribute to our understanding of cellular biology and the molecular basis 
of human disease, and may help develop clinically approved therapeutic drugs. In the current 
study, further insights are provided into Ad virology from a range of serotypes, and through 
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Ad-host interactions the molecular function of potentially novel cellular mechanisms are 
explored. 
 
1.2 THE DNA DAMAGE RESPONSE    
1.2.1 DNA damage and cancer  
Genome integrity is under constant challenge from endogenous and environmental sources. 
To cope with these assaults cells have evolved a series of biochemical pathways to detect, 
and repair, damaged DNA. However, when these processes are compromised, errantly-
repaired DNA or unrepaired DNA can lead to genomic instability and the development of 
cancer. The two main cytotoxic lesions that threaten genome integrity are DNA double-strand 
(DSBs) and single-strand breaks (SSBs). Generally, DSBs are generated through exposure of 
cells to ionising radiation (IR) while SSBs are caused by ultraviolet (UV) radiation, however, 
there is a large amount of crosstalk between the pathways involved in signalling these 
lesions. In addition, errors in DNA replication, stalled or collapsed replication forks and the 
production of reactive oxygen intermediates can also elicit DDR reactions during normal S 
phase progression (Cha and Kleckner, 2002, Petermann and Caldecott, 2006). 
Defects in DDR pathways contribute to neurodegenerative disorders, immune deficiencies, 
cardiovascular disease and other inheritable human diseases. Notably, individuals with 
germline mutations in their DDR genes are characterized by sensitivity to DNA damaging 
agents, and are commonly predisposed to tumour development (Gorgoulis et al., 2005). 
These genomic instability syndromes include, but are not limited to, ataxia telangiectasia (A-
T), ataxia telangiectasia-like disorder (ATLD), Fanconi anaemia (FA), Li-Fraumeni 
syndrome, LIG4 syndrome (DNA ligase IV), Nijmegen breakage syndrome (NBS), NBS-like 
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syndrome, RIDDLE (radiosensitivity, immunodeficiency, dysmorphic features and learning 
difficulties) syndrome and Seckel syndrome (Jackson and Bartek, 2009). 
Current cancer treatments such as radiotherapy and alkylating drugs exploit the DDR by 
inducing toxic lesions in cells. Many of these strategies however pose adverse side effects 
and are often non-specific. Therefore, it is not surprising that specific DNA-damaging agents 
are being developed and trialled in combination with traditional therapies, and are at the 
forefront of the latest cancer therapy research. Although the therapeutic outcome of this 
strategy remains to be determined, several DNA-damaging drugs have proven to be highly 
effective for the induction of cell cycle arrest and cell death, and have increased the efficacy 
of current treatments for breast and ovarian cancer in clinical trials (Helleday et al., 2008). 
One promising example are inhibitors that target the poly(ADP-ribose) polymerase (PARP) 
which is a scaffold protein that recruits other proteins necessary for DNA repair. Studies have 
successfully demonstrated that irrespective of p53 status PARP inhibitors preferentially kill 
neoplastic cells to reduce harmful off-target effects, and can induce human tumour regression 
in combination with chemotherapy (Weil and Chen, 2011). This is due to the fact that tumour 
cells, because of their frequency of replication and genomic susceptibility, have increased 
frequency of mutations which can be exploited by drugs such as PARP inhibitors.  
 
1.2.2 p53  
Often described as the ‘guardian of the genome’, the p53 protein is mutated in over 50% of 
human cancers and regulates an array of cellular processes including DNA repair, cell cycle 
arrest and apoptosis, as demonstrated in Figure 1.4 (Lane, 1992, Vogelstein et al., 2000, 
Whibley et al., 2009). The p53 gene was first described in 1979 by six independent 
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researchers who believed it to be an oncogene, however it later became clear that p53 was in 
fact a tumour suppressor gene (Vogelstein et al., 2000). Tumourigenesis can inactivate p53 
by several mechanisms including DNA mutations (e.g. lung, brain and colon tumours), viral 
infection (e.g. cervical and liver tumours and lymphoma) and mislocalization from the 
nucleus to the cytoplasm (e.g. breast tumours and neuroblastoma). In unstressed cells p53 
remains inactive by its key negative regulator MDM2 (murine double minute 2) via two 
mechanisms. Firstly by directly binding to the N-terminal transactivation domain of p53 to 
inhibit its function as a transcription factor, and secondly by functioning as an E3 ubiquitin 
ligase to target p53 for proteasomal degradation (Oliner et al., 1993, Wu et al., 1993, Haupt 
et al., 1997, Fang et al., 2000). Furthermore, p53 transcriptionally activates MDM2 through a 
p53 response element causing the expression levels of p53 and MDM2 to be regulated 
through an autoregulatory negative feedback loop (Wu et al., 1993, Fang et al., 2000). 
MDM2 itself is often described as an oncogene as it is overexpressed in more than forty 
different types of malignancies, and although the basis of this oncogenicity remains unclear it 
is speculated that MDM2 multiplication stimulates excessive p53 degradation (Leach et al., 
1993, Rayburn et al., 2005). 
 
Of the various pathways that activate the p53 network, the molecular mechanisms behind p53 
activation in response to DSBs are perhaps the most comprehensively understood and will be 
discussed in more detail later in this Chapter. In short, upon DNA damage p53 accumulates 
to induce cell cycle arrest allowing time for the DNA to repair. If this repair fails p53 can also 
trigger cell suicide by apoptosis to prevent the lesion being passed on to daughter cells. 
Besides activation by the DDR (often via phosphorylation), Figure 1.4 demonstrates that a 
plethora of other proteins from other pathways can also regulate p53 function via post-       
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Fig 1.4. The p53 pathway  
 
This illustration highlights the complexity of p53 regulation and its importance in 
maintaining genome integrity. p53 function is regulated by at least 50 known 
enzymes (only some of which are listed above) which affect its interaction with 
MDM2. As a transcription factor, p53 can activate or repress genes involved in 
DNA repair, cell cycle arrest, apoptosis and senescence, while through protein-
protein interactions it can also induce apoptosis via the mitochondrial pathway. 
All of the responses regulated by p53 are fundamental for normal cell growth and 
development, however, if compromised they can lead to tumourigenesis (adapted 
from Whibley et al., 2009). 
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translational modifications, such as acetylation and methylation, which disrupt interactions 
with MDM2 and generally result in the stabilization of p53 (Whibley et al., 2009). p53 exerts 
its function as a tumour suppressor in two ways. Firstly, via physical interactions with 
members of the BCL-2 family, p53 has the ability to promote apoptosis by inducing the 
release of cytochrome c from the mitochondria (Oda et al., 2000, Mihara et al., 2003). 
Secondly, its role as a transcription factor allows p53 to bind to p53 response elements within 
a broad spectrum of target genes in order to active or repress their expression. Of particular 
importance to this study is p21 which is activated by p53 in response to DNA damage, and is 
a potent regulator of cell cycle progression through interactions with cyclin-CDK (cyclin-
dependent kinase) complexes (Harper et al., 1993). 
 
1.2.3 Cell cycle checkpoints  
The cellular response to DNA damage involves a series of proteins classed as sensors, 
mediators, transducers and effectors which form an integrated network to rapidly detect and 
signal DNA lesions (Fig 1.5). Within seconds of DNA damage induction, many of these 
proteins dynamically accumulate on chromatin domains flanking the lesion in focal PML-
containing POD structures termed foci. These nuclear structures reflect local chromatin 
expansion, histone modification and the assembly of diverse proteins within the vicinity 
(Kruhlak et al., 2006).  
The detection of DNA damage initiates pathways that affect cell cycle control, DNA repair 
and transcription, and if the damage is beyond repair, apoptosis. Integral components of the 
DDR are the distinct checkpoint pathways which act as safeguards to arrest cells at specific 
stages throughout the cell cycle to allow the cell time to carry out the appropriate DNA repair 
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functions. This temporary pause is lifted upon completion of the repair and cells can continue 
an error-free cycle.  
Transitions between cell cycle phases are tightly controlled, thus activated checkpoints in 
damaged cells can block S phase entry (G1/S checkpoint), delay S phase progression (intra-S 
phase checkpoint) or prevent mitotic entry (G2/M phase checkpoint). A simplified illustration 
of the mammalian cell cycle and the mechanisms behind its regulation is shown in Figure 1.6. 
Recent evidence has suggested there is a lack of a DNA damage checkpoint during mitosis, 
as although early response events are triggered, full DDR activation does not occur until cells 
enter G1 and the DNA is less condensed, and presumably more accessible (Giunta et al., 
2010).  
Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) proteins, which 
belong to the phosphatidylinositol 3-kinase-like kinase (PIKK) family, are key upstream 
players in checkpoint pathways (Sancar et al., 2004, You et al., 2005). Mutation of these 
genes result in rare genetic human conditions (A-T and Seckel syndrome), however while the 
ATM gene is non-essential, ATR-null mice are inviable suggesting that this kinase is essential 
for cell and organism survival (Brown et al., 2000, Liu et al., 2000). ATM responds primarily 
to DSBs, while ATR responds to stalled DNA replication forks and ssDNA (single-stranded 
DNA) generated by DNA damaging agents (Bakkenist and Kastan, 2004). However, there is 
also evidence of some overlap and cross-talk between these two pathways in vivo (Matsuoka 
et al., 2000, Zhao and Piwnica-Worms, 2001, Gatei et al., 2003). Indeed, ATR also responds 
to DSBs in an ATM-dependent manner and ATM has been shown to be activated through 
ATR signalling during UV and hydroxyurea (HU) treatment (Adams et al., 2006, Jazayeri et 
al., 2006, Stiff et al., 2006). Furthermore, overexpression of  ATR complements the 
radioresistant DNA synthesis defect in cells lacking ATM (Cliby et al., 1998). 
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Fig 1.5. DNA damage signal transduction 
 
DNA damage is signalled by a cascade involving sensors, mediators, transducers 
and effectors. Initially DNA damage is recognized by sensor proteins which 
activate the signalling cascade. The recruitment of transducers, with the help of 
mediators, amplifies the signal to suppress effector proteins. This triggers cell 
cycle arrest at specific phases, DNA repair or apoptosis if the damage is too 
severe.  
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Fig 1.6. The mammalian cell cycle 
 
The four distinct phases of the cell cycle (G1, S, G2 and M) which encompass 
DNA synthesis and mitotic cell division are shown above. Cell cycle progression 
is positively regulated by the activity of cyclins and CDKs, shown in blue, and 
negatively regulated by proteins shown in pink. Red arrows indicate the locations 
of cell cycle checkpoints while the blue arrow signifies the restriction point where 
cells are irreversibly committed to the next cell division (adapted from Kong et 
al., 2003). 
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1.2.4 Activation of the ATM kinase 
The hierarchical assembly of proteins at sites of DSBs is highly ordered, rapid (reaching 
maximal accumulation within a few minutes) and dependent on a string of phosphorylation 
and ubiquitin mediated events (Fig 1.7). The ATM protein kinase has a central function in 
communicating the detection of DSBs by phosphorylating key players in various branches of 
the DDR network. In unirradiated cells, ATM exists as an inactive dimer where its kinase 
domain is bound to an internal domain of a neighbouring ATM molecule containing serine 
1981. Upon the induction of DNA damage, the kinase domain of one ATM molecule 
phosphorylates the serine 1981 residue of an interacting ATM molecule which leads to the 
dissociation of active ATM monomers (Bakkenist and Kastan, 2003). 
A number of proteins that contain BRCT (BRCA1 C-terminal) domains are involved in the 
efficient activation and relocalization of ATM in response to DNA damage, including Nbs1 
and the mediator of DNA damage checkpoint 1 (MDC1) protein. Specifically, via its 
interaction with the C-terminal region of Nbs1 (a member of the Mre11-Rad50-Nbs1, or 
MRN, complex), ATM recruitment is dependent on MDC1 (Desai-Mehta et al., 2001, Uziel 
et al., 2003, You et al., 2005, Chapman and Jackson, 2008, Melander et al., 2008, Spycher et 
al., 2008). Indeed, recent data has shown that association between the Nbs1-FHA (forkhead-
associated) domain and the MDC1-SDT (Ser-Asp-Thr) repeat region constitutively 
phosphorylated by casein kinase 2 (CK2), is required for the relocalization of the MDC1-
MRN-ATM complex (Chapman and Jackson, 2008, Melander et al., 2008, Spycher et al., 
2008). The MDC1-MRN-ATM complex is tethered to damaged chromatin via interactions 
between tandem MDC1-BRCT repeat regions and the ATM-phosphorylated form of a variant 
histone H2A (histone 2A), H2AX (γH2AX). H2AX phosphorylation is one of the earliest 
events in DSB signalling and γH2AX serves as a major marker for damaged chromatin by  
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Fig 1.7. The cellular response to DSBs 
 
DSBs, generated from IR or collapsed DNA replication forks, are sensed by the 
MRN complex which induces ATM kinase activation. ATM phosphorylates 
H2AX and, along with MRN, recruits and activates a series of mediator proteins 
(i.e. MDC1) and the transducer kinase Chk2. RNF8 and RNF168 act to amplify 
this signal by ubiquitylating γH2AX allowing further recruitment. The transduced 
signal subsequently activates a number of downstream effector proteins such as 
p53 and 53BP1 to mediate checkpoint signalling, DSB processing and DNA 
repair. P, phosphate; M, methyl; Ub, ubiquitin (Weitzman et al., 2010). 
53BP1
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flanking DNA breaks (Rogakou et al., 1999, Lee et al., 2005, Stucki et al., 2005). Equally, 
the de-phosphorylation of γH2AX is important for attenuating the checkpoint signal to allow 
sister chromatid separation and the cell cycle to resume after DNA repair (Chowdhury et al., 
2005). 
Along with Nbs1 and MDC1, a number of other proteins that contain BRCT domains are also 
involved in the efficient activation of ATM. Two such proteins are BRCA1 (breast cancer 
susceptibility gene 1) and 53BP1 (p53-binding protein 1) which, as well as being 
phosphorylated by ATM at sites of DNA damage, act as co-activator or mediator proteins to 
facilitate ATM function (Xu et al., 2002, Lee et al., 2010). 
Once recruited and activated, ATM phosphorylates a number of transducer and effector 
substrates which triggers a signalling cascade and results in checkpoint activation (Bakkenist 
and Kastan, 2004). One crucial target for the ATM kinase is the checkpoint kinase 2 (Chk2) 
protein which is phosphorylated on threonine residue 68 at sites of DNA damage (Matsuoka 
et al., 2000). Chk2 is a central effector kinase responsible for the activation of cell cycle 
checkpoints and apoptosis by stabilizing p53 (Hirao et al., 2000). 
 
1.2.5 Activation of the ATR kinase 
In human cells, ATR exists in a stable heterodimeric complex along with the regulatory 
protein ATR-interacting protein (ATRIP) which is often referred to as an obligate ATR 
subunit as there is no difference in phenotype from the loss of these genes (Cortez et al., 
2001). In contrast to ATM, the ATR-ATRIP complex is not post-translationally modified 
following DNA damage, nor does it have any increased activity in kinase assays (Bakkenist 
and Kastan, 2004). This complex binds indirectly to DNA lesions or sites of stalled 
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replication via an interaction between ATRIP and replication protein A (RPA) which is a 
heterotrimeric ssDNA-binding complex (Fig 1.8; Wold, 1997, Zou and Elledge, 2003). In this 
regard, ssDNA can directly trigger checkpoint activation as it is generated both at stalled 
replication forks and by 5’ to 3’ resection of DSBs (presumably by the MRN complex) which 
leaves long 3’-ended tails (Garvik et al., 1995). Although RPA recruits ATR to ssDNA it is 
not sufficient for ATR activation. This is dependent on the Rad9-Hus1-Rad1 (9-1-1 or RHR) 
complex which functions as a sliding checkpoint clamp and is topologically linked to DNA 
by the Rad17-RFC2-5 (RSR) “clamp loader” complex (Zou et al., 2001, Ellison and Stillman, 
2003, Majka and Burgers, 2007). This “loading” is driven by ATP and is independent of ATR 
function or localization (Zou et al., 2001, Ellison and Stillman, 2003). The Rad17 protein is 
also an important substrate for ATR kinase activity. This phosphorylation requires Hus1 
which suggests that the 9-1-1 complex enables ATR to target its substrates (Zou et al., 2001).  
Two other mediator proteins, Claspin and TOPBP1 (topoisomerase [DNA] II binding protein 
1), are also required for ATR to phosphorylate its key downstream target, checkpoint kinase 1 
(Chk1; Kumagai et al., 2005, Liu et al., 2006, You et al., 2006). TOPBP1 binds directly to 
the phosphorylated C-terminus of Rad9 and interacts with ATR via its co-activator protein 
ATRIP, while Claspin (activated by an as yet unidentified kinase) binds directly to the kinase 
domain of Chk1 to mediate its recruitment to ATR in a process dependent on TIMELESS and 
TIPIN (TIMELESS-interacting protein) association (Jeong et al., 2003, Chou and Elledge, 
2006, Liu et al., 2006, Mordes et al., 2008). 
Chk1 is phosphorylated by ATR on serine residues 317 and 345 and has diverse roles in 
activating DNA damage, DNA replication and mitotic spindle checkpoints (Liu et al., 2000, 
Zhao and Piwnica-Worms, 2001, Dai and Grant, 2010). Chk1, like ATR, has been shown to 
be an essential gene in mice, and as discussed below has vital roles in cell cycle regulation in 
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Fig 1.8. The cellular response to ssDNA 
 
ssDNA generated from UV radiation, stalled DNA replication forks or processed 
DSBs becomes coated in RPA which recruits the ATR-ATRIP complex. The 9-1-
1 complex is independently recruited to ssDNA along with claspin and TOPBP1, 
which together activate ATR-ATRIP kinase activity enabling it to phosphorylate 
the downstream transducer protein Chk1. Chk1 subsequently activates effector 
proteins to trigger cell cycle arrest and maintain replication fork stability. P; 
phosphate (Weitzman et al., 2010). 
~ 36 ~ 
 
response to checkpoint activation (Liu et al., 2000).  
 
1.2.6 The MRN complex 
Amongst the first proteins to be recruited to DNA damage foci is the MRN complex which 
contains three members Mre11, Rad50 and Nbs1. Chromatin immunoprecipitation (ChIP) 
analysis used to examine protein recruitment at sites of DSBs discovered that Mre11 binding 
is rapid and is distributed within 10 kb of the break, while being most concentrated in the first 
2 kb (Shroff et al., 2004). This is a crucial event in the DSB response, highlighted by the fact 
that functional MRN is required for efficient ATM kinase activation (Uziel et al., 2003, You 
et al., 2005). 
In addition to being an early sensor of DSBs, MRN is often considered to be a keystone 
complex as it connects multiple cellular pathways including DNA damage checkpoint 
signalling, DNA repair and telomere maintenance (Williams et al., 2007). Given its diverse 
involvement in the DDR, it is no surprise that this complex is often targeted during viral 
infection and a major focus of this study will concentrate on MRN complex regulation by 
adenoviruses. The three members of the MRN complex each contribute in different ways to 
its function and have very distinct properties as reflected by their domain organization (Fig 
1.9). Inherited mutations in Mre11, Nbs1 and Rad50 genes result in ATLD, NBS and NBS-
like chromosome instability syndromes, respectively, which although are clinically distinct 
all exhibit DNA damage checkpoint defects (Taalman et al., 1983, Stewart et al., 1999, 
Waltes et al., 2009). 
Mre11 is a highly conserved nuclease and phosphoesterase protein. Specifically, it harbours 
dsDNA 3′-to-5′ exonuclease, ssDNA endonuclease, DNA annealing, and unwinding abilities 
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(Paull and Gellert, 1998, Trujillo et al., 1998, Assenmacher and Hopfner, 2004, Williams et 
al., 2008). The Mre11 protein also confers the MRN complexes’ ability to bind DNA through 
two C-terminal DNA-binding domains (DBD; de Jager et al., 2001). Two Mre11 and two 
Rad50 molecules make up the “core” heterotetrameric fraction of the complex which has 
versatile DNA-binding capabilities.  
Rad50 is composed of N- and C-terminal nucleotide binding motifs which dimerize to form a 
bipartite ATP-binding cassette (ABC)-ATPase domain and consequenctly bind and unwind 
dsDNA termini (Hopfner et al., 2000). The central portion of the protein contains a zinc hook 
(CxxC) motif separating a coiled-coil domain to form two flexible “arms” which protrude 
away from the DNA to mediate interactions between DNA termini (de Jager et al., 2001, 
Hopfner et al., 2002). Currently, structural and functional data suggest a model whereby 
Mre11 facilitates short-range tethering of DNA ends, and the long coiled-coil Rad50 “arms” 
enables long-range synapsis of DNA to prevent chromosome separation (Hopfner et al., 
2002, Williams et al., 2008). 
While the core MRN complex possesses DNA binding abilities, its final member, Nbs1 
which gives an overall stoichiometry of Mre112Rad502Nbs12, is essential for communicating 
the presence of DNA breaks to the rest of the checkpoint machinery. Nbs1 is eukaryotic 
specific and directly binds Mre11 and ATM through distinct motifs within its C-terminal 
region, an interaction required for their recruitment to DNA lesions (Desai-Mehta et al., 
2001, You et al., 2005). Nbs1 itself is also a downstream substrate for ATM-mediated 
phosphorylation which is important for ensuring appropriate checkpoint activation in 
response to DNA damage (Lim et al., 2000, Wu et al., 2000). As mentioned, Nbs1 also has  
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Fig 1.9. Linear representation of Mre11, Rad50, and Nbs1 proteins 
 
Large coloured boxes indicate catalytic domains within Mre11, Rad50 and Nbs1 
while arrows and small coloured boxes indicate the location of known binding 
motifs (Lamarche et al., 2010). 
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N-terminal FHA and BRCT domains which mediate the phospho-dependent interactions 
necessary for recruiting repair and checkpoint proteins to DNA damage foci (Lukas et al., 
2004, Chapman and Jackson, 2008, Lloyd et al., 2009). 
 
1.2.7 Mediator proteins 
Mediator proteins are a class of proximal checkpoint regulators that play important roles in 
amplifying, and maintaining, the cellular responses which are signalled by ATM and ATR. 
This group of proteins includes 53BP1, BRCA1, TOPBP1 and MDC1, all of which contain 
BRCT protein-protein interaction domains (Schultz et al., 2000, Yamane et al., 2002, Stewart 
et al., 2003). All of these mediators are phosphorylated by ATM or ATR and act by 
simultaneously associating with DNA damage sensors such as γH2AX, transducers such as 
Chk1 and Chk2, and effectors such as p53 to confer signal transduction specificity at certain 
phases of the cell cycle (Zhang et al., 1998, Schultz et al., 2000, Lukas et al., 2004, Stucki et 
al., 2005). Other mediator proteins include SMC1 (structural maintenance of chromosomes 1) 
and Claspin, the latter of which, along with its requirements for ATR activation, is also 
involved in DNA replication and sensing of replication forks (Yazdi et al., 2002, Liu et al., 
2006, Yoo et al., 2006). 
Mediator proteins often have multiple roles in the DDR. In addition to activating ATR kinase 
activity in response to ssDNA, experiments carried out in Xenopus laevis discovered that in 
response to dsDNA ends TOPBP1 is phosphorylated by ATM to activate ATR in an RPA-
independent manner (Yoo et al., 2007). Moreover, as well as localizing the MRN complex, 
MDC1 is also required to recruit the ubiquitin ligase RNF8 (RING-finger 8) to sites of DNA 
damage (Huen et al., 2007, Mailand et al., 2007). RNF8 mono-ubiquitylates histones H2A 
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and H2AX, and through this higher order chromatin restructuring allows for a second wave 
of protein accumulation including 53BP1 and BRCA1 (Mailand et al., 2007). These 
ubiquitylation modifications are also augmented by another ligase, RNF168 (RING-finger 
168), which recognizes ubiquitylated histones and amplifies the signal by generating lysine 
63-linked poly-ubiquitin chains (Doil et al., 2009, Stewart et al., 2009). Recently another E3 
ubiquitin ligase, HERC2 (HECT domain and RLD 2), was also found to promote H2AX 
poly-ubiquitylation at sites of DNA damage. HERC2 forms a complex with RNF8 to mediate 
its interaction with the E2 enzyme Ubc13 (ubiquitin-conjugating enzyme 13) and to maintain 
levels of RNF168 (Bekker-Jensen et al., 2010). It has also been recently suggested that 
chromatin relaxation occurs in two stages, beginning with γH2AX poly-ubiquitylation and 
the recruitment of sensor proteins, and followed by ubiquitylation of another histone H2B 
(Moyal et al., 2011). ATM-dependent mono-ubiquitylation of H2B by the RNF20-RNF40 E3 
ubiquitin ligase heterodimer is thought to facilitate the recruitment of proteins necessary for 
timely DSB repair (Moyal et al., 2011).  
 
1.2.8 Transducer and effector proteins 
The mechanisms and molecular components involved in checkpoint activation are specific to 
the cell cycle phase and nature of the lesion (Sancar et al., 2004, Zierhut and Diffley, 2008). 
While many of the initial signalling events and sensor and transducer proteins are common to 
all pathways, the effector components of these pathways which actively inhibit phase 
transition give checkpoints their unique properties (Sancar et al., 2004). 
The two key transducers of the DDR are the serine/threonine protein kinases Chk1 and Chk2, 
which are substrate specific and function in different pathways. DSB signals are transduced 
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via ATM-dependent phosphorylation of Chk2, and UV-induced signals are transduced via 
ATR-dependent phosphorylation of Chk1, although as mentioned there is also evidence of 
some overlap and cross-talk between the two pathways (Matsuoka et al., 2000, Zhao and 
Piwnica-Worms, 2001, Gatei et al., 2003). Upon activation, these transducer kinases become 
dissociated from chromatin in order to facilitate signal transmission to multiple soluble 
effector proteins throughout the cell, such as p53 and the CDC25A phosphotyrosine 
phosphatase which are essential regulators of cell cycle progression (Chen et al., 2003, Li and 
Stern, 2005, Smits et al., 2006, Boutros et al., 2007). As mentioned above, the specificity of 
DDR pathways between phases of the cell cycle manifests in the distinctive recruitment of 
these effector proteins, a few of which are discussed below. ATM pathways are activated 
rapidly in response to DNA damage, irrespective of the cell cycle phase, whereas ATR is 
activated more slowly and predominantly only in S or G2 phase cells (Cimprich and Cortez, 
2008). 
The G1/S checkpoint activates two pathways to prevent DNA damaged cells from entering S 
phase by inhibiting the initiation of replication. Initially, activated transducer kinases 
phosphorylate CDC25A targeting it for proteolytic degradation (Falck et al., 2001). This lack 
of active CDC25A results in the accumulation of phosphorylated CDK2 complexes, which 
are unable to facilitate the loading of CDC45 onto the replication origins necessary for DNA 
replication induction (Costanzo et al., 2000). The second series of events is less rapid and 
required for a sustained G1/S arrest. In this pathway the critical effector protein p53 is 
phosphorylated and activated by ATM, both directly and indirectly, allowing it to 
transactivate a number of target proteins (Canman et al., 1998). One such protein is the CDK 
inhibitor p21
WAF1/Cip1 
which binds CDK proteins to inhibit cyclin E-CDK2 and cyclin D-
CDK4 complex formation to obstruct S phase entry (Harper et al., 1993, Bunz et al., 1998, 
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Lavin and Jackson, 1999). In the case of cyclin D-CDK4 dissociation, this is achieved as the 
inactivated complex fails to phosphorylate Rb an event required to release it from E2F to 
initiate transcription (Lin et al., 2001). Both of these pathways are primarily mediated by 
Chk2, however basal Chk1 activity is required for constitutive CDC25A turnover in 
unperturbed cells (Dai and Grant, 2010). 
The intra-S phase checkpoint is activated by DNA damage encountered during S phase, or by 
unrepaired DNA that evaded the G1/S checkpoint and caused a block in replication 
(Paulovich and Hartwell, 1995). The activation of this checkpoint is mediated by two p53-
independent pathways, one of which is synonymous to the CDC25A-CDK2 pathway 
described for the G1/S phase checkpoint, and one involving SMC1 and the Fanconi anaemia 
complementation group D2 (FANCD2) protein (Falck et al., 2001, Xiao et al., 2003, Pichierri 
and Rosselli, 2004). In the second pathway, Nbs1- and BRCA1-dependent phosphorylation of 
SMC1 and FANCD2 leads to replication inhibition supposedly through SMC1 
phosphorylation repressing sister chromatid cohesion; the mechanism behind FANCD2 
repression remains unclear however is thought to involve BRCA1 (Michaelis et al., 1997, 
Lim et al., 2000, Kim et al., 2002, Nakanishi et al., 2002, Xu et al., 2002, Pichierri and 
Rosselli, 2004). Both of these pathways are p53-independent, however recent evidence 
suggests that p53 may be involved in a novel p53-dependent intra-S phase checkpoint 
involving Chk1 which acts to prevent DNA synthesis (Attardi et al., 2004, Ahmed et al., 
2011). 
The function of an activated G2/M checkpoint is to prevent cells from undergoing mitotic 
division in the presence of DNA damage. For this to occur, two parallel pathways are again 
induced both of which require ATM and ATR kinase activity; ATM- and MRN complex-
dependent DSB resection generates ssDNA to recruit ATR (Xu et al., 2002, Carson et al., 
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2003, Jazayeri et al., 2006). The ultimate target of these pathways is the cyclin B-CDK1 
complex which, when dephosphorylated by CDC25A phosphatase, promotes progression into 
mitosis (Coleman and Dunphy, 1994). Initially, Chk1/Chk2-dependent phosphorylation 
inactivates CDC25A to ensure that cyclin B-CDK1 complexes remain phosphorylated and 
cells arrest at the G2/M transition (Peng et al., 1997, Sanchez et al., 1997). The subsequent 
non-essential pathway involves p53 which, through transcriptional induction of CDK 
complex inhibitors such as p21, promotes the maintenance of checkpoint arrest (Lavin and 
Jackson, 1999, Taylor and Stark, 2001). 
 
1.2.9 DNA Repair 
The repair mechanisms signalled by checkpoints to fix DNA damage are also lesion- and cell 
cycle phase-specific, and involve distinct sequences of catalytic events mediated by multiple 
proteins (Sonoda et al., 2006). Indeed, failure to coordinate DNA repair with cell cycle 
progression can lead to genomic instability, cell death and cancer (Branzei and Foiani, 2008).  
In mammalian cells SSBs are restored through base excision repair (BER), a mechanism 
which is initiated by DNA glycosylases and that uses the sister strand as a template to direct 
repair (Sancar et al., 2004). DSBs are predominantly repaired via an illegitimate process 
called non-homologous end-joining (NHEJ), where the two ends of a DSB are ligated 
together without the need for sequence homology between the ends (Sargent et al., 1997). In 
brief, NHEJ involves detection of DSBs by a DNA-dependent protein kinase (DNA-PK) 
complex consisting of the Ku70/Ku80 heterodimer and the DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs), processing of DNA end termini by MRN, Artemis and various 
DNA polymerases, and finally ligation via the XRCC4 (X-ray repair complementing 
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defective repair in Chinese hamster cells 4)/DNA ligase IV complex (Gottlieb and Jackson, 
1993, Lee et al., 1997, Weterings and Gent, 2004, Collis et al., 2005). 
 While NHEJ can repair DNA at every stage of the cell cycle, accurate homologous 
recombination (HR) requires a sister chromatid to serve as a template to copy DNA 
sequences and is therefore restricted to S or G2 phase (Sargent et al., 1997, Sonoda et al., 
2006, Branzei and Foiani, 2008). HR is a multi-step process and although several HR sub-
pathways exist, their initiation is dependent on the MRN complex which functions together 
with the C-terminal binding protein interacting protein (CtIP) to generate ssDNA by the 5’-3’ 
resection of DSBs (Limbo et al., 2007). HR also requires RecQ helicase family members and 
a Rad51 nucleoprotein filament, to facilitate the unwinding of DNA, and catalyse the transfer 
of DNA via a holliday junction which forms between the two sister chromatids, respectively 
(Yu et al., 2001, Hu et al., 2007). 
 
1.2.10 The role of ubiquitin 
Protein ubiquitylation is a post-translational modification that modifies protein function, and 
in doing so regulates many critical cellular pathways including cell cycle progression, cellular 
differentiation, apoptosis and DNA repair (Welchman et al., 2005). Ubiquitin itself is a small 
highly conserved polypeptide that is “ubiquitously” expressed in eukaryotic organisms and 
targets an exponentially growing list of cellular proteins including tumour suppressors, 
growth modulators and transcriptional activators (Ciehanover et al., 1978, Wilkinson et al., 
1980, Weissman, 2001). 
While ubiquitin modifications encompass vast functional diversities, one major role is the 
targeting of proteins, including misfolded proteins, for degradation by a multi-subunit ATP-
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dependent protease termed the proteasome (Thrower et al., 2000, Glickman and Ciechanover, 
2002, Xie, 2010). 
Ubiquitylation, as illustrated in Figure 1.10 is a multistep process resulting in the covalent 
attachment of ubiquitin onto target proteins, and involves the activity of at least three types of 
enzyme: the E1 ubiquitin-activating enzyme, the E2 ubiquitin-conjugating enzyme and the E3 
ubiquitin ligase (Hershko et al., 1983, Welchman et al., 2005). Initially, free ubiquitin is 
activated by ATP-dependent adenylation allowing thioester bonds to form between the 
activated ubiquitin and the active site of the E1 enzyme. A trans-thiolation reaction then 
conjugates the modified ubiquitin onto the E2 enzyme which is able to associate with an E3 
enzyme; which may or may not already have the substrate bound (Weissman, 2001). The 
final step in this reaction is the transfer of ubiquitin onto the amino group of the substrate 
(often a lysine residue) via an isopeptide bond in a process that depends on the E3 enzyme. 
 E3 ubiquitin ligase enzymes are highly diverse and are divided into two main classes that are 
characterized by the presence of either a HECT (homologous to the E6-AP carboxyl 
terminus) or RING (really interesting new gene) domain (Al-Hakim et al., 2010). For HECT 
E3 ubiquitin ligases, ubiquitin is first transferred onto the HECT domain before being passed 
onto the substrate, while RING E3 ubiquitin ligases act as scaffold proteins and facilitate the 
transfer of ubiquitin directly from the E2 to the substrate (Al-Hakim et al., 2010). It should 
also be noted that ubiquitylation is a dynamic and reversible process, and numerous de-
ubiquitylating (DUBs) enzymes also exist in the cell to catalyse the hydrolysis of ubiquitin-
substrate bonds (Wilkinson, 2000). 
The fate of ubiquitin-tagged proteins is dependent on the type of linkage. For example, a 
single protein can be modified on more than one lysine residue and this can be either by a 
single ubiquitin molecule (mono-ubiquitylation) or a chain of ubiquitin molecules linked via 
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lysine residues (poly-ubiquitylation). There are seven lysine residues within ubiquitin that can 
potentially be linked to form poly-ubiquitin chains, each of which assigns a different 
function. Chains comprising of four or more K48-linked ubiquitin molecules target the 
conjugated substrate to the 26S proteasome for degradation, while amongst other processes, 
K63-linkages are vital for the regulation of DNA repair (Spence et al., 1995, Thrower et al., 
2000). Indeed, in conjunction with phosphorylation, the importance of ubiquitylation in the 
cellular DDR is become increasingly evident with a growing number of E3 ubiquitin ligases 
being identified including RNF8, RNF186 and HERC2 which promote the sustained 
recruitment of downstream checkpoint and repair proteins at sites of damage (Huen et al., 
2007, Mailand et al., 2007, Stewart et al., 2009, Bekker-Jensen et al., 2010).  
Several multi-subunit E3 ubiquitin ligases also exist in eukaryotic cells, including the 
SCF
Fbw7 
(Skp/cullin/F-box) and the APC/C (anaphase promoting complex/cyclosome) 
complexes which control cell cycle checkpoints by targeting cyclins and other proteins for 
degradation (Busino et al., 2003, Peschiaroli et al., 2006, Peters, 2006). These complexes are 
characterized by the presence of a catalytic RING finger protein, an adaptor protein, a 
substrate recognition protein and a cullin (or cullin-like) scaffold subunit (Zheng et al., 2002, 
Peters, 2006). In addition to checkpoint regulation, cullin-based E3 ubiquitin ligase 
complexes have also been found to facilitate the degradation of viral substrates. The nature of 
this regulation with regards to Ad infection will be discussed later in this Chapter.  
Although less significant to the current study, it should also be noted that in addition to 
phosphorylation and ubiquitylation, other post-translational modifications such as acetylation, 
methylation, SUMOylation and neddylation are also utilised to regulate protein function in 
the DDR (Oberle and Blattner, 2010). 
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Fig 1.10. The ubiquitin system 
 
Ubiquitylation is a process whereby ubiquitin is covalently attached to target 
proteins by a hierarchical set of three enzymes. The E1 enzyme catalyses the 
ATP-dependent activation of ubiquitin and transfers it to the E2 ubiquitin 
conjugating enzyme. This complex then associates with the E3 ubiquitin ligase 
enzyme which attaches ubiquitin to a lysine residue in the target protein via one 
of two mechanisms. RING domain E3 ubiquitin ligases directly transfer ubiquitin 
from the E2 to its substrate, while the active-site of HECT domain E3 ubiquitin 
ligases must first associate with ubiquitin before transferring it to the substrate. 
Ub, ubiquitin (adapted from Di Fiore et al., 2003). 
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1.3 REGULATION OF THE CELLULAR DNA DAMAGE RESPONSE DURING 
ADENOVIRUS INFECTION 
1.3.1 Concatemerization of Ad genomes 
Adenoviruses have been known to affect many cellular processes to ensure their own 
integrity, namely by evading the host cell’s immune response and apoptotic programmes. In 
more recent history, research has shown that in order to ensure monomeric Ad genomes 
remain intact and replication efficient, they must also circumvent the host cell’s DDR. It is 
suggested that upon entry of Ad linear dsDNA into cells the terminal portions of this 
“foreign” DNA are recognised by the DDR as DSBs; at late times of infection the cell can be 
presented with as many as 100 000 of these Ad dsDNA ends (Weitzman and Ornelles, 2005). 
If unsuppressed, this recognition would lead to a cascade of signalling events and the 
recruitment of sensor, mediator, transducer and effector proteins necessary to elicit a DDR 
and process or repair the DNA ‘break’. Therefore, adenoviruses have developed to interact 
with the cellular DDR apparatus in order to over-ride this obstacle and establish a productive 
infection. 
The first indication of this came from observations of Ad5 mutant viruses harbouring 
deletions in the E4 region (dl366 and dl808). Infections with these viruses resulted in the 
formation of large concatemers of viral DNA as visualized by pulsed field gel electrophoresis 
(PFGE; Weiden and Ginsberg, 1994). Concatemers are covalently linked monomers of DNA 
which are joined by no specific orientation i.e. junctions can consist of head-to-head, head-to-
tail or tail-to-tail joints (Weiden and Ginsberg, 1994). Since ITRs containing the viral origins 
of DNA replication are lost in this linkage process, concatemers are often described as dead-
end molecules unable to replicate. Furthermore, this cumulative effect results in Ad DNA 
being too large to be packaged within the viral capsid (Bett et al., 1993). 
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As direct ligation of viral genomes, and the presence of large deletions at these junctions, 
during E4 mutant virus infection implied that the DDR and NHEJ pathways are targeted by 
proteins encoded by the E4 region, later studies addressed the role of specific DNA repair 
factors in the formation of Ad concatemers. In 2002, Stracker et al. carried out important 
studies using an Ad5 mutant virus, dl1004, which lacked the entire E4 region. dl1004 was 
defective for DNA replication and late protein synthesis, and upon DNA analysis by PFGE it 
was clear that this was due to the formation of viral concatemers (Stracker et al., 2002). The 
authors then went on to investigate the importance of the core components of the NHEJ 
pathway on viral concatemer formation using mutant cell lines that fail to express Mre11 
(ATLD), DNA-PKcs (MO59J) and DNA ligase IV (180BRM). Significantly, they found that 
these mutant cell lines were capable of rescuing the concatemer phenotype observed during 
dl1004 infection, suggesting that Mre11, DNA-PKcs and DNA ligase IV are important for 
concatemer formation and likely to be inactivated during wild-type (wt) Ad infection 
(Stracker et al., 2002). In contrast, the dl1004 mutant phenotype was not rescued in A-T cells 
which lack a functional ATM protein, suggesting that ATM is not required for 
concatemerization (Stracker et al., 2002). Continuing studies from the same laboratory also 
determined that the MRN complex is required for ATM and ATR activation in response to 
DNA damage, since dl1004 infection activated cellular DDR pathways, while wt Ad infection 
did not (Carson et al., 2003). 
E4 mutant viruses are defective for DNA replication and late protein synthesis, but until 2008 
it was unclear if this was indeed a consequence of DDR signalling and concatemer formation. 
Using the E1B55K R240A mutant protein and H354 insertion mutant protein, which both 
induce DNA ligase IV degradation and prevent concatemer formation, it was found that only 
R240A (which degrades the MRN complex) promoted Ad replication (Lakdawala et al., 
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2008). In addition, Ad concatemer formation was prevented by treating A-T cells with 
caffeine to inhibit ATM and ATR signalling, although the defective replication of dl1004 was 
not rescued. This suggested that DDR pathway activation and concatemer formation does not 
inhibit viral DNA replication, and rather it is a direct consequence of MRN activity 
(Lakdawala et al., 2008). 
 
1.3.2 Adenoviral proteins target cellular proteins for degradation 
As alluded to above, Ad oncoproteins target cellular substrates for destruction via the 
ubiquitin-dependent proteasome-mediated pathway. Ubiquitylation (as previously described; 
Fig 1.10) is an enzymatic process whereby the small, highly conserved regulatory protein 
ubiquitin is conjugated to a substrate through covalent linkage of a lysine residue 
(Ciehanover et al., 1978, Wilkinson et al., 1980). This often leads to substrate degradation via 
the 26S proteasome which is a major protease complex composed of one 20S core cylinder 
particle, and two regulatory cap-shaped 19S particles (Wilkinson et al., 2000, Xie, 2010). The 
26S proteasome is involved in the ATP- and ubiquitin-dependent degradation of regulatory 
and abnormal proteins within the cell, and has important roles in cell cycle regulation and 
cellular immune and stress responses (Xie, 2010).  
The current study focuses on the impact Ad infection has on RING E3 ubiquitin ligases, 
however there is some evidence to suggest that penton base proteins of adenoviruses can 
interact with HECT E3 ubiquitin ligases, presumably to modulate viral internalization 
(Galinier et al., 2002). One class of multi-subunit RING E3 ubiquitin ligases are the cullin-
based E3 ubiquitin ligases (CRLs; Zheng et al., 2002, Peters, 2006). CUL1 was the first 
cullin protein to be identified in 1996 and since then six further members have been 
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discovered (CUL2, 3, 4A, 4B, 5 and 7), along with two proteins which contain a cullin 
homology domain (APC2 and PARC/CUL9; Kipreos et al., 1996, Yu et al., 1998, Petroski 
and Deshaies, 2005, Skaar et al., 2007). To date Ad oncoproteins are known to influence 
CUL1-, CUL2- and CUL5-based E3 ubiquitin ligases, as well as the APC/C which is another 
multi-subunit RING E3 ubiquitin ligase (Querido et al., 2001, Turnell et al., 2005, Isobe et 
al., 2009). Indeed, via its ability to bind p300/CBP, E1A interferes with the activity of the 
APC/C in order to regulate mitotic progression and/or promote genomic instability and 
cellular transformation (Turnell et al., 2005). Ad E1A can also attenuate the activity of the 
SCF
Fbw7
 complex by directly binding to its CUL1 component. This complex is usually 
involved in cell cycle control and signal transduction, thus presumably it is deregulated by 
Ad to aid unrestrained proliferation (Isobe et al., 2009). 
Of importance to the work described here is the effect Ad infection has on CUL2- and CUL5-
based E3 ubiquitin ligases. Cellular complexes containing these scaffold proteins also include 
a heterodimeric Elongin BC adaptor complex which links CUL2 and CUL5 to the substrate 
recognition receptor boxes VHL (von Hippel-Lindau) and SOCS (suppressor of cytokine 
signalling), respectively (Kamura et al., 2004, Mahrour et al., 2008). Other members of the 
cullin family utilise different substrate receptors (Petroski and Deshaies, 2005)  
The catalytic E3 ubiquitin ligase activity of the RING domain (often known as RBX1 or 
ROC1) is bound to a C-terminal cullin-homology domain in all CRLs, and is controlled by 
the covalent attachment of NEDD8 (neural precursor cell-expressed developmentally down-
regulated 8) in a process known as neddylation; indeed, NEDD8 attachment is a prerequisite 
for the E3 ubiquitin ligase activity of these complexes (Petroski and Deshaies, 2005, Duda et 
al., 2008). NEDD8 is a member of the ubiquitin-like protein family, and as such its linkage is 
analogous to ubiquitylation involving its own E1, E2 and E3 enzymes (Pintard et al., 2003). 
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Furthermore, its conjugation is reversible and while NEDD8 attachment to a cullin protein is 
thought to induce CRL activity through conformational alterations, deneddylation has the 
reverse effect (Duda et al., 2008).  
The two major negative regulators of CRLs are CAND1 (cullin-associated and neddylation-
dissociated) and the COP9 signalosome (CSN). The CSN possess isopeptidase 
metalloprotease activity to remove NEDD8 from cullin proteins causing CRL deactivation 
through entry into the CAND1 cycle (Lyapina et al., 2001, Cope et al., 2002). CAND1 binds 
only to CRLs lacking both neddylation and adaptors, and actively blocks cullin neddylation 
conjugation and adaptor protein binding sites (Min et al., 2003). The purpose of this 
regulation and relationship to CSN regulation is uncertain, however it is likely to impact CRL 
complex stability and E3 ubiquitin ligase function (Bosu and Kipreos, 2008). 
Adenoviruses were first found to interact with cullin members in 2001, when an 
Ad5E1B55K/E4ORF6 complex was discovered to essentially hijack CUL5- RBX1- and 
Elongin BC-containing E3 ubiquitin ligase complexes in order to ubiquitylate p53 (Querido 
et al., 2001, Blanchette et al., 2004). In this instance it was the viral protein E1B55K that 
formed the substrate recognition subunit rather than the cellular SOCS-box, while E4ORF6 
directly bound the Elongin BC unit via one of its three BC box motifs (Blanchette et al., 
2004, Luo et al., 2007). Other Ad serotypes have evolved different methods of inhibiting p53 
and other cellular proteins. Indeed, our laboratory has previously shown that Ad12 utilises a 
CUL2-based CRL to induce the degradation of p53 (Blackford et al., 2010). 
Not surprisingly there are a growing number of cellular proteins (particularly those involved 
in the DDR) that are being identified as Ad E1B55K/E4ORF6 substrates. As described, 
Mre11 and DNA ligase IV inactivation is also driven by E1B55K/E4ORF6-dependent 26S 
proteasome degradation, however, the specific E3 ubiquitin ligases responsible for this 
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remains a matter of dispute in the literature (Stracker et al., 2002, Baker et al., 2007, Cheng 
et al., 2011; more detail to follow in Chapter 5). It is suggested that input viral DNA is 
sufficient to induce DDR pathways since MRN complex inactivation occurs prior to viral 
DNA accumulation (Karen et al., 2009). In addition, DNA ligase IV is also dissociated from 
the XRCC4 complex by E4ORF6 in an E1B55K-independent manner prior to degradation to 
prevent the NHEJ of viral genomes (Jayaram et al., 2008).  
As mentioned, the potent ATR activating protein TOPBP1 is also degraded by Ad12 via 
CUL2-mediated ubiquitylation to circumvent ATR activation and inhibit Chk1 
phosphorylation, interestingly however, this process is Ad12E1B54K-independent and 
wholly reliant on Ad12E4ORF6 (Blackford et al., 2010). This suggests that Ad12E4ORF6 
has the capacity to independently behave as both a substrate recognition unit and as an 
adaptor linker protein (Blackford et al., 2010). 
Another component of the DDR, Bloom helicase (BLM), is also degraded by Ad5 in an 
E1B55K/E4ORF6- and CUL5-dependent manner (Orazio et al., 2011). BLM is a RecQ DNA 
helicase and has been previously implicated in DNA end resection, however the functional 
relevance of this Ad-induced degradation remains unknown since HeLa-shBLM cells 
revealed that BLM is not responsible for concatemer formation (Gravel et al., 2008, Orazio et 
al., 2011). 
The multifunctional death domain-associated protein (Daxx) has also recently been identified 
as an Ad5 substrate and is degraded by the 26S proteasome at late time points (Schreiner et 
al., 2010). In contrast to other Ad substrate degradation mechanisms, Ad5E4ORF6 is 
dispensable for Daxx depletion while Ad5E1B55K is suggested to establish a CUL5-based 
CRL through a highly conserved BC box motif. Ad5 infections in a Daxx knockdown cell 
line resulted in increased viral progeny and early viral protein production, suggesting that 
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Daxx may impact upon transcriptional repression during the early phase of infection 
(Schreiner et al., 2010). 
In addition to intracellular proteins, the Ad5E1B55K/E4ORF6 CRL complex has also been 
shown to degrade the cell surface protein integrin alpha 3, presumably to either prevent re-
infection or to promote the release and spread of progeny virions (Dallaire et al., 2009b). This 
degradation is almost absolute 16 hours post-infection (identical to Mre11) and was shown to 
be mediated by a CUL5-based CRL. Interestingly, integrin alpha 3 also acts as an alternative 
cellular receptor to facilitate internalization of Ad5 particles by endocytosis, and the onset of 
its degradation shows correlation with cell detachment from the extracelluar matrix (Salone et 
al., 2003, Dallaire et al., 2009b). During Ad5 infection, CUL5-based viral CRLs are also 
necessary for the stimulation of late viral protein synthesis by preventing dsRNA-dependent 
protein kinase (PKR) activity towards the translation factor eIF2α (eukaryotic initiation factor 
2 alpha), and by stimulating viral nuclear mRNA export (Woo and Berk, 2007, Spurgeon and 
Ornelles, 2009). 
Taken together the current literature suggests that different Ad serotypes have evolved 
varying mechanisms to degrade a broad spectrum of cellular proteins and to evade the host 
cell’s DDR and NHEJ pathways. 
 
1.3.3 E4ORF3 promotes the relocalization of cellular proteins 
In addition to proteasomal degradation, cellular proteins are also inhibited by relocalization 
within the cell in order to negate DDR pathways. For instance, E4ORF3 has the capacity to 
restructure the nucleus and cytoplasm of infected cells and relocalize the tumour suppressors 
p53 and PML into nuclear track structures (Carvalho et al., 1995, Konig et al., 1999). The 
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basis of this remains elusive, however recent evidence suggests that immobilization of p53 in 
this manner prevents p53-DNA binding (Soria et al., 2010). Other proteins that associate with 
PODs and are degraded by adenoviruses, are similarly relocalized by E4ORF3 during Ad5 
infection; however they have been described as separable events from PML reorganization 
(Konig et al., 1999, Araujo et al., 2005, Stracker et al., 2005). These proteins include the 
MRN complex which associates with PODs in response to IR, and Daxx whose 
transcriptional repression activity is thought to be inhibited by PML association (Li et al., 
2000, Mirzoeva and Petrini, 2001, Stracker et al., 2005). The cellular localization of DNA 
ligase IV during Ad infection has yet to be determined. 
MRN complex relocalization from the nucleoplasm into nuclear tracks by E4ORF3 is 
uncoupled from PML reorganization, and is thought to facilitate its degradation during Ad 
infection (Evans and Hearing, 2005, Stracker et al., 2005). Furthermore, in Ad5E1B55K 
transformed cells, and partially during Ad infection, Mre11 can also be found localized with 
E1B55K at centrosomes in cytoplasmic inclusion bodies called aggresomes (Araujo et al., 
2005). Aggresomes are juxtanuclear establishing when aggregated proteins are transported by 
the motor protein, dynein, along microtubules towards the centrosome and can be formed by 
the individual expression of E4ORF3 or E1B55K (Garcia-Mata et al., 2002). These structures 
are scarce in normal cells but are believed to function as sites for rapid proteasomal 
degradation during times of cellular stress (such as viral infection, heat shock and chemical 
treatment) as they amass misfolded proteins and are enriched in components of the ubiquitin-
proteasome pathway (Garcia-Mata et al., 2002). Studies have shown that 8 hours post-Ad5 
infection Mre11 is immobilized into nuclear tracks, while 24 hours post-infection it is 
relocalized in an E4ORF3-dependent manner into E1B55K-containing aggresomes, which 
coincides with Mre11 degradation (Araujo et al., 2005, Liu et al., 2005). The direct binding 
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partner for E4ORF3 within the MRN complex has yet to be determined, although Nbs1 is 
dispensable for E4ORF3 to relocalize Rad50 and Mre11 (Araujo et al., 2005). The same 
scenario of relocalization also contributes to the inactivation of p53 during Ad5 infection, 
suggesting that adenoviruses exploit cellular aggresome formation in order to disrupt the 
restrictive effects of cellular DDR machinery on virus growth (Liu et al., 2005). 
This process differs in cells infected with Ad4 and Ad12 viruses where, although Mre11 is 
still degraded, their E4ORF3 proteins lack the key isoleucine residue necessary for its ability 
to relocalize Mre11 into nuclear track structures. As a consequence, Mre11 does not localize 
to nuclear tracks but instead accumulates in nuclear viral replication centres (VRCs) where it 
could potentially cause problems for the virus by activating the DDR (Stracker et al., 2005, 
Carson et al., 2009). Therefore, to impede ATR signalling Ad12 has evolved to also induce 
the degradation of TOPBP1 (Blackford et al., 2010). 
Relocalization into nuclear tracks during Ad infection is not the fate for all POD components. 
Indeed, TOPBP1 and BLM which associate with PODs in response to IR, are found at VRCs 
during Ad infection (Zhong et al., 1999, Xu et al., 2003, Stracker et al., 2005, Blackford et 
al., 2010). Although the significance of this relocalization is currently unknown, it is 
presumed that their residence at VRCs is not detrimental to viral DNA replication.  
While the main objective of Ad is to ensure productive viral DNA replication by evading the 
cellular DDR, other key proteins of the pathway remain stable. For instance 53BP1, MDC1, 
BRCA1, ATRIP and the PIKK family members ATM, ATR and DNA-PK are not degraded 
by adenoviruses and reside in VRCs during Ad5 infection, albeit transiently in some cases 
(Carson et al., 2003, Mathew and Bridge, 2007). However, while H2AX is phosphorylated 
during Ad infection (suggesting some early DDR activation) the kinase activities of PIKKs 
are blocked through Mre11 and TOPBP1 degradation (Carson et al., 2003, Carson et al., 
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2009). During Ad12, but not Ad5, infection ATR-dependent phosphorylation of RPA and 
Rad9 is also evident, however Chk1 phosphorylation is absent (Blackford et al., 2010). This 
further confirms that E4ORF6-induced TOPBP1 degradation prevents full ATR activation 
during Ad12 infection, while during Ad5 infection ATR activation is inhibited through 
combined Mre11 degradation and relocalization. 
In addition to the ability of adenoviruses to circumvent the DDR to promote their own 
replication, E4ORF3 is also able to prevent ATR-dependent DNA damage signalling induced 
by non-viral sources (Carson et al., 2009). Indeed, in Ad5E4ORF3 transfected cells MDC1 is 
localized to sites of UV damage, while the MRN complex remains in nuclear tracks. This 
immobilization is sufficient to inhibit ATR-dependent events such as RPA phosphorylation 
(Carson et al., 2009). 
 
1.3.4 Regulation of the cellular DNA damage response by other viruses 
The role of DDR pathways during viral infection has received growing interest in recent 
years and is an evolving branch of cellular defence research. There are now a large number of 
viral proteins from an array of viruses that are known to interact with the DDR machinery, to 
either exploit or counter the effects of DDR pathways.  
The circular HPV dsDNA virus is another example where cellular DDR pathways are 
deregulated during infection. This is achieved through the degradation of p53 and through the 
inhibition of the DNA single-strand break repair protein XRCC1 (Scheffner et al., 1993, 
Iftner et al., 2002). In contrast to Ad infection, epithelial differentiation by HPV has also 
been shown to activate the ATM pathway as ATM-dependent phosphorylation events are 
necessary to promote viral genome amplification (Moody and Laimins, 2009). 
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Interestingly, some viruses have also been shown to require, utilise and exploit DDR 
pathways to aid viral growth. The herpes simplex virus (HSV), for example, has evolved 
complex mechanisms to promote the efficient replication of its linear dsDNA genome, and its 
impact on the cellular DDR is multi-faceted. Indeed, DDR proteins such as ATM, ATR and 
53BP1 are recruited to sites of HSV DNA replication possibly through ICP0, a viral E3 
ubiquitin ligase protein. ICP0 has been shown to degrade the cellular histone ubiquitin 
ligases, RNF8 and RNF168, to promote mobilization of the repair proteins listed above 
(Lilley et al., 2010). The recruitment of these proteins to replication compartments benefits 
HSV, as ATM-dependent Chk2 phosphorylation and checkpoint activation is required for 
viral growth, and recent evidence has suggested that the presence of ATR/ATRIP may also 
promote viral gene expression and virus production (Li et al., 2008, Mohni et al., 2010). In 
contrast to this, other DDR proteins such as DNA-PK and Ku70 are targeted by ICP0 for 
proteasomal degradation, presumably to inhibit NHEJ (Parkinson et al., 1999). 
Replication of SV40 is also dependent on the ability of the SV40 large tumour antigen (TAg) 
to exploit the DDR by promoting ATM and ATR kinase activity (Shi et al., 2005, Rohaly et 
al., 2010). DDR proteins, including the MRN complex and components of the Fanconi 
anemia pathway, are also recruited to VRCs where they are suspected to play an active role in 
SV40 DNA replication (Boichuk et al., 2010). Akin to Ad proteins, TAg has also been shown 
to induce the proteolysis of Mre11 at late times during infection, however its role in SV40 
infection is unknown (Zhao et al., 2008). RNA viruses are also known to trigger DDR 
signalling pathways. Indeed, the HIV-1 accessory protein Vpr (viral protein R) induces G2 
arrest, and triggers the phosphorylation of repair proteins by activating the ATR kinase (Lai 
et al., 2005). This induction is thought to be mediated through the DNA damage-binding 
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protein 1 (DDB1)-CUL4A E3 ubiquitin ligase complex which promotes the degradation of 
unidentified cellular substrates (Belzile et al., 2010). 
Together, these viruses serve as powerful tools for molecular biology purposes and have been 
integral in unravelling the complex nature of genome maintenance as they often induce 
signalling through the same cellular cascades. Furthermore, understanding the relationship 
between the DDR and viral infections has offered insights into viral pathology and may 
generate ideas for the development of antiviral drugs. 
 
1.4 The TRIM family of proteins 
1.4.1 TRIM proteins 
Members of the TRIM (RBCC) family of proteins are characterized by an N-terminal 
tripartite motif which contains a RING finger moiety, one or two zinc-binding motifs named 
B-boxes, and a coiled-coil domain which is necessary for oligomerization and association 
with subcellular structures (Reymond et al., 2001, Meroni and Diez-Roux, 2005). The 
functional significance of B-box domains is poorly understood, however some evidence 
suggests that they may be important for the formation of cytoplasmic bodies and for higher-
order oligomerization (Diaz-Griffero et al., 2009). To date there are 75 members in this 
multi-domain protein family and recent genomic analysis suggests that they can be divided 
into two groups based on domain structure, genome organization and evolutionary properties 
(Sardiello et al., 2008). Group 1 TRIM members contain a variety of C-terminal domains and 
are highly conserved, while group 2 members are less conserved and contain a C-terminal 
SPRY (splA/ryanodine receptor) domain (Sardiello et al., 2008).  
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A key feature of most TRIM proteins is their N-terminal RING domain implying a role for 
these proteins in ubiquitylation (Fig 1.10). Indeed, TRIM proteins have the potential to 
operate as single protein RING finger E3 ubiquitin ligases to mediate the direct transfer of 
ubiquitin from E2 enzymes to substrates. This has been demonstrated for several TRIM 
proteins where, through ubiquitylation and subsequent proteasomal degradation, they can 
mediate the expression of proteins involved in cell cycle regulation and cytokine signalling 
(Toniato et al., 2002, Urano et al., 2002). Although the role of TRIM protein C-terminal 
regions in ubiquitylation is unclear, data suggest that besides the RING finger, N-terminal B-
box and coiled-coil domains may be responsible for substrate binding (Meroni and Diez-
Roux, 2005). 
TRIM proteins are involved in an array of biological processes ranging from apoptosis to 
transcriptional control and cell cycle regulation and as a consequence, when compromised, 
are also implicated in a variety of human pathologies including cancer (Meroni and Diez-
Roux, 2005). Several TRIM proteins including TRIM1, TRIM5α, TRIM19 (PML), TRIM22 
and TRIM30 are also implicated in the cellular response to viral infection where they often 
interfere with the virus replicative cycle (Nisole et al., 2005).  
 
1.4.2 The TIF1 family 
In addition to TRIM proteins being divided into two groups, they are also further divided into 
11 highly homologous subfamilies (Carthagena et al., 2009). One such family is the 
transcriptional intermediary factor 1 (TIF1) family which contains four members in 
mammals: TIF1α (TRIM24), TIF1β (TRIM28), TIF1δ (TRIM66) and TIF1γ (TRIM33; 
Figure 1.11). Besides containing the N-terminal tripartite motif (TRIM/RBCC), TIF1 proteins 
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also harbour C-terminal plant homeobox (PHD) and bromodomains (BRD), and a unique 
TIF1 signature sequence (TSS) which is likely to participate in TIF1 dependent repression 
(Venturini et al., 1999). The presence of PHD and BRD motifs is characteristic of proteins 
known to function at the chromatin level. Indeed, previous studies have demonstrated that in 
TIF1α these domains mediate nucleosome interactions, possibly through hydrophobic bonds 
between PHD motifs and the alkyl groups of unmodified histones (Remboutsika et al., 2002, 
Slama and Geman, 2010, Tsai et al., 2010). PHD motifs are also highly reminiscent of RING 
fingers and while they have not been directly implicated in ubiquitylation, the PHD motif of 
TIF1β determines its activity as an E3 SUMO ligase and is required for SUMOylation of 
itself (auto-SUMOylation) and other substrates such as MDM2 (Wang et al., 2005, Ivanov et 
al., 2007, Zeng et al., 2008).  
Akin to the domain homology witnessed between TIF1 family members, each of these 
proteins have demonstrated, or have the potential, to function as regulators of transcription 
(although the genes they regulate are somewhat variable). TIF1α, TIF1β and TIF1δ have all 
been shown to interact with, and phosphorylate, members of the heterochromatin protein 1 
(HP1) family though PxVxL motifs to promote silencing on euchromatic genes (Nielsen et 
al., 1999, Khetchoumian et al., 2004). TIF1α and TIF1β also function as co-repressors when 
tethered to DNA thorough interactions with the widely distributed transcriptional silencing 
KRAB (Krüppel-associated box) domain of the Krüppel-like protein KOX1 (Friedman et al., 
1996, Kim et al., 1996, Le Douarin et al., 1998). In addition, TIF1α has exclusively been 
found to mediate the transactivaton of a host of nuclear receptors including retinoid X (RXR), 
retinoic acid (RAR), vitamin D3 (VDR), oestrogen (ER) and progesterone (PR) receptors         
which are ligand-dependent  transregulators that are capable of controlling  gene  expression  
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Fig 1.11. Linear representation of the TIF1 family of proteins 
 
Coloured boxes correspond to the conserved domains of the TIF1 isoforms α, β, δ 
and γ: RING finger (yellow), B-boxes 1 and 2 (pink), coiled-coil (blue), TIF1 
signature sequence (TSS), heterochromatin protein 1 (HP1) and nuclear receptor 
interaction (NRID) domains (green), plant homeobox domain (PHD; red) and 
bromodomain (BRD; purple). 
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(Le Douarin et al., 1996, Zhong et al., 1999). The clinical significance of TIF1 proteins is 
also highlighted by the fact that TIF1β and TIF1γ deficiencies in mice are embryonically 
lethal, and while TIF1α is not essential for embryogenesis it is a potent liver-specific tumour 
suppressor (Cammas et al., 2000, Khetchoumian et al., 2007, Kim and Kaartinen, 2008, 
Morsut et al., 2010). Furthermore, a recent study in mice discovered that besides TIF1α, 
hepatocellular carcinoma (HCC) formation is also promoted by the inactivation of TIF1β and 
TIF1γ, demonstrating that TIF1 proteins can also interact physically and functionally 
(Herquel et al., 2011). In contrast to its tumour suppressive properties, TIF1α is reportedly 
overexpressed in breast cancer where it aberrantly regulates ERα-mediated transcriptional 
activation leading to cellular proliferation and neoplasia in breast cells (Tsai et al., 2010). 
 
1.4.3 TIF1γ 
Low-stringency hybridization screens identified TIF1γ as the third member of the TIF1 
family (Venturini et al., 1999). Although it was not implicated in nuclear receptor 
transactivation or found to associate with either KOX1 or the HP1 family, it nevertheless 
exhibited a strong silencing activity when tethered to a promoter (Venturini et al., 1999). 
Subsequent studies prompted by the Chernobyl disaster of 1986, discovered that thyroid 
papillary carcinomas (TPC) can be caused by defects in TIF1γ (Klugbauer and Rabes, 1999). 
More specifically, a chromosomal rearrangement occurs where the N-terminal portion of 
TIF1γ becomes fused to the tyrosine kinase domain of the RET (rearranged during 
transfection) proto-oncogene, forming a RET fused gene (RFG) which inappropriately 
activates tyrosine kinase activity and other protein functions (Klugbauer and Rabes, 1999). 
Recently, TIF1γ has also been identified as a tumour suppressor in the haematological 
malignancy chronic myelomonocytic leukemia (CMML) where it is downregulated by 
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hypermethylation of its gene promoter, and pancreatic ductal adenocarcinoma (PDAC) where 
it is thought to cooperate with the KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene 
homolog) oncogene (Vincent et al., 2009, Aucagne et al., 2011).  
Studies into the transcriptional activities of TIF1γ have discovered that it can function as both 
a repressor and de-repressor of gene transcription. Indeed, through TRIM domain 
interactions, TIF1γ forms hetero-oligomers with TIF1α where it is hypothesised to partially 
relieve TIF1α-mediated repression of nuclear receptors (Peng et al., 2002). TIF1γ also has an 
imperative role in the transforming growth factor beta (TGF-β) signalling pathway. TGF-β is 
a multi-functional cytokine that controls cellular proliferation, differentiation and 
homeostasis, and is often referred to as a tumour suppressor due to its antiproliferative 
properties during early tumour development and the fact that TGF-β pathway components are 
frequently mutationally inactivated in cancer (Derynck et al., 2001, Tian et al., 2011). In 
contrast however, a growing amount of evidence indicates that TGF-β can also promote 
processes that support tumour progression, such as angiogenesis and metastasis, suggesting a 
dual role for the cytokine (Pepper, 1997, Blobe et al., 2000, Tian et al., 2011). 
Canonical TGF-β signalling is initiated by TGF-β binding, and activating, serine/threonine 
protein kinase receptors which leads to phosphorylation of the R-SMADS (small and mothers 
against decaplentaplegic-related), SMAD2 and SMAD3 (Massague et al., 2005). Once 
activated, R-SMADS form heterodimeric complexes with the common mediator SMAD4 
which then collectively enters the nucleus to regulate the expression of various genes 
(Massague et al., 2005). TIF1γ has been shown to regulate this pathway by antagonizing the 
transcription of TGF-β responsive genes and there are two proposed mechanisms of how this 
is achieved. In the first model, Ectodermin (Xenopus homolog to TIF1γ) directly constrains 
SMAD4-dependent TGF-β signalling in embryonic development where it limits the 
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responsiveness of Nodal, a TGF-β superfamily ligand, by functioning as an E3 ubiquitin 
ligase to promote SMAD4 monoubiquitylation on lysine residue 519 (Dupont et al., 2005, 
Morsut et al., 2010). This modification disassembles R-SMAD-SMAD4 transcriptional 
complexes and promotes the relocalization of SMAD4 from the nucleus into the cytoplasm, 
where it is degraded by the proteasome (Dupont et al., 2005). There is also evidence to 
suggest that SMAD2 forms a trimeric complex with TIF1γ and SMAD4 to modulate this 
monoubiquitylation (Dupont et al., 2009). 
In contrast, the second model found no evidence of TIF1γ-mediated SMAD4 ubiquitylation 
or degradation, and instead found that TIF1γ acts as a negative regulator of SMAD4 by 
competing with it to interact with activated R-SMADS (He et al., 2006). This association is 
proposed to stimulate erythroid differentiation of haematopoietic stem cells (HSC), as 
SMAD4 association inhibits their proliferation (He et al., 2006). It is of course possible that 
SMAD4 regulation by TIF1γ varies depending on the cellular context (i.e. embryonic or 
haematopoietic cells). In addition, the zebrafish TIF1γ homolog which is encoded by the 
moonshine (mon) gene is considered essential for embryonic and adult haematopoiesis as 
mutations in mon result in anaemia (Ransom et al., 1996, Ransom et al., 2004). This was 
recently attributed to TIF1γ/mon regulating the transcriptional elongation of erythroid genes 
by linking positive elongation factors to blood-specific transcription complexes (Bai et al., 
2010). 
 
1.4.4 TIF1α  
As described above TIF1α possesses E3 ubiquitin ligase activity. This function is involved in 
p53 regulation where, together with the UbcH8 E2 ubiquitin conjugating enzyme, the RING 
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domain of TIF1α targets p53 for degradation and therefore acts as a negative regulator of 
p53-dependent pathways (Allton et al., 2009). This is further highlighted by the fact that 
siRNA mediated knockdown of TIF1α in human tumour-derived cells, and mutations of the 
TIF1α homolog, bonus, in Drosophila, cause unrestrained p53 activity and spontaneous 
apoptosis (Allton et al., 2009). Given the multiple roles of TIF1α, it is possible that this 
protein may lie at an intersection between signalling pathway networks regulated by p53 
and/or nuclear receptors. Consequently, TIF1α has been suggested to be a therapeutic target 
to restore tumour suppression by p53, which is reflected by a recent finding that TIF1α 
overexpression in breast cancer is associated with poor prognosis and survival (Chambon et 
al., 2011). 
TIF1β (also known as Krüppel-associated box [KRAB] domain-associated protein 1; KAP1) 
has also been shown to repress apoptotic pathways. Firstly by cooperating with MDM2, 
TIF1β promotes p53 ubiquitylation and degradation which stimulates p53–HDAC1 (histone 
deacetylase 1) interactions and p53 deacetylation (Wang et al., 2005). And secondly by 
inhibiting the activity of the E2F1 transcription factor, in a pRb-independent manner, TIF1β 
stimulates E2F1-HDAC1 interactions and E2F1 deacetylation (Wang et al., 2007).  
 
1.4.4 Viral interactions with TRIM proteins 
A growing number of TRIM proteins are believed to exhibit antiviral properties. The most 
documented of these proteins is PML (TRIM19) which has been shown to impair virus 
replication by sequestering viral proteins, inhibiting the synthesis of viral mRNA and 
inducing p53-dependent apoptosis. Thus, in addition to the aforementioned regulation by 
adenoviruses, at least 10 other DNA or RNA viruses have evolved various strategies to 
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abrogate the antiviral capacity of PML (Carvalho et al., 1995, Geoffroy and Chelbi-Alix 
2011). 
The initial observation that PML is disrupted during virus infection came from Maul et al. in 
1993. This paper reported that during HSV-1 infection, PML became redistributed in the 
nucleus by the immediate early gene 1 product, ICP0, which was later discovered to induce 
the proteasomal-degradation of PML via its function as an E3 ubiquitin ligase (Maul et al., 
1993, Chelbi-Alix and de Thé, 1999). E6 and E7 HPV oncoproteins have also been reported 
to promote PML degradation during infection in order to prevent growth arrest and perturb 
transcriptional activation of p53 (Bischof et al., 2005, Louria-Hayon et al., 2009). Like 
adenoviruses, many other DNA viruses including the human cytomegalovirus (HCMV), 
KSHV, and EBV disorganize PML to evade cellular resistance mechanisms (Maul et al., 
1993, Adamson and Kenney, 2001, Kang et al., 2006, Louria-Hayon et al., 2009). PML is 
also active against RNA virus replication. Indeed, the pre-integration complex (PIC) of HIV-
1 triggers the rapid and transient, exportin-mediated relocalization of PML into the 
cytoplasm, however this mechanism remains controversial (Turelli et al., 2001). 
Numerous other TRIM family members have also been discovered to exhibit antiviral 
activities. Indeed, one systematic screen of 55 TRIM proteins identified 20 which had 
antiviral activities towards HIV-1, murine leukemia virus (MLV) and avian leukosis virus 
(ALV) by affecting viral entry or release (Uchil et al., 2008). During HIV-1 infection, 
TRIM5α, TRIM11 and TRIM31 were found to restrict virus entry, TRIM22 and TRIM32 
attenuated transcription of the HIV-1 long terminal repeat (LTR) transcriptional promoter, 
and TRIM25, TRIM31 and TRIM62 inhibited virus release from cells (Tissot and Mechti, 
1995, Stremlau et al., 2004, Uchil et al., 2008). The antiviral properties of TRIM5α, the 
largest isoform of the TRIM5 gene, have received much interest in recent years in relation to 
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MLV and HIV-1 infection. Initial reports indicated that the C-terminal SPRY domain of 
TRIM5α was sufficient to cause HIV-1 restriction, however recent data suggest partial 
involvement of the proteasome system (Yap et al., 2005, Campbell et al., 2008). In addition, 
the ability of TRIM5α to obstruct HIV-1 infection in the cytoplasm at the 
postentry/preintegration phase by disrupting the uncoating of the viral capsid, has made it an 
attractive target in the development of gene therapy vectors for the treatment of AIDS 
(Anderson et al., 2009).  
The transcriptional repressor properties of TIF1β have also been implicated in the antiviral 
response of cells infected with MLV and KSHV. During MLV infection, TIF1β is required 
for the primer binding site-dependent restriction of virus replication in embryonic stem and 
embryonic carcinoma cells (Wolf and Goff, 2007). While KSHV has been found to silence 
gene expression, and maintain a state of latency, by exploiting the chromatin remodelling 
functions of TIF1β. In this model, the switch from viral latency to lytic replication during 
KSHV infection is mediated via the viral protein kinase (vPK)-dependent phosphorylation of 
TIF1β which causes a decrease in TIF1β SUMOylation and consequently in its ability to 
condense chromatin on viral promoters (Chang et al., 2009). In addition, TIF1β has been 
reported to associate with the E8-E2C HPV gene during the inhibition of transcription and 
DNA replication, and with the EBV origin, oriLyt, during lytic DNA replication (Liao et al., 
2005, Ammermann et al., 2008). 
Of great significance to the current study is research carried out by Yondola and Hearing in 
2007 who used a proteomic approach to identify novel cellular proteins that interact with the 
Ad E4ORF3 protein. Through mass spectrometry the authors identified TIF1α as a putative 
binding partner and successfully confirmed a direct interaction both in vivo and in vitro. This 
finding was particularly noteworthy because, unlike previously identified E4ORF3-binding 
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proteins, TIF1α was not found to be degraded by the 26S proteasome however it was 
relocalized into PML-containing nuclear tracks (Yondola and Hearing, 2007). Indeed, it was 
discovered that TIF1α relocalization was dependent on Ad E4ORF3 targeting the N-terminal 
TRIM domain of the protein which possesses E3 ubiquitin ligase activity, however the 
significance of this interaction was undetermined. 
The authors did however speculate that Ad-mediated relocalization of TIF1α may cooperate 
with E4ORF3 in the activation of the glucocorticoid nuclear receptor which, amongst others, 
regulates genes controlling the immune response (Wienzek and Dobbelstein, 2001, Teyssier 
et al., 2006, Yondola and Hearing, 2007). Furthermore, the transcriptional nature of TIF1α 
suggests a possible role for the protein in the activation of viral gene expression, or equally 
suggests that sequestration by E4ORF3 prevents TIF1α from regulating cellular gene 
expression. While the functional consequence of the interaction between E4ORF3 and TIF1α 
remains elusive, due to its conserved nature among all serotypes so far investigated it is likely 
to be of critical importance to Ad infection. 
While other members of the TIF1 family are yet to be implicated in Ad infection, it is 
interesting to note that several cellular process involving TIF1β and TIF1γ are abrogated 
during Ad infection such as the DDR and TGF-β signalling, respectively (Tarakanova and 
Wold, 2003, Weitzman et al., 2010).  
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2.1 TISSUE CULTURE TECHNIQUES 
2.1.1 Cell lines 
The cell lines used throughout this study are summarised in Table 2.1 below. 
 
Table 2.1. Human cell lines used in this study. 
Cell Line Cell Type Source Origin 
Culture 
Medium 
ATCC
®
 
Number 
A549 epithelial 
small cell lung 
carcinoma 
human DMEM CCL-185 
H1299 epithelial 
large cell lung 
carcinoma 
human DMEM/puro CRL-5803 
H1299 
shCUL5 
epithelial 
large cell lung 
carcinoma 
human DMEM/puro 
(Cheng et al., 
2007) 
HEK293 epithelial 
embryonic 
kidney 
human RPMI CRL-1573 
HeLa epithelial 
cervical 
carcinoma 
human DMEM CCL-2 
HER10 epithelial 
embryonic 
retinoblast 
human RPMI 
(Grabham et 
al., 1988) 
 
 
2.1.2 Cell culture media  
Cell lines were maintained in either DMEM (Dulbecco’s modified Eagle’s medium) or RPMI 
(Roswell Park Memorial Institute) medium (both Invitrogen) supplemented with 2 mM L-
glutamine and 8% foetal calf serum (FCS; Invitrogen) and stored at 4 °C.  H1299 cells were 
supplemented with 5 μg/ml puromycin (puro) which was removed prior to viral infection.  
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2.1.3 Maintenance and passage of cell lines 
All tissue culture techniques were carried out in specialised flow hoods under sterile 
conditions. Cell passage involved removing existing medium, washing twice with phosphate 
buffered saline (PBS), adding 1 ml of trypsin (Invitrogen) per dish and incubating at 37 °C 
for 5 minutes. Culture medium was then added to completely detach cells, which were then 
pelleted by centrifugation at 428 x g for 5 minutes. Pellets were resuspended in fresh medium 
pre-warmed to 37 °C, and re-plated at a calculated dilution before being transferred to 
humidified incubators set at 37 °C and supplied with 5% CO2. 
 
2.1.4 Cryopreservation of cell lines 
Cells were trypsinised and pelleted, as detailed above, and resuspended in 10% of the 
cryoprotectant dimethyl sulphoxide made up in DMEM or RPMI supplemented with 8% 
(v/v) FCS. Aliquoted cells were cooled gradually to -80 °C in isopropanol overnight and 
subsequently transferred for long term storage in liquid nitrogen tanks at -180 °C. When 
required, cells were rapidly thawed to 37 °C, pelleted, washed once with the appropriate 
culture medium and resuspended in fresh culture medium. 
 
2.2 CELL BIOLOGY TECHNIQUES 
2.2.1 Viruses 
Ad3, Ad4, Ad5, Ad7, Ad11 and Ad12 wt viruses were either obtained from the American 
Type Culture Collection (ATCC) or were a gift from Prof. Joe Mymryk (University of 
Western Ontario, Canada). Ad9 was a kind gift from Prof. Ronald Javier (Baylor College of 
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Medicine, Texas). Several Ad5 and Ad12 mutant viruses were also used in this study. Ad5 
dl1520 is an E1B55K-null virus generated by deletional mutagenesis, with two stop codons at 
nucleotides 3 and 3336 and a deletion from nucleotides 2496 to 3323 (Barker and Berk, 
1987). Ad5 dl355 is an E4ORF6-null virus which lacks 14 base pairs (bp) between 
nucleotides 2331 and 2346 (Halbert et al., 1985). Ad5 dlH5pm4155 was a kind gift from 
Prof. Thomas Dobner (HPI, University of Hamburg, Germany) and contains two separate 1 
bp deletions which result in the knockout of E4ORF3 and E4ORF6 (Forrester et al., 2011). 
The two Ad12E1B54K-null viruses used in this study were dl620 and hr703 which contain an 
in-frame deletion in the large E1B open reading frame from nucleotides 2129 to 2825 and a 
point mutant-derived stop codon, respectively (Byrd et al., 1988). 
 
2.2.2 Viral infections 
Prior to infection cells were grown to 80% confluency and washed twice in DMEM without 
FCS. Viruses were applied at a multiplicity of infection (MOI) of 20 and diluted in DMEM 
without FCS before being added to 6 cm or 10 cm tissue culture dishes, or directly applied 
onto individual wells of glass multispot microscope slides (Hendley-Essex). Infected cells 
were incubated at 37 °C with agitation every 15 minutes. After 2 hours, virus-containing 
medium was removed and replaced with fresh culture medium supplemented with 8% (v/v) 
FCS. 
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2.2.3 RNA interference (RNAi) 
Individual control small-interfering RNAs (siRNAs) and individual specific siRNAs targeting 
CUL1, CUL3, CUL4A, CUL4B, CUL7, TIF1α and TIF1γ gene expression are shown in Table 
2.2. CUL2 and CUL5 were silenced using SMARTpool siRNAs where four separate pools of 
siRNA are combined to increase silencing and reduce off-target activities. 
 
Table 2.2. siRNAs used in this study. 
Target siRNA Sense sequence Supplier 
control/non-
silencing 
AllStars Proprietary Qiagen 
CUL1 s16054 5’ CCGUCAGAGUUGGAACGUAtt 3’ Ambion 
CUL2 SMARTpool 
5’ GGAAGUGCAUGGUAAAUUU 3’ 
5’ CAUCCAAGUUCAUAUACUA 3’ 
5’ GCAGAAAGACACACCACAA 3’ 
5’ UGGUUUACCUCAUAUGAUU 3’ 
Dharmacon 
CUL3 s16050 5’ CCAGCGUAAGAAUAACAGUtt 3’ Ambion 
CUL4A s16045 5’ GGUUUAUCCACGGUAAAGAtt 3’ Ambion 
CUL4B s16044 5’ GAAGCUAUUCAGAAUAGUAtt 3’ Ambion 
CUL5 SMARTpool 
5’ GACACGACGUCUUAUAUUA 3’ 
5’ GCAAAUAGAGUGGCUAAUA 3’ 
5’ UAAACAAGCUUGCUAGAAU 3’ 
5’ CGUCUAAUCUGUUAAAGAA 3’ 
Dharmacon 
CUL7 s18991 5’ CCACUUUUGAGCAUUAUUAtt 3’ Ambion 
TIF1α s16786 5’ CGACUGAUUACAUACCGGUtt 3’ Ambion 
TIF1γ Custom 5’ CCUGCAUCUAGAAAGUGAAtt 3’ Ambion 
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siRNA transfection was carried out in both HeLa and H1299 cell lines. 40 x 10
4
 cells were 
plated into 6 cm tissue culture dishes 24 hours prior to transfection in DMEM supplemented 
with 8% (v/v) FCS. The following day the transfection reagent Oligofectamine (OF; 
Invitrogen) was used to deliver siRNA duplexes into cells at 40% confluency as follows. Per 
dish, 20 μl of OF was added to 80 μl of Opti-MEM (Invitrogen) and left in a tube for 5 
minutes, after which time 8.5 μl of the appropriate siRNA (40 M) and 350 μl of Opti-MEM 
was added to the OF mixture. OF-siRNA complexes were left to form at room temperature 
for 20 minutes; during which time the cells to be transfected were washed twice with Opti-
MEM pre-warmed to 37 °C. Finally OF-siRNA complexes were added to plated cells with a 
further 1 ml of Opti-MEM and incubated for 4-6 hours at 37 °C. After this time transfection 
medium was removed and replaced with fresh DMEM supplemented with 8% (v/v) FCS and 
returned to a humidified incubator at 37 °C for 72 hours. Where appropriate cotransfections 
were carried out with two siRNA molecules. As, and when required, cells were infected with 
virus 24 hours post-RNAi treatment. 
 
2.2.4 Transient DNA transfections 
The following plasmids were used in this study: pCS2 TIF1γ, wt and mutant, which were 
FLAG-tagged and a kind gift from Prof. Stefano Piccolo (Dupont et al., 2005); pCMV-
Ad5E4ORF3; pCMV-Ad5E4ORF6; pXC15-Ad5E1B55K; pcDNA3Ad12E4ORF3; 
pcDNA3Ad12E4ORF6; pcDNA3Ad12E1B54K. All adenovirus constructs were HA-tagged. 
Plasmid DNA was introduced into HeLa cells using a calcium phosphate transfection 
protocol. 80 x 10
4
 cells were plated into 6 cm tissue culture dishes 24 hours prior to 
transfection in DMEM supplemented with 8% (v/v) FCS. The following day a solution 
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containing 22 μl CaCl2, 5 μg DNA and 157 μl H2O was added drop wise into a tube 
containing 180 μl of 2x HEPES buffered saline (HBS) pH 7.0 (50 mM HEPES [4-(2-
hydoxyethyl)piperazine-1-ethanesulfonic acid], 280 mM NaCl, 1.5 mM Na2HPO4[7H2O]). 
This transfection medium was left at room temperature for 30 minutes to allow the formation 
of calcium-DNA precipitate, which was subsequently directly added drop wise and evenly 
onto plated HeLa cells at 90% confluency. Transfected cells were then incubated at 37 °C and 
harvested at the appropriate times. TIF1γ transfections were carried out 48 hours prior to Ad 
infection, and where indicated cotransfections were carried out with two DNA plasmids. 
 
2.2.5 Drug treatments 
Following Ad infection, and where indicated, cells were treated with 10 μM of the 
proteasome inhibitor MG132 (N-carbobenzoxy-L-leucinyl-L-leucinyl-L-leucinal), 30 μM of 
the DNA damaging agent HU, 5 mM of the ATR kinase inhibitor caffeine or 20 μM of the 
CDK kinase inhibitor roscovitine (all Sigma-Aldrich). All drugs were solubilized in DMSO, 
except for HU which was solubilized in water. Mock treated cells were treated with 
solubilizing liquid alone. 
 
2.2.6 IR and UV irradiation 
HeLa cells were either mock-irradiated or irradiated from a 137Cs ionizing γ-ray source at a 
dose rate of 2.5 Gy/minute and left to recover for 1 hour. In the case of UV treatment, prior to 
UV irradiation cells were washed with PBS and mock-irradiated or irradiated with a 25 J/m2 
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dose of UV light from a 254 nm UV light source, after which the culture medium was 
replaced. 
 
2.3 PROTEIN BIOCHEMISTRY TECHNIQUES 
2.3.1 Preparation of whole cell lysates 
Cell lysates were prepared by initially removing culture medium and washing twice in ice-
cold saline. Samples were lysed and harvested by scraping in a denaturing buffer (9 M urea, 
50 mM Tris-HCl [pH 7.3], 150 mM β-mercaptoethanol). Lysed cells were collected and 
sonicated twice for 15 seconds on ice and subsequently centrifuged for 20 minutes at 16 000 
x g to remove cell debris. The supernatant was then removed with a syringe into new sample 
tube ready for use or storage at -80 °C. 
 
2.3.2 Quantification of protein concentration 
Protein concentrations were determined by Bradford assay (Bio-Rad) using six bovine serum 
albumin (BSA) standards at known dilutions ranging from 0 - 50 μg/ml made up in deionised 
H2O; 10 μl of each standard was added to 4 wells of a flat bottomed 96 well microplate. 
Typically, 5 μl of each prepared protein lysate was then added to 45 μl of deionised H2O and 
10 μl of this mixture was also added to 4 wells of a flat bottomed 96 well microplate. 200 μl 
of Bradford reagent (Bio-Rad) diluted 1:4 with deionised H2O was then added to each 
standard and sample well and gently mixed by pipetting. Finally absorbance readings were 
determined using a microplate reader (Bio-Rad) at 595 nm and sample concentrations were 
calculated by generation of a standard curve. 
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2.3.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Clarified cell lysates were separated based on their molecular weight by SDS (sodium 
dodecyl sulphate)-PAGE. Polyacrylamide gels were made using a stock 30% (w/v) 
Acrylamide/Bis solution (Severn Biotech Ltd) diluted with deionised H2O to the appropriate 
percentage (8% or 12% depending on molecular weight of the protein) in the presence of 100 
mM Tris, 100 mM Bicine, 0.1% (w/v) SDS and 0.3% (v/v) N,N,N’,N’ -
tetramethylethylenediamine-1,2-diamine (TEMED). Acrylamide polymerisation was initiated 
by the addition of ammonium persulphate (APS) to a final concentration of 0.06% (v/v). Gel 
assembly was carried out according to the manufactures’ instructions (Hoeffer Scientific) and 
run in a buffer containing 100 mM Tris, 100 mM Bicine and 0.1% (v/v) SDS. Protein cell 
lysate (50 μg) or Protein G-Sepharose beads were denatured by the addition of Laemmli 
Sample Buffer (Bio-Rad) and incubation at 90 °C for 5 minutes. Denatured samples were 
then loaded into gels along with pre-stained protein molecular weight markers (Fermentas) 
using a long syringe (Hamilton). Gels were then run overnight at a constant current 
depending on the molecular weight of the protein of interest. 
 
2.3.4 Staining of polyacrylamide gels 
Following electrophoresis, gels were placed in a staining solution containing 0.1% (v/v) 
Coommassie Brilliant Blue G-250 (Sigma-Aldrich), 1.6% (v/v) orthophosphoric acid, 8% 
(w/v) ammonium sulphate and 20% (v/v) methanol in deionised H2O and agitated at room 
temperature for 10 minutes. Destaining was carried out in 10% (v/v) glacial acetic acid and 
20% (v/v) methanol made up in deionised H2O until protein banding was visible.  
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2.3.5 Preparation of proteins for analysis by mass spectrometry 
Protein bands detected by Coomassie Brillaint Blue G-250 staining were excised under sterile 
conditions using a scalpel blade. Excised bands were then washed twice in 400 μl of 50% 
(v/v) acetonitrile and 50 mM ammonium bicarbonate by agitation for 45 minutes at 37 °C. 
The wash buffer was then removed and the proteins were reduced for 1 hour at 56 °C in 250 
μl of 50 mM dithiothrietol (DTT) made up in 10% (v/v) acetonitrile and 50 mM ammonium 
bicarbonate. The supernatant was then removed and replaced with 50 μl of an alkylating 
solution containing 200 mM iodoacetamide, 10% (v/v) acetonitrile and 50 mM ammonium 
bicarbonate in which samples were incubated at room temperature for 30 minutes in the dark. 
Samples were then washed 3 times in 10% (v/v) acetonitrile and 40 mM ammonium 
bicarbonate by agitation for 15 minutes at room temperature, and dried in a DNA mini 
centrifugal evaporator (Heto Holten) for 1 hour.  
Proteins were digested by rehydration in 20 μl of 12.5 μg/ml modified trypsin (Sigma-
Aldrich) which cleaves C-terminal to arginine and lysine residues. Following a 1 hour 
incubation at room temperature, 20 μl of 10% (v/v) acetonitrile and 40 mM ammonium 
bicarbonate was added to the trypsinized sample and left to incubate with agitation overnight 
at 37 °C. The next day the supernatant was removed and stored in a specialised mass 
spectrometry tube. The digested proteins in the remaining gel slice were then twice eluted 
with 40 μl of 3% (v/v) formic acid, 10% (v/v) acetonitrile and 40 mM ammonium 
bicarbonate for 30 minutes at room temperature with agitation before the supernatant was 
added to the mass spectrometry tube. Finally, the resulting peptides were then separated using 
an AmaZon ion trap electron-transfer dissociation (ETD)-enabled mass spectrometer 
(Bruker), and processed and analysed by the ProteinScape central bioinformatic platform 
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(Bruker). Mass spectrometric separation and analysis of peptides was provided as an internal 
service by Ashley Martin and Neil Shimwell. 
 
2.4 IMMUNOCHEMISTRY TECHNIQUES 
2.4.1 Antibodies 
All antibodies used in this study are described in Table 2.3. 
 
Table 2.3. Antibodies used in this study. 
Antigen Antibody Origin Use Supplier Reference 
Ad12E1A M13 Mouse  WB, IF Ed Harlow 
Harlow et 
al., 1985 
Ad12E1B54K XPH9 Mouse 
WB, IF, 
IP 
In-house 
Merrick et 
al., 1991 
Ad5E1A M73 Mouse WB Ed Harlow 
 Harlow et 
al., 1985 
Ad5E1B55K 2A6 Mouse  
WB, IF, 
IP 
Arnold Levine 
Sarnow et 
al., 1982b 
Ad5E4ORF3 6A11 Mouse WB, IF 
Thomas 
Dobner 
Nevels et al., 
1999 
Ad5E4ORF6 RSA1 Mouse WB, IF 
Thomas 
Dobner 
Marton et 
al., 1990 
ATR N-19 Goat WB Santa Cruz - 
Chk1 G-4 Mouse WB Santa Cruz - 
CUL1 105781 Rabbit WB Gene Tex - 
CUL2 Ab1870 Rabbit WB Abcam - 
CUL3 111274 Rabbit WB Gene Tex - 
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CUL4A 113876 Rabbit WB Gene Tex - 
CUL4B 113875 Rabbit WB Gene Tex - 
CUL5 a302-173a rabbit  WB Bethyl - 
CUL7 109785 Rabbit WB Gene Tex - 
Cyclin E M-20 Rabbit WB Santa Cruz - 
Daxx M1/2 Mouse WB Santa Cruz - 
DNA ligase IV LIGIV Rabbit WB  
Stephen 
Jackson 
Critchlow et 
al., 1997 
Flag Anti-Flag M2 Mouse  WB, IF Stratagene - 
H2AX 07-627 Rabbit WB Millipore - 
HA 
Anti-HA 
12CAS 
Mouse WB, IF Sigma-Aldrich - 
MDM2 2A10 Mouse WB Arnold Levine 
Chen et al., 
1993 
Mre11 12D7 Mouse WB, IF GeneTex - 
NBS1 1C3 Mouse WB GeneTex - 
p21 DCS60 Rabbit WB Cell Signalling - 
p53 DO-1 Mouse WB, IF David Lane 
Vojtĕsek et 
al., 1992 
p-Chk1 S345 133D3 Rabbit WB Cell Signalling - 
PML PG-M3 Mouse IF Santa Cruz - 
PML H-238 Rabbit IF Santa Cruz - 
p-RPA S468 a300-245 Rabbit  WB Bethyl - 
p-TIF1β S824 5824 Rabbit WB Bethyl - 
pRB RB1 Mouse WB 
Fitzgerald 
Industries 
- 
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2.4.2 Immunoprecipitation 
Cells cultured in a 10 cm diameter tissue culture dish were harvested by washing twice in ice 
cold saline and subsequently solubilized in 1 ml of immunoprecipitation (IP) buffer 
containing 20 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid 
(EDTA), 1% (v/v)  Nonidet P-40, 25 mM NaF and 25 mM β-glycerophosphate. For 
immunoprecipitations carried out for mass spectrometric analysis, the IP buffer used 
additionally contained 1 mM Na3VO4 to act as a phosphatase inhibitor. Cell lysates were then 
homogenized twice with 10 strokes while being kept on ice and centrifuged at 16 000 x g for 
RPA32 Ab-2 Mouse IF Calbiochem - 
RPA32 ab10359 Rabbit IF Abcam - 
TIF1α A300-815A Rabbit WB, IF Bethyl - 
TIF1β A300-274A Rabbit WB, IF Bethyl - 
TIF1γ 197 Rabbit 
WB, IF, 
IP  
In-house 
Sedgwick 
and Turnell, 
unpublished  
TOPBP1 (5H)52 Rabbit WB, IF Ian Morgan 
Boner et al., 
2002 
β-actin AC-74 Mouse WB Sigma-Aldrich - 
γ-H2AX JBW301 Mouse WB, IF Millipore - 
Mouse IgG 
Anti-mouse-
HRP 
Goat WB Dako - 
Rabbit IgG 
Anti-rabbit-
HRP 
Swine WB Dako - 
Rabbit IgG 
Alexa Fluor® 
555 anti-rabbit 
Goat IF Invitrogen - 
Mouse IgG 
Alexa Fluor® 
488 anti-mouse 
Goat IF Invitrogen - 
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30 minutes at 4 °C. Supernatant was then removed from cell debris using a syringe and the 
appropriate antibodies were added to samples to form antigen-antibody complexes at 4 °C 
overnight with rotation. After this time 40 μl of Protein G-Sepharose beads (Sigma-Aldrich) 
were added to all samples to capture and isolate immune complexes for 2 hours at 4 °C with 
rotation. The beads were then washed five times by centrifugation at 800 x g in ice cold IP 
buffer, eluted in 30 μl of Laemmli sample buffer (Bio-Rad) and ran on SDS-PAGE gels for 
Western blotting.  
 
2.4.3 Western blotting 
Following separation by SDS-PAGE, proteins where transferred onto a nitrocellulose 
membrane (PALL) using a Hoeffer Scientific transfer system. Briefly, gels were placed onto 
nitrocellulose membranes pre-soaked in blotting buffer (50 mM Tris, 190 mM glycine, 20% 
(v/v) methanol) and sandwiched between two pieces of 3MM blotting filter paper (Whatman) 
and two blotting sponges. These were then placed in plastic cassettes and slotted into the 
blotting tank (Hoeffer Scientific). The electro-transfer was set at 280 mA and continued for 
approximately 6 hours, after which time the membrane was placed in a staining solution 
containing 0.1% (w/v) Ponceau S (Sigma-Aldrich) and 3% (w/v) trichloroacetic acid for 2 
minutes and rinsed with deionised water several times to detect protein bands. The stain was 
then removed by washing with 0.1% (v/v) Tween 20 in Tris-buffered saline (TBS) containing 
150 mM NaCl and 20 mM Tris-HCl (TBST) pH 7.3. 
Nitrocellulose membranes were blocked in 5% (w/v) dried milk powder in TBST for 45 
minutes at room temperature with agitation, and subsequently washed in TBST. Membranes 
were often trimmed down to the approximate size of the protein of interest and blot sections 
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were incubated overnight with antibodies made up in TBST containing 5% (v/v) milk at 4 °C 
with agitation. The following day, membranes were washed four times in TBST and 
incubated with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody 
(Dako) made up in TBST containing 5% (v/v) milk at room temperature for 2 hours with 
agitation. Finally, membranes were washed four times in TBST and antigens were detected 
using enhanced chemiluminescence (ECL) reagents (GE Healthcare) and autoradiography 
film (Kodak). 
 
2.4.4 Immunofluorescence 
Cells were grown on glass 12-well multispot microscope glass slides (Hendley-Essex) at 
densities of 2 x 10
4
 cells/well. Slides were gently washed twice in PBS, and prepared by 
treatment in ice cold pre-extraction buffer (10 mM PIPES [piperazine-N,N′-bis(2-
ethanesulfonic acid)] pH 6.8, 20 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 0.5% (v/v) 
Triton X-100) for 5 minutes, and fixing in 4% (w/v) paraformaldehyde in PBS for 10 
minutes. Following three PBS washes, cells were blocked in 10% (v/v) FCS in PBS for 1 
hour at room temperature. Primary antibodies were diluted with 8% (v/v) FCS in PBS and 
incubated on cells for 1 hour at room temperature, after which time slides were washed three 
times in PBS and incubated for a further hour at room temperature in the dark with 
fluorescent Alexa Fluor® secondary antibodies (Invitrogen) diluted with 8% (v/v) FCS in 
PBS. Finally slides were washed three times in PBS and mounted in Vectashield mounting 
medium (Vector Laboratories) containing 4’,6-diamidino-2-phenylindole (DAPI), and 
protected with 20-70 mm glass coverslips (Menzel-Gläser). 
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Cells were viewed using a LSM 510 META confocal laser scanning microscope (Carl Zeiss) 
equipped with a 364 nm UVA laser and two visible laser lines (488 and 543 mn). Typically a 
40x oiled objective was utilised with each channel (laser) set to an equal optical slice and a 
pinhole diameter of approximately 1 Airy unit. Final 8 bit images at 1024 pixels of resolution 
were acquired using a scan speed of 6 and a scan average of 4 to achieve a high resolution 
image with a good signal-to-noise ratio. These images were then imported into a Zeiss LSM 
image browser for formatting. 
 
2.4.5 Irradiation-induced DNA damage 
DNA damage was induced in cells following a protocol published by Kruhlak and colleagues 
in 2009. Cells were grown to 70% confluency in chambered coverglass dishes (Thermo 
Scientific) and pre-sensitized at 37 °C with 7.5 μg/ml of the DNA binding dye Hoechst 33342 
(Sigma-Aldrich) in phenol red-free DMEM microscopy medium containing 2 mM L-
glutamine and 25 mM HEPES (Gibco)  for 30 minutes. Pre-sensitized cells were then rinsed 
once in, and supplemented with, 400 μl of microscopy medium not containing the Hoechst 
dye. Irradiation was carried out using a LSM 510 Meta confocal laser scanning microscope 
(Carl Zeiss) equipped with a 364 nm UVA laser and temperature controlled chamber pre-
heated to 37 °C. Briefly, the configurations used included a 50% UVA laser output, a scan 
speed of 7 and 10 iterations of the region of interest (ROI). Following UVA treatment, cells 
were harvested and immunofluorescence was carried out as described in section 2.4.4. A 
comprehensive protocol for this technique was reported previously (Kruhlak et al., 2009). 
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2.5 MOLECULAR BIOLOGY TECHNIQUES 
2.5.1 Preparation of DNA for pulsed field gel electrophoresis (PFGE) 
DNA for PFGE was prepared from Ad infected HeLa cells according to the manufacturer’s 
instructions (Bio-Rad) and as described previously (Formstone et al., 1993). Forty-eight 
hours post-infection cells were trypsinized, pelleted and washed twice in PBS before being 
resuspended in PBS at a concentration of 2 x 10
7
 cells/ml. A 1% (w/v) solution of InCert 
agarose (Bio-Rad) in PBS was prepared and cooled to 45 °C. Equal volumes of the cell 
suspension and InCert agarose were mixed to give a final concentration of 1 x 10
7
 cells/ml, 
and 200 μl of this mixture was immediately decanted into plug moulds (Bio-Rad) which were 
left to set at 4 °C for 30 minutes. After the plugs had set they were carefully removed and 
immersed in filtered NDS lysis buffer (1% [w/v] N-lauroyl sarcosine, 0.5 M EDTA, 10 mM 
Tris) at pH 9.5, containing proteinase K (1 mg/ml), and left at room temperature for 30 
minutes. They were then incubated at 50 °C overnight. The following day plugs were 
removed into fresh NDS buffer containing proteinase K and incubated for a further 20 hours 
at 50 °C.  They were then rinsed twice for 1 hour in NDS buffer minus proteinase K, and 
stored in fresh NDS buffer at 4 °C until required. 
 
2.5.2 PFGE 
DNA was separated using a contour-clamped homogeneous electric field (CHEF-DR II) 
electrophoresis system (Bio-Rad) which is a hexagonal array of 24 electrodes. 
Electrophoresis was carried out in 2 litres of 0.5 x TBE running buffer (45 mM Tris, 45 mM 
Boric acid, 1 mM EDTA) which was pre-cooled to 4 °C for 1 hour and circulated at a rate of 
1 litre/minute using a circulating pump (Bio-Rad). 1% (w/v) agarose (Bio-Rad) gels made in 
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0.5 x TBE were cast using specialised combs. After the gel had set, sample plugs and lambda 
(λ) ladder standard plugs (Bio-Rad) were loaded into the front of the gel wells and sealed 
using 1% (w/v) InCert agarose. Gels were submerged into the electrophoresis chamber and 
DNA was subjected to PFGE for 22 hours before being stained in 0.5 μg/ml ethidium 
bromide made in 0.5 x TBE for 30 minutes, and then destained in 0.5 x TBE for 1 hour. DNA 
was visualized and digital images were captured using a UV transilluminator with an 
integrated camera (Bio-Rad). 
 
2.5.3 p53 reporter assay 
The effect of infection on p53 transcriptional activity was determined using a dual-luciferase 
reporter assay system (Promega). H1299 cells, which carry a homologous deletion of the p53 
gene, were grown in 6 cm dishes and transfected with the pBK-CMV vector with a p53 
cDNA insert and the PG13-Luc reporter construct which contains p53-binding sites upstream 
of the luciferase gene (both kind gifts from Dr Ester Hammond), together with the control 
Renilla luciferase reporter plasmid pRL-TK (a kind gift from Dr John O’Neil). Transfection 
was performed using Lipofectamine LTX according to the manufacturer’s instructions 
(Invitrogen). After 24 hours cells were Ad infected, harvested after a further 24 hours, and 
lysed using a passive lysis buffer (Promega). The luciferase activity was measured using a 
luminometer according to the manufacturer’s instructions (Promega). 
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2.5.4 Semiquantitative reverse transcriptase PCR (RT-PCR) 
Semiquantitative RT-PCR was carried out in HeLa and A549 cells. Total RNA was extracted 
from cell lysates using the RNeasy mini kit (Qiagen). Total RNA (1 μg) was converted into 
single-strand cDNA using the Reverse Transcriptase System (Promega) and semiquantitative-
PCR was performed using the following primers: p21 forward, 5’-
CGACTGTGATGCGCTAATGG-3’; p21 reverse, 5’-CCGTTTTCGACCCTGAGA-3’; 
gapdh forward, 5’-ACCCCTTCATTGACCTCA-3’; gapdh reverse, 5’-
CAGCGCCAGTAGAGGCAG-3’. Semiquantitative RT-PCR thermal cycler conditions were 
as follows: p21: 1 cycle of 94 
o
C for 3 minutes; 30 cycles of 94 
o
C for 30 seconds, 55 
o
C for 
30 seconds, 72 
o
C for 2.5 minutes followed by a 10 minute extension at 72 
o
C; gapdh: 1 cycle 
of 94 
o
C for 3 minutes; 30 cycles of 94 
o
C for 30 seconds, 58 
o
C for 30 seconds, 72 
o
C for 2.5 
minutes followed by a 10 minute extension at 72 
o
C. 
 
 2.5.5 Agarose gel electrophoresis 
PCR products were analysed by agarose gel electrophoresis. Agarose powder (0.8 g; Sigma-
Aldrich) was dissolved in 100 ml of 1 x TBE buffer (89 mM Tris, 89 mM Boric acid, 2 mM 
EDTA) and heated to boiling point. The agarose was allowed to cool before ethidium 
bromide was added to a final concentration of 0.5 μg/ml. Samples were diluted with 6 x 
loading buffer containing 0.25% (w/v) bromophenol blue and 30% (v/v) glycerol made in a 
10 mM Tris, 1 mM EDTA, (pH 8.0) solution. Samples were then loaded and gel 
electrophoresis was performed in 1 x TBE at 120 V for 30 minutes. DNA was visualized and 
digital images were captured using a UV transilluminator with an integrated camera (Bio-
Rad). 
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ADENOVIRAL SEROTYPES DIFFERENTIALLY 
REGULATE THE DNA DAMAGE RESPONSE 
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3.1 INTRODUCTION 
The introduction of linear double-stranded adenoviral DNA into cells represents a target for 
cellular DDR pathways which recognise viral DNA as DSBs, and it has been determined that 
activation of DDR pathways limit Ad replication. The first evidence for this came from 
observations that infection with Ad5 mutant viruses harbouring deletions in the E4 region 
resulted in the formation of large covalently-linked concatemers of viral DNA (Weiden and 
Ginsberg, 1994).  
In order to identify the cellular proteins involved in concatemer formation, nearly a decade 
later a similar mutant Ad5 E4-deletion virus, dl1004, virus was used to infect human cell 
lines carrying mutations in DNA repair genes (Stracker et al., 2002). This study reported that 
dl1004 infection of Mre11-deficient ATLD cells rescued the concatemer phenotype seen in 
normal fibroblasts, suggesting a role for Mre11 in viral genome concatemerization (similar 
findings were reported for cells lacking DNA-PKcs and DNA ligase IV; Stracker et al., 
2002). As the MRN complex is involved in the activation of the ATM and ATR kinases 
during DNA damage signalling, it was hypothesized that cells infected with the E4 mutant 
virus were unable to inhibit Mre11, such that both ATM and ATR signalling cascades were 
activated leading to viral genome concatemerization (Carson et al., 2003). Further research 
demonstrated members of the MRN complex being relocalized into PML (also known as 
TRIM19)-containing foci adjacent to sites of viral replication (VRCs), and suggested that 
Mre11 degradation by the virus occurs in a proteasome-dependent manner which is mediated 
by a cullin-containing E3 ubiquitin ligase complex (CRL); this process is now known to 
correlate with the onset of viral DNA replication (Mathew and Bridge, 2007). The 
importance of Ad-mediated degradation during Ad infection and the role of E3 ubiquitin 
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ligases in this process are discussed further in this Chapter and also in the Introduction and 
Chapter 5.  
Other components of the DNA repair machinery are also targeted for proteasomal 
degradation by adenoviruses to optimise the cellular environment, including p53, DNA ligase 
IV, TOPBP1, BLM and Daxx (Nevels et al., 1997, Steegenga et al., 1998, Baker et al., 2007, 
Blackford et al., 2010, Schreiner et al., 2010, Orazio et al., 2011). In addition, the Ad5 
coreceptor integrin alpha 3 has also been identified as an Ad5 substrate (Salone et al., 2003, 
Dallaire et al., 2009b). 
In many cases, the degradation of these substrates is preceded by their relocalization by 
E4ORF3 into distinctive nuclear tracks, or for TOPBP1 into VRCs (Blackford et al., 2010). 
Interestingly several reports have observed that nuclear tracks eventually surround sites of 
viral replication during late times of infection (Doucas et al., 1996). Although the 
significance of this is unknown, it may be hypothesized that sequestering proteins into 
nuclear tracks is a mechanism used to prevent cellular proteins from interfering with viral 
DNA replication. Significantly, E4ORF3-induced nuclear tracks also contain PML which in 
unstressed cells is tightly bound to the nuclear matrix in discrete nuclear foci (Carvalho et al., 
1995). In uninfected cells PML-containing nuclear structures are functionally heterogeneous 
and are implicated in many cellular processes including the DDR, transcription, senescence, 
apoptosis and innate immunity (Zimber et al., 2004, Bernardi and Pandolfi, 2007). 
Furthermore they often organize the delivery and storage of proteins essential for these 
processes (Zimber et al., 2004, Bernardi and Pandolfi, 2007). 
During Ad infection, interactions with PML by viral proteins have been linked to oncogenic 
transformation potential (Nevels et al., 1999). It was recently reported that Ad5E1B55K 
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represses p53 through its innate E3 SUMO1 ligase activity, and that this modification is 
carried out within PML nuclear tracks (Muller and Dobner, 2008, Pennella et al., 2010). This 
suggests that the virus may exploit the dynamic nature of PML to promote the inactivation of 
the DDR, however the function of these interesting structures remains largely unknown. 
With advances in proteomic technology many new Ad targets are being identified amongst 
members of the DDR pathways. Recently, our lab identified TOPBP1 as a novel Ad substrate 
which is targeted for ubiquitin-dependent proteasome-mediated degradation during Ad12 
infection, but which remains unaffected during Ad5 infection. This leads to the possibility 
that other serotypes may differentially regulate the DDR, although the majority of research 
has focused on Ad5 (species C) and Ad12 (species A) serotypes which have been well 
characterized. There are however over 50 other serotypes, divided into seven species (A to 
G), that have been relatively overlooked. In the current study previously uncharacterized 
serotypes (with regard to their relationship to the DDR) Ad3 (species B1), Ad7 (species B1), 
Ad11 (species B2), Ad9 (species D) and Ad4 (species E) were studied for their effect on the 
DDR proteins Mre11, p53, DNA ligase IV and TOPBP1 with regard to protein expression 
and cellular localization. The effect these viruses have on ATM and ATR kinase activity 
were also studied.  
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3.2 AIMS 
The specific aims of this study were to: 
a) Investigate Ad serotype representatives from species A to E for their ability to 
degrade proteins involved in DDR pathways. 
b) Examine the ability of these serotypes to relocalize cellular proteins during Ad 
infection. 
c) Determine the effect Ad infection has on the DDR in relation to ATM and ATR 
kinase activation. 
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3.3 RESULTS 
3.3.1 Validation of infection with Ad serotypes 
All viral serotypes used in this study (Table 1.1) have previously been titred using plaque 
forming assays. Since the viruses were supplied from various sources, however, they were 
also authenticated in the HeLa cell line which was predominantly used during this study. 
Commercial antibodies against viral proteins are generally only available for the more 
common serotypes (Ad5 and Ad12), therefore in order to test the efficacy of infection by the 
other viruses two approaches were adopted. Firstly, adenoviral structural proteins expressed 
in the late stages of infection were visualised by Ponceau S staining. HeLa cells were thus 
infected with the panel of seven serotypes representative of species A to E (Ad3, Ad4, Ad5, 
Ad7, Ad9, Ad11 and Ad12) at an MOI of 20 and harvested at intervals over a period of 72 
hours. Lysates were subjected to SDS-PAGE and Western blotting, and the nitrocellulose 
membranes were treated with Ponceau S to stain the proteins (Fig 3.1). Arrows indicate 
expression of the ~117 k hexon structural protein, which for most serotypes is evident by at 
least 32 hours post-infection.  
Secondly, evidence that all serotypes were entering into a viral lifecycle and replicating their 
DNA was evident from the establishment of RPA32-positive nuclear viral replication and 
transcription centres, as visualised by confocal microscopy (Figs 3.6-3.8). These methods 
demonstrate that all serotypes used in this study were capable of expressing late viral 
structural proteins and forming VRCs in HeLa cells. Based on the evolutionary divergence 
between serotypes, one would also expect them to have comparable but different lifecycles 
and effects on the host cell. 
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Fig 3.1A-G. Validation of infection with Ad serotypes by visualisation of 
structural protein production 
HeLa cells were infected with Ad3 (A), Ad4 (B), Ad5 (C), Ad7 (D), Ad9 (E), 
Ad11 (F) and Ad12 (F) and harvested at the indicated time points. Proteins were 
separated by SDS-PAGE and membranes were stained with Ponceau S. Arrows 
indicate viral hexon expression. 
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3.3.2 All serotypes induce reduction of DNA ligase IV protein levels 
It is well established that Ad5 and Ad12 inactivate the host cell DDR by facilitating the 
ubiquitin-dependent proteasome-mediated degradation of Mre11, DNA ligase IV and p53 
(Querido et al., 2001, Stracker et al., 2002, Baker et al., 2007). This is achieved through the 
hijack of various cellular complexes by E1B55K and E4ORF6 viral proteins, to form specific 
E3 ubiquitin ligase protein complexes (Querido et al., 2001, Harada et al., 2002). 
To investigate whether the degradation of Mre11, DNA ligase IV and p53 by Ad5 and Ad12 
is representative for all adenoviruses, the panel of serotypes were examined. HeLa cells were 
infected with viruses at an MOI of 20 and harvested at various time points before being 
prepared for Western blotting. Several clear differences in protein expression were evident; 
although p53 was transiently increased (by the action of E1A) before being degraded during 
Ad4, Ad5 and Ad12 infection, Ad3, Ad7, Ad9 and Ad11 infection all caused the expression 
of p53 to appreciably  increase with no sign of degradation (Fig 3.2C).  
More variation was seen with Mre11 protein expression, where Ad4, Ad5 and Ad12 induced 
rapid and complete depletion starting at 32 hours post-infection, while Ad3, Ad7, Ad9 and 
Ad11 had no effect even at late time points (Fig 3.2A). Interestingly, all serotypes used in this 
study were capable of reducing DNA ligase IV protein levels (Fig 3.2B); an observation that 
was previously only seen with Ad5 and Ad12. In the present study DNA ligase IV depletion 
by Ad4, Ad5, Ad7, Ad11 and Ad12 was evident 32 hours post-infection, while during Ad3 
and Ad9 infection the depletion occurred more gradually and at later time points. This 
depletion of protein expression by the previously uncharacterized viruses is assumed to be 
mediated via proteasomal degradation as is reported for Ad5 and Ad12. 
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Fig 3.2A-E. Expression of Mre11, DNA ligase IV, p53 and TOPBP1 following 
Ad infection 
HeLa cells were infected with Ad3, Ad4, Ad5, Ad7, Ad9, Ad11 and Ad12 
serotypes. Cells were harvested at the indicated times post-infection and examined 
by Western blotting for Mre11 (A), DNA ligase IV (B), p53 (C), TOPBP1 (D) and 
β-actin as a loading control (E). 
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Levels of TOPBP1 protein expression were also investigated during infection with the panel 
of serotypes. While TOPBP1 was found to be rapidly degraded during Ad12 infection, levels 
remained stable during infection with all other serotypes (Fig 3.2D). Western blotting with an 
antibody against β-actin has been included as a loading control (Fig 3.2E), and all data 
presented here are representatives of at least 3 separate experiments.  
It may be hypothesized that variations in the rate of protein depletion may be due to 
differences in the rate of expression of viral early region proteins. Despite this, all viruses 
examined had the potential to abrogate the DDR by depletion of one or more key components 
of the pathway. 
 
3.3.3 Overexpressed p53 during Ad infection is transcriptionally inactive 
p53 regulation during Ad infection has been studied in detail and it has been established, at 
least for Ad5 and Ad12, that during early times of infection E1A acts to stabilize p53 protein 
expression (Debbas and White, 1993, Lowe and Ruley, 1993). Subsequently, in order to 
counteract these apoptotic events large E1B proteins act to facilitate p53 inactivation by 
relocalization and degradation (Berk et al., 2005). Data presented here show Ad4, Ad5 and 
Ad12 infections that are consistent with this model of Ad-mediated regulation of p53 (Fig 
3.2C). Interestingly however, during Ad3, Ad7, Ad9 and Ad11 infection, p53 protein 
expression was rapidly induced and stabilized up to 72 hours post-infection (Fig 3.2C). 
In order to ascertain whether this overexpressed p53 is transcriptionally active, three 
approaches were adopted. Firstly, Western blotting was performed with the same lysates used 
in Fig 3.2C to probe for the p53-regulated, and p53-directed, E3 ubiquitin ligase MDM2 (Wu 
et al., 1993, Fang et al., 2000, Rodriguez et al., 2000). Interestingly, infection with all 
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serotypes resulted in the rapid loss of MDM2 protein expression (Fig 3.3), suggesting that the 
high levels of p53 protein expressed during Ad3, Ad7, Ad9 and Ad11 infection are 
transcriptionally inactive.  
Secondly, a direct measurement of p53 transcriptional activity was undertaken using a 
luciferase reporter assay. H1299 cells were cotransfected with a luciferase reporter 
downstream of multiple copies of a p53 consensus DNA-binding site, and a plasmid 
expressing p53. After 24 hours cells were mock-treated or infected with Ad3 or Ad7 and 
harvested after a further 24 hours. Levels of protein expression were detected by Western 
blotting (Fig 3.4A), and relative luciferase activity was measured using a luminometer (Fig 
3.4B). Data indicated that while p53 protein levels were elevated significantly during Ad3 
and Ad7 infection, its relative luciferase activity only marginally increased compared to the 
mock sample, suggesting that the p53 is transcriptionally inactive. 
The transcriptional activity of p53 was thirdly assessed by measuring the levels of the p53-
responsive gene p21, at the mRNA and protein level following infection. HeLa and A549 
cells were infected with Ad3 and Ad7, respectively, and samples were either subjected to 
Western blotting or semiquantitative RT-PCR. Once again p53 protein levels increased 
during infection, but despite this p21 protein levels decreased (Fig 3.5A). As a positive 
control A549 cells were treated with 3 Gy of IR and harvested after 2 hours, and as expected 
this sample showed a marked increase in both p53 and p21 protein levels. To measure p21 
mRNA levels, RNA was extracted from infected cell lysates and converted into cDNA before 
semiquantitative RT-PCR was performed. These data confirmed that reduced levels of p21 
protein expression was due to reduced p21 mRNA; and likewise for the IR-treated A549 cells 
an increase in p21 mRNA was observed (Fig 3.5B). Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was included as a loading control for this experiment.  
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Fig 3.3. Expression of the p53 regulated protein MDM2 following adenoviral 
infection 
HeLa cells were infected with Ad3, Ad4, Ad5, Ad7, Ad9, Ad11 and Ad12 
serotypes. Cells were harvested at the indicated times post-infection and examined 
by Western blotting for MDM2. 
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Fig 3.4A and B. Transcriptional activity and protein expression levels of p53 
following Ad3 and Ad7 infection  
H1299 cells were co-transfected with a luciferase reporter construct and cDNA 
expressing p53 before being mock-treated or infected with Ad3 or Ad7. Cells were 
then harvested 24 hours post-infection and Western blotted for p53 expression 
along with β-actin as a loading control (A). Relative p53 protein levels are shown 
in grey columns and relative luciferase activity, as measured by luminescence, is 
shown in black columns (B). 
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Fig 3.5A and B. Transcriptional activity of p53 directed towards p21 following 
Ad3 and Ad7 infection  
HeLa and A549 cells were infected with Ad3 and Ad7 as indicated and harvested at 
the indicated times. Cells were examined by Western blotting for p53, p21 and β-
actin as a loading control (A). Samples were also subjected to semiquantitative RT-
PCR for p21 along with GAPDH as a loading control (B). Right-hand lanes 
labelled “IR” indicate A549 cells that have been treated with ionizing radiation (3 
Gy) and harvested after 2 hours to act as a positive control.  
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As for those serotypes that caused a reduction in p53 protein levels after infection (Ad4, Ad5 
and Ad12), one can reasonably assume that this would automatically prevent it from 
activating the transcription of target genes. Taken together these experiments suggest that 
while p53 protein levels largely increase following infection with some serotypes, this 
overexpressed product is not transcriptionally active (at least towards MDM2 and p21). 
 
3.3.4 Ad serotypes differentially relocalize p53, Mre11 and TOPBP1 
Following Ad infection, a number of cellular proteins are sequestered and relocalized in order 
to negate the host cell’s DDR. This deactivation is advantageous for the virus and necessary 
for viral replication, and perhaps evasion of the cellular immune response. 
Significantly, Ad5E1B55K exhibits several distinct staining patterns during infection by 
localizing to sites of viral replication and transcription, cytoplasmic aggresomes and nuclear 
track-like structures (Zantema et al., 1985, Dosch et al., 2001). Since these early reports other 
proteins have also been detected with similar staining patterns; for example the ssDNA-
binding protein replication protein 32 (RPA32) is now commonly used as marker for VRCs 
when viral antibodies are unavailable, and for the same purpose PML is often used to stain 
for nuclear tracks.  
Immunofluorescence and confocal microscopy was used to investigate the capabilities of the 
less studied serotypes to relocalize cellular proteins. Briefly, HeLa cells were grown on glass 
slides before being infected and harvested after 24 and 48 hours by treatment with a pre-
extraction buffer and fixation in 4% PFA (see Chapter 2 for more details). Fixed cells were 
then stained with antibodies against Mre11, p53 and TOPBP1, as well as antibodies against 
RPA32 and PML to act as markers for the virally-induced structures. Cells were then finally 
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mounted in a DAPI-containing medium to stain the DNA and visualised by confocal 
microscopy. 
Consistent with previous studies, Mre11 was relocalized into PML-containing nuclear tracks 
during Ad5 infection, and RPA32-positive VRCs during Ad12 infection (Fig 3.6A and B). 
However, contrary to a previous study, Ad4 appeared to promote Mre11 accumulation at 
nuclear tracks and not at VRCs (Fig 3.6C). Infection with Ad3, Ad7 and Ad11, all of which 
were unable to induce Mre11 degradation, were also unable to relocalize the protein away 
from VRCs, such that during infection Mre11 colocalized with RPA32 (Fig 3.6B). 
Interestingly, Ad9, which was also unable to degrade Mre11, still had the capacity to 
relocalize the protein into nuclear tracks (Fig 3.6A). 
Consistent with previous findings, Ad5 and Ad12 infection promoted the accumulation of 
p53 into nuclear tracks (Fig 3.7B). In this regard, Ad4 infection also promoted p53 
relocalization to nuclear tracks prior to degradation (Fig 3.7B). While Western blot analysis 
revealed that Ad3, Ad7 and Ad11 infection enhanced p53 protein expression to above basal 
levels (Fig 3.2C), confocal microscopy indicated that p53 is relocalized to VRCs during these 
infections (Fig 3.7A). Ad9 infection also showed moderate stabilization of p53 protein 
expression by Western blotting (Fig 3.2C), however, in contrast to Ad3, Ad7 and Ad11, this 
serotype was capable of relocalizing p53 into nuclear tracks (Fig 3.7B).  
Since protein levels of TOPBP1 were solely affected by Ad12 infection (Fig 3.2D), its 
localization during infection with the other serotypes was also studied. During Ad3, Ad4, 
Ad5, Ad7, Ad9 and Ad11 infection TOPBP1 was found relocalized from a pan-nuclear state 
into RPA32-positive VRCs (Fig 3.8). This is the same pattern seen during early times of 
Ad12 infection before the protein is targeted for ubiquitin-mediated proteolysis. 
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Fig 3.6A-D. Localization of Mre11 following Ad infection 
HeLa cells were mock-treated or infected with Ad5 and Ad9 (A), Ad3, Ad7, Ad11 
and Ad12 (B), and Ad4 (C and D) for the times shown. Cells were then treated 
with a pre-extraction buffer and fixed in 4% paraformaldehyde before being stained 
for Mre11 (green), PML (red), RPA32 (red), and DAPI (blue) and visualised by 
confocal microscopy. Colocalization of proteins is evident in the right-hand merge 
column (yellow). 
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Fig 3.7A and B. Localization of p53 following Ad infection 
HeLa cells were mock-treated or infected with Ad3, Ad7 and Ad11 (A), and Ad4, 
Ad5, Ad9 and Ad12 (B) for the times shown. Cells were then treated with a pre-
extraction buffer and fixed in 4% paraformaldehyde before being stained for p53 
(green), PML (red), RPA32 (red), and DAPI (blue) and visualised by confocal 
microscopy. Colocalization of proteins is evident in the right-hand merge column 
(yellow). 
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Fig 3.8A and B. Localization of TOPBP1 following Ad infection 
HeLa cells were mock-treated or infected with Ad3, Ad4, Ad5 and Ad7 (A), and 
Ad9, Ad11 and Ad12 (B) for the times shown. Cells were then treated with a pre-
extraction buffer and fixed in 4% paraformaldehyde before being stained for 
TOPBP1 (red), PML (green), RPA32 (green), and DAPI (blue) and visualised by 
confocal microscopy. Colocalization of proteins is evident in the right-hand merge 
column (yellow). 
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Table 3.1. Summary of protein degradation and localization following 
infection with Ad3, Ad4, Ad5, Ad7, Ad9, Ad11 and Ad12. 
#
Upreg, upregulated expression; VRCs, VRCs 
Species
Ad 
serotype
Protein Upreg.
Transient 
upreg.
Stable Degraded Tracks VRCs
A 12
p53  
Mre11  
TOPBP1  
DNA lig IV 
B1 3
p53  
Mre11  
TOPBP1  
DNA lig IV 
B1 7
p53  
Mre11  
TOPBP1  
DNA lig IV 
B2 11
p53  
Mre11  
TOPBP1  
DNA lig IV 
C 5
p53   
Mre11  
TOPBP1  
DNA lig IV 
D 9
p53  
Mre11  
TOPBP1  
DNA lig IV 
E 4
p53   
Mre11  
TOPBP1  
DNA lig IV 
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The localization of endogenous DNA ligase IV was not determined in this study due to the 
lack of suitable antibodies to detect the protein by immunofluorescence. The data collected 
from Figures 3.2 and 3.6-3.8 are summarized in Table 3.1. 
 
3.3.5 DDR proteins are differentially phosphorylated during Ad infection 
Ad5 and Ad12 infections neutralize host cell DDR pathways to prevent viral DNA 
concatemer formation, although they have evolved different mechanisms for this evasion 
(Carson et al., 2003). During Ad5 infection, the relocalization and subsequent degradation of 
Mre11 can negate the DDR, whilst it has been shown that during Ad12 infection TOPBP1 is 
degraded to inhibit ATR activation (Blackford et al., 2010). To date, no evidence of ATM or 
ATR activation has been observed following wt Ad infection, but since Ad5 and Ad12 adopt 
different mechanisms the ability of the other serotypes to regulate DDR pathways was 
explored. Thus, Western blots were performed with the same HeLa lysates used in Fig 3.2 to 
probe for ATR activation via Chk1 serine 345 phosphorylation, and ATM activation via 
TIF1β serine 824 phosphorylation.  
No Chk1 phosphorylation was evident during Ad5, Ad9 and Ad12 infection, which is likely 
to reflect their ability to degrade Mre11, relocalize Mre11 or degrade TOPBP1, respectively 
(Fig 3.9). Interestingly, although Ad4 infection promotes Mre11 degradation (Fig 3.2A), it is 
unable to inhibit Chk1 phosphorylation, and Ad3, Ad7 and Ad11 infections similarly induced 
the phosphorylation of Chk1 (Fig 3.9). HeLa cells treated for 2 hours with 30 μM of HU were 
used as a positive control for Chk1 phosphorylation. 
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Fig 3.9A and B. Phosphorylation of Chk1 following Ad infection 
HeLa cells were infected with Ad3, Ad4, Ad5, Ad7, Ad9, Ad11 and Ad12 
serotypes. Cells were harvested at the indicated times points post-infection and 
examined by Western blotting for Chk1 (A) and phospho-Chk1 (Ser345; B). The 
final track labelled as HU in the Ad12-infected cells Western blotted for phospho-
Chk1 blots shows HeLa cells treated with HU as a positive control. 
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Fig 3.10A and B. Phosphorylation of TIF1β following Ad infection 
HeLa cells were infected with Ad3, Ad4, Ad5, Ad7, Ad9, Ad11 and Ad12 
serotypes. Cells were harvested at the indicated time point post-infection and 
examined by Western blotting for TIF1β (A) and phospho-TIF1β (Ser824; B). 
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TIF1β is phosphorylated at serine 824 by ATM in response to genotoxic stress (White et al., 
2006, Li et al., 2007). Figure 3.10 shows that 24 hours post-infection, all serotypes examined 
here also induce TIF1β phosphorylation and hence activation of ATM; although the kinetics 
varied appreciably (Fig 3.10). For Ad3, Ad4, Ad7 and Ad9 serotypes, TIF1β phosphorylation 
was evident 24 hours post-infection and increased up to 72 hours. Ad5-induced TIF1β 
phosphorylation was more intense and detected from early to late infection time points. The 
kinetics of TIF1β phosphorylation during Ad11 and Ad12 infection was transient, with 
phosphorylation visible at 24 hours but not 72 and 52 hours post-infection, respectively.  
In summary, these data indicate that despite targeting different cellular proteins for 
degradation all serotypes studied here were capable of activating the cellular DDR to some 
extent, although the presence of VRCs and production of late structural proteins suggest that 
this aspect of activation is not deleterious to the viral life cycle. 
 
3.3.6 Activation of ATM and ATR signalling pathways during Ad infection does not 
lead to viral concatemer formation 
Early studies showed that a mutant Ad5 virus lacking the E4 region (ΔE4) was defective for 
DNA replication and mRNA translation (Halbert et al., 1985), a failing which was later 
attributed to the formation of large DNA concatemers by the covalent linkage of viral 
genomes (Weiden and Ginsberg, 1994). This E4 region is partly responsible for targeting the 
early DSB sensor protein Mre11 for proteasomal degradation. Therefore during Ad5ΔE4 
infection, concatemers are formed due to the host cell’s ability to recognise and process linear 
viral genome ends as DSBs. Since many of the serotypes studied here were unable to deplete 
or relocalize components of the DDR (specifically Mre11), or inhibit ATM and ATR kinase 
~ 113 ~ 
 
activity, the possibility that these infections could lead to viral DNA concatemerization was 
investigated. HeLa cells were thus infected with the wt viruses Ad3, Ad7, Ad9, Ad11 and 
Ad12, and the Ad5 mutant viruses dl355 and H5pm4155 which lack the E4ORF6 and 
E4ORF3/E4ORF6 regions, respectively. Forty-eight hours post-infection, cells were 
harvested and the DNA was analysed by PFGE. As expected infection with the H5pm4155 
mutant virus resulted in the formation of multimeric viral DNA of varying sizes (Fig 3.11). 
Infection with the dl355 mutant also resulted in viral genome concatemerization, but to a 
lesser extent than H5pm4155 (Fig 3.11). Infection with Ad3, Ad7 and Ad11 revealed only 
~35 Kb monomeric viral DNA, suggesting that although certain DDR pathways were 
activated by these viruses, concatemerization was avoided.  
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Fig 3.11. Absence of DNA concatemer formation in wt adenoviral infections 
HeLa cells were infected with wt Ad3, Ad7, Ad9, Ad11 and Ad12, as well as 
mutant viruses dl355 (Ad5ΔE1B55K) and H5pm4155 (Ad5ΔE4ORF3/E4ORF6). 
Cells were harvested 24 hours post-infection, set into agarose plugs, digested with 
proteinase K and subsequently subjected to PFGE. DNA was visualised through 
ethidium bromide staining. 
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3.4 DISCUSSION 
Previous reports have determined that adenoviruses neutralize the host cell DDR by targeting 
various proteins for 26S proteasome-dependent degradation, and that viruses can 
differentially regulate these pathways (Stracker et al., 2005, Blackford et al., 2010). Results 
shown here have expanded these findings and examined the effect previously uncharacterized 
serotypes have on proteins involved in the DDR. All serotypes studied had some effect on the 
DDR, and although Ad5 and Ad12, as previously published, share broadly similar tactics 
more diversity has been revealed amongst other serotypes.  
Of notable difference was the effect serotypes had on Mre11 and p53. Ad4, Ad5 and Ad12 
infection promoted the degradation of both of these proteins as has been previously described 
in a proteasome-dependent manner (Querido et al., 2001; Stracker et al., 2005), while during 
Ad3, Ad7, Ad9 and Ad11 infection p53 protein levels were upregulated and Mre11 protein 
levels were unaffected (Fig 3.2). The localization of Mre11 also varied; during Ad3, Ad7, 
Ad11 and Ad12 infection it was found at sites of viral replication, while during Ad4, Ad5 and 
Ad9 infection it was found colocalizing with PML in nuclear tracks. The Ad4-mediated 
relocalization of Mre11 reported here (Fig 3.6C) is in contrast to a previous study which 
reported that another member of the MRN complex, Nbs1, was observed at RPA32-positive 
VRCs (Stracker et al., 2005). This discrepancy may reflect the use of different cells lines or 
multiplicities of infection, or be because the previous study used Nbs1 as a marker for the 
MRN complex rather than Mre11. Since the dynamics of this complex during Ad infection is 
unknown, MRN components may dissociate into discrete cellular compartments. It should 
also be noted that microscopy images from the previous publication portray only a partial 
colocalization with RPA32, and the extra diffuse staining rather resembles nuclear tracks. 
Ad5 infection has been shown to disrupt ATR signalling via relocalization of the MRN 
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complex into nuclear tracks (Carson et al., 2009). The differing result seen here with Ad4 
demonstrates that even though Mre11 is relocalized before degradation, the ATR substrate 
Chk1 is still phosphorylated, suggesting that the MRN complex may exert some effect on 
ATR activation, or that pathways independent of MRN function promote Chk1 activation 
following infection. 
The study by Carson et al. also demonstrated that Mre11 relocalization requires the 
Ad5E4ORF3 isoleucine residue at position 104, which is specific to species C adenoviruses 
(Carson et al., 2009). The authors found that mutating this residue to arginine (I104R), which 
is the residue present in all other groups, prevented the ability of Ad5E4ORF3 to relocalize 
Mre11, but not PML, into nuclear tracks. Interestingly, the current study found that Ad4 
(species E) and Ad9 (species D) which both have an arginine at position 104 in E4ORF3, still 
relocalized Mre11 into nuclear tracks during infection; although Ad9 was unable to induce its 
degradation. This suggests that E4ORF3 proteins may have evolved alternative methods, and 
have different requirements, for relocalizing cellular proteins during infection. It is also 
reasonable to suggest that the Ad9-mediated relocalization of Mre11 into nuclear tracks may 
inactivate the protein without the necessity of degradation, which would account for the lack 
of Chk1 phosphorylation observed during Ad9 infection.  
Ad3, Ad7, Ad9 and Ad11 infections induced a marked accumulation of the p53 gene product, 
which was subsequently deemed to be transcriptionally inactive by luciferase assay and 
semiquantitative RT-PCR analysis of RNA (Fig 3.2-3.5). This is a novel observation for a 
protein involved in the DDR, and may be attributed to the actions of E1A which is known to 
induce p53 protein expression during early times of infection via p19
ARF 
activity. The results 
presented here correlate well with another study where a single amino acid Ad5E1B55K 
mutant (R250A) bound poorly to p53 in comparison to wt Ad5, and was unable to induce p53 
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degradation (Shen et al., 2001). Indeed, this poorly conserved arginine residue is not present 
in Ad3, Ad7, Ad9 and Ad11 E1B55K proteins which might explain their inability to degrade 
p53 (Blackford et al., 2010). It has also been suggested that enhanced p53 expression does 
not provoke the assumed pro-apoptotic effect viruses aim to avoid, but instead can be 
advantageous for the adenoviral lytic cycle by cooperating with Ad5E1A to enhance 
transcription from the MLP (Royds et al., 2006). Moreover, the localization of p53 to VRCs 
during infection with Ad3, Ad7 and Ad11 infection is likely to reflect lack of the key 
isoleucine residue in their E4ORF3 proteins as mentioned above. 
TOPBP1 has recently been identified as a novel Ad12 substrate, resulting in the inactivation 
of the ATR pathway. It is targeted for proteasomal degradation through the action of 
Ad12E4ORF6 alone, without the necessity for Ad12E1B54K (Blackford et al., 2010). In the 
current study only Ad12 infection was able to induce TOPBP1 degradation, while during 
Ad3, Ad4, Ad5, Ad7, Ad9 and Ad11 infection TOPBP1 levels remained stable. Infection 
with all serotypes studied led to the accumulation of TOPBP1 at RPA32-positive VRCs. The 
function of TOPBP1 at these structures remains unknown, however in the case of Ad12 its 
initial localization to these sites is only evident 24 to 48 hours post-infection before it is 
targeted for degradation. Presumably, accumulation of TOPBP1 at VRCs by viruses other 
than Ad12 is sufficient to negate its function. 
DNA ligase IV protein levels were reduced during infection with all serotypes studied. NHEJ 
is thought to promote the illegitimate repair of viral genomes, and since DNA ligase IV, 
when complexed with XRCC4, catalyzes the final step of this ligation it could inhibit viral 
replication if not inactivated. Indeed, when human fibroblasts expressing an inactive DNA 
ligase IV mutant (180BR) were infected with the Ad5 mutant virus dl1004, the 
concatemerization phenotype was rescued (Stracker et al., 2002). Despite being targeted by 
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all viruses, it has previously been shown that DNA ligase IV degradation is not absolutely 
necessary to inhibit NHEJ as Ad5E1B55K-independent Ad5E4ORF6-dependent dissociation 
of DNA ligase IV from XRCC4 (which is not degraded) inhibits the function of this complex 
(Jayaram et al., 2008).  
MDM2 protein levels were used in this study as an indicator of p53 activity, and helped 
demonstrate that p53 accumulated during Ad3, Ad7, Ad9 and Ad11 infection was not 
transcriptionally active. As mentioned, MDM2 and p53 form a negative feedback loop to 
regulate their expression, however, MDM2 is also able to autoubiquitylate itself leading to its 
own proteolysis; a scenario induced by DNA damage and which causes p53 stabilization 
(Fang et al., 2000). The balance between MDM2 autoubiquitylation and substrate 
ubiquitylation is dependent on its association with Daxx and the deubiquitylating enzyme 
HAUSP, such that MDM2 association with the adaptor protein Daxx induces HAUSP to 
direct MDM2 ligase activity away from autoubiquitylation and towards p53 ubiquitylation 
(Li et al., 2004, Ronai, 2006). Ad5 infection has recently been shown to induce Ad5E1B55K-
dependent Daxx degradation, making it possible that the depletion of MDM2 protein levels 
seen here is facilitated by dissociation from the Daxx/HAUSP complex (Schreiner et al., 
2010). Although no changes in HAUSP protein levels were detected during Ad5 and Ad12 
infection, Daxx was depleted during Ad4, Ad5 and Ad12 infection (data not shown). 
Interestingly these were the only serotypes capable of degrading p53, which suggests that 
during Ad3, Ad7, Ad9 and Ad11 infection a different series of events is likely to account for 
p53 inactivation, such as inappropriate post-translation modifications. Furthermore, recent 
evident suggests that DNA damage induces the casein kinase I-dependent (CKI) 
phosphorylation of MDM2, which targets the protein for destruction by the SCF
β-TRCP
 E3 
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ligase complex (Inuzuka et al., 2010). Thus, more research is needed to determine how 
MDM2 is regulated during Ad infection, and what relationship this has to p53 regulation. 
Data presented here suggest that infection with all serotypes studied lead to some form of 
DDR activation. Indeed, all serotypes activated ATM kinase activity as demonstrated by 
TIF1β phosphorylation (Fig 3.10), regardless of Mre11 regulation, which suggests that viral 
replication is not compromised by some level of DDR pathway activation. This is in contrast 
to a previous study suggesting that Mre11 degradation during Ad infection inhibits ATM 
kinase activity towards 53BP1 and Chk2, although low levels of phosphorylation were 
observed (Carson et al., 2003). Furthermore, recent studies have suggested that widespread 
phosphorylation of H2AX during Ad5 and Ad12 infection, which occurs after Mre11 
degradation, is dependent on ATM kinase activity (Blackford et al., 2008; Nichols et al., 
2009). Although the promiscuity of TIF1β as a substrate for phosphorylation has been 
scrutinized, the latest publications suggest that this modification is ATM-specific (Goodarzi 
et al., 2009); however this awaits confirmation by other laboratories. To determine if ATM is 
responsible for the TIF1β phosphorylation observed here future experiments could be carried 
out in ATM shRNA cells. 
ATR activation was somewhat varied between serotypes. Infection with Ad3, Ad4, Ad7 and 
Ad11 initiated ATR kinase activity towards Chk1 (Fig 3.9), which mostly correlates with 
their inability to degrade Mre11 (Fig 3.2A) or mislocalize it into nuclear tracks (Fig 3.6). Ad4 
infection however promoted Mre11 degradation (Fig3.2A) and recruitment to nuclear tracks 
(Fig 3.6), suggesting that Mre11 relocalization and degradation is not sufficient to ablate 
Chk1 phosphorylation, and indicates that another protein may activate ATR. In contrast, Ad9 
which can relocalize but not degrade Mre11, does inhibit Chk1 phosphorylation suggesting 
that different serotypes have evolved different mechanisms to activate or inhibit DDR 
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pathways. Despite these wide variations in kinase activation, the genomes of all the serotypes 
studied here were present as momomers with no trace of concatemer formation suggesting 
that the presence of Mre11 and p53 during infection may not be detrimental to the viral 
lifecycle. It is assumed however, that Mre11 and p53 are functionally inactivated in these 
cells; indeed this was determined for p53 at least (Fig 3.3-3.5). Given these data, it is possible 
that the degradation of DNA ligase IV may be sufficient to obstruct the DDR during Ad3, 
Ad7 and Ad11 infection, or that these viruses have evolved novel mechanisms to prevent 
viral genome concatemerization.  
It was also observed through PFGE that the dl355 mutant lacking the E4ORF6 region formed 
DNA concatemers, although not to the extent of H5pm4155 (ΔE4ORF3/ORF6). This may be 
attributable to the action of E4ORF3, which is sufficient to relocalize Mre11 into nuclear 
tracks and subsequently E1B55K-postive cytoplasmic aggresomes (Liu et al., 2005). Also as 
E4ORF3 and E4ORF6 encode redundant gene products, either protein is sufficient for DNA 
replication and lytic viral infection (Weiden and Ginsberg, 1994). 
Data presented here are consistent, to some extent, with another recent study examining the 
substrate specificity of a separate panel of adenoviruses (Cheng et al., 2011). This 
independent study cloned and expressed the coding sequences of E1B55K and E4ORF6 from 
Ad12 (species A), Ad16 (species B1), Ad34 (species B2), Ad5 (species C), Ad9 (species D), 
Ad4 (species E) and Ad40 (species F). Consistencies between the two studies include the 
observations that infection with all serotypes initiated the degradation of DNA ligase IV but 
had varying effects on p53 and Mre11 degradation; traits that were attributed to heterogeneity 
in ubiquitin ligase complex composition (Cheng et al., 2011). There are a few discrepancies 
between the current study and the study by Cheng et al. For instance, Cheng et al. indicated 
that Ad4E1B55K/E4ORF6 expression did not promote the degradation of p53 or Mre11, 
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whereas data presented here, in agreement with previous reports, revealed that Ad4 infection 
does promote p53 and Mre11 degradation (Fig 3.2C; Stracker et al., 2005). Cheng et al. also 
showed some Mre11 degradation with Ad9E1B55K/E4ORF6, whereas the current study did 
not observe this (Fig 3.2A). Similarly, their E1B55K/E4ORF6 constructs from species B1 
(Ad16) and species B2 (Ad34) viruses also promoted some Mre11 degradation, in contrast to 
the species B1 (Ad3 and Ad7) and species B2 (Ad11) viruses used here which did not (Fig 
3.2A). 
Since both studies have utilised only a representative serotype from each Ad group, directly 
comparing different serotypes from the same species might be inappropriate. Differences may 
also have arisen from the different techniques utilised; Cheng et al. transfected E1B55K and 
E4ORF6 plasmid DNA into H1299 cells, whereas the current study used HeLa cells in the 
context of a full infection, and it is possible that other viral gene products may regulate their 
capacity to target cellular proteins and pathways. 
Cheng et al. also examined Ad40, one of two serotypes from species F. They found that 
E1B55K and E4ORF6 proteins from this virus were capable of degrading p53, Mre11 and 
DNA ligase IV in a manner highly comparable to Ad12. This similarity was also extended by 
the ability of Ad12 and Ad40 E4ORF6 proteins to form CUL2-based E3 ubiquitin ligase 
complexes, while all other viruses conveyed CUL5 specificity (Cheng et al., 2011). This 
result might have been anticipated, since sequence homology data suggests that serotypes 
from species A and F are highly related and the most divergent from those of other species 
(Bailey and Mautner, 1994). Given this evidence it is possible that species F serotypes, akin 
to Ad12, have the ability to degrade TOPBP1 in a CUL2-dependent manner, and broader 
studies will reveal if all members from each species evade the DDR by the same mechanism. 
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It will be interesting to analyse the ability of the serotypes used in this study to degrade 
integrin alpha 3 and BLM, two recently identified Ad5E1B55K/E4ORF6 substrates (Dallaire 
et al. 2009b, Orazio et al., 2011). During the early stages of Ad5 infection BLM is 
relocalized into VRCs (a novel observation for an Ad5 substrate), and its degradation is an 
independent event from Mre11 degradation (Orazio et al., 2011). As there is no obvious 
homology among E1B55K/E4ORF6 substrates, it is also possible that different regions of 
these viral proteins mediate interactions with distinct substrates. In view of the ever emerging 
variations regarding Ad substrate specificities and their abilities to evade the host cells 
defence mechanisms, some of which are presented here, there are likely to be many as yet 
unidentified cellular targets for adenoviruses.  
It cannot be discounted that variations seen amongst the serotypes used in this study arise 
from differing rates of infections and expression of viral proteins. Although visualisation of 
late hexon proteins has provided some validation, further authentication could be obtained by 
analysing the cell cycle distribution of infected cells by FACS analysis (as cells arrest in S-
phase in response to E1A expression; Grand et al., 1998), or by using RQ-PCR to measure 
viral genome accumulation. It should also be noted that although Ad3, Ad7 and Ad11 
infections failed to relocalize any of the DDR proteins studied here into nuclear tracks, these 
track structures were still established within the cell as observed by PML staining (data not 
shown). 
In conclusion, there was no observed correlation between the degradation and localization of 
cellular proteins following infection with a broad spectrum of Ad serotypes, raising the 
likelihood that viruses from specific species have evolved varying strategies to circumvent 
host cells’ defence mechanisms and stimulate viral replication. However, it seems likely that 
the importance of degrading DNA ligase IV throughout Ad evolution has been maintained. 
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Please note that the data presented in this Chapter has been published; Forrester et al., (2011) 
J.Virol 85:2201-2211. 
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ADENOVIRUS E1B55K- AND E4ORF3-   
INTERACTING PROTEIN 
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4.1 INTRODUCTION 
Ad oncoproteins act rapidly to target and degrade cellular proteins that would otherwise 
interfere with their own viral lifecycle. For example, proteins involved in DDR pathways 
such as p53 and Mre11, are bound by Ad E1B55K/E4ORF6 complexes and targeted for 
proteasomal degradation (Nevels et al., 1997, Querido et al., 2001, Stracker et al., 2002). 
Previously, novel Ad substrate and co-activator proteins have been identified using human 
mutated cell lines (ATLD and 180BRM; Stracker et al., 2002), by conventional 
immunoprecipitation and Western blotting techniques (Baker et al., 2007, Blackford et al., 
2010) and through the use of mass spectrometry (Querido et al., 2001, Harada et al., 2002, 
Dallaire et al., 2009a). 
Mass spectrometry is a proteomic technique that can be used to study protein complexes by 
the analysis of fragmented peptides, following collision-induced dissociation (CID) or 
electron-transfer dissociation (ETD). CID is useful for the identification of peptides from 
proteins isolated following immunoprecipitation, but provides limited peptide-sequence 
information and unstable post-translational modifications such as phosphorylation, 
glycosylation and acetylation are often cleaved off the backbone during fragmentation 
(Mikesh et al., 2006). In contrast, ETD is capable of providing extensive sequence coverage 
and unstable modifications such as phosphorylation are preserved on the peptide chain 
(Sobott et al., 2009). Modifications such as phosphorylation play a major role in regulating 
protein activity and stability, localizing proteins to specific cellular compartments and 
facilitating interactions with other proteins. Indeed, Ad infection is known to stimulate the 
phosphorylation of several DDR proteins including RPA32 and H2AX (Blackford et al., 
2008, Nichols et al., 2009). Furthermore, data presented in Chapter 3 show that TIF1β and 
Chk1 are phosphorylated as a consequence of Ad infection.  
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4.2 AIMS 
The specific aim of this study was to use a proteomic approach to identify novel 
Ad12E1B54K-binding proteins, and then to: 
a) Corroborate any novel findings using immunological techniques. 
b) Determine the status of these proteins during infection with regard to their expression 
and cellular localization. 
c) Examine if/how these cellular proteins are regulated by Ad proteins.  
d) Investigate possible novel roles for these proteins during Ad infection. 
e) Investigate possible novel roles for these proteins in the DDR. 
Theoretically, proteins which interact with each other may be involved in the same biological 
pathways; therefore it was hoped that these experiments would also provide general insight 
into Ad-mediated regulation of the cellular environment. The results of findings from these 
studies are presented in this Chapter. 
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4.3 RESULTS 
4.3.1 Mass spectrometric analysis of anti-Ad12E1B54K immunoprecipitates  
In order to identify novel Ad12E1B54K-binding proteins, Ad12 E1-transformed HER10 cells 
were harvested in NETN lysis buffer and an anti-Ad12E1B54K antibody was used to 
immunoprecipitate Ad12E1B54K, and associated proteins, from the lysate (Merrick et al., 
1991). These immunoprecipitates were incubated with Protein G-Sepharose beads to form 
immunocomplexes, and bound proteins were eluted by boiling in SDS sample buffer before 
being separated by SDS-PAGE. Two negative control samples were also included, one being 
control mouse IgG with cell lysate and Protein G-Sepharose, and the other being anti-
Ad12E1B54K antibody with lysis buffer but without cell lysate. Gels were immersed in a 
solution of Coomassie Brillaint Blue G-250 protein stain, however, curiously no obvious 
protein bands were detected, so random gel slices were excised using a clean scalpel blade 
and digested with modified trypsin which cleaves C-terminal to arginine or lysine residues. 
The resulting peptides were then separated using an AmaZon ion trap ETD-enabled mass 
spectrometer, and processed and analysed by the ProteinScape central bioinformatic platform. 
A number of peptides were identified in this screen, many of which were specifically 
detected in test samples and were not found in negative controls (Table 4.1). Table 4.1 is 
divided into known and unknown Ad12E1B54K-interacting proteins, and the third column 
refers to the number of peptides identified from each protein, which along with Mascot scores 
help determine the likelihood that the protein interaction is valid. Thus, if two or more 
peptides are identified with a Mascot score of 21 or above, it represents a p-value of less than 
0.01 per peptide (Perkins et al., 1999). 
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Protein MW (kDa)
Number of 
peptides
Sequence
coverage
Known adenoviral binding proteins
HNRNPU1 90 10 10%
BLM 159 6 5.2%
Mre11 81 2 3.3%
Other DNA damage response/repair proteins
DDB1 127 13 11.9%
BRCA2 384 2 1.0%
UBR5 309 2 1.0%
TIF1 family members
TIF1γ 122 17 16.3%
TIF1β 89 9 11.1%
TIF1α 117 2 2.8%
Ubiquitin pathway proteins
USP9/FAM 289 7 3.2%
CUL7 191 4 2.8%
SMURF2 86 1 1.5%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1. Summary of Ad12E1B54K-interacting proteins identified by mass 
spectrometric analysis. 
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Three previously verified Ad12E1B54K-interacting proteins were identified in this screen 
supporting the validity of the technique, these were Mre11, HNRNPUL1 (also known as 
E1B55K-associated protein 5; E1B-AP5) and BLM (Stracker et al., 2002, Blackford et al., 
2008, Orazio et al., 2011). Of the numerous peptides identified from proteins previously 
unknown to interact with Ad12E1B54K, six will be discussed in more detail below. 
Three of these proteins, DDB1, BRCA2 and UBR5 (E3 ubiquitin-protein ligase 5) are known 
components of the DDR. Thirteen peptides from DDB1, which is involved in nucleotide 
excision repair, were detected in HER10 immunoprecipitates and indeed this protein was 
subsequently found to bind Ad5E1B55K (data not shown). BRCA2 and UBR5 have roles in 
HR and DNA damage-induced Chk2 activation, respectively; the ability of these proteins to 
bind Ad12E1B54K awaits verification. 
Interestingly three members from the TIF1 family of transcriptional repressors (TIF1α, TIF1β 
and TIF1γ) were also detected in immunocomplexes with Ad12E1B54K. Two peptides were 
identified from TIF1α, 9 peptides were identified from TIF1β and 17 peptides were identified 
from TIF1γ, all of which had Mascot scores of 142 or above. TIF1 family members are 
defined by the presence of an N-terminal TRIM domain, a TSS and tandem PHD and BRD 
domains (Yan et al., 2004).  
TRIM domain proteins possess E3 ubiquitin ligase activity through their RING finger motif 
and while TIF1γ serves as an antagonist of TGF-β signalling by ubiquitylation SMAD4, 
TIF1α has been found to directly ubiquitylate p53 (Dupont et al., 2005, Allton et al., 2009). 
Interestingly, TIF1α has also been previously identified as a target for E4ORF3-mediated 
relocalization during Ad5 infection (Yondola and Hearing, 2007). And TIF1β is an ATM 
kinase substrate during the DDR which may make it an attractive target for Ad proteins 
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during infection (White et al., 2006, Li et al., 2007). More detail on TIF1 function can be 
found in Chapter 1. 
Other potentially novel Ad12E1B54K-interacting proteins that function in ubiquitin pathways 
were also identified, including USP9 (a DUB also known as FAM) and SMURF2 which both 
have roles in the TGF-β signalling pathway. CUL7, a cullin family member was also 
identified, however, the known Ad12E1B54K-binding protein CUL2 was not (Table 4.1) 
 
4.3.2 TIF1γ and TIF1β bind to adenoviral proteins in vivo 
Proteomic approaches to identify protein-protein interactions are not definitive and further 
immunological analysis is required to corroborate any novel interactions. To validate TIF1γ 
association with Ad12E1B54K, and to determine whether it also binds to Ad5E1B55K, co-
immunoprecipitation experiments were carried out using lysates from Ad12 E1-transformed 
HER10 and Ad5 E1-transformed HEK293 cell lines. Briefly, Ad12E1B54K, Ad5E1B55K 
and TIF1γ were immunoprecipitated from 4 mg of cell lysate, and bound proteins were 
eluted, resolved by SDS-PAGE and detected by Western blotting using the appropriate 
antibodies.  
In reciprocal co-immunoprecipitation experiments TIF1γ was found to interact with both 
Ad12E1B54K and Ad5E1B55K (Fig 4.1). To confirm this interaction during viral infection, 
HeLa cells were mock-treated or infected with Ad12 and harvested after 24 hours. 
Ad12E1B54K and TIF1γ were then immunoprecipitated from lysates and assayed as 
described for Fig 4.1. Western blot analysis revealed that TIF1γ interacts with Ad12E1B54K 
in infected cells (Fig 4.2), and interestingly that TIF1γ protein levels are reduced following 
Ad infection (Fig 4.2, cf.  input lanes 11 and 12). 
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Fig 4.1A C. Ad12- and Ad5E1B55K interacts with TIF1γ in transformed cell 
lines 
Ad12E1B54K, Ad5E1B55K and TIF1γ were immunoprecipitated from 4 mg of 
HER10 (anti-XPH9 antibody) and HEK293 (anti-2A6 antibody) cell lysate, 
respectively. After incubation with Protein G-Sepharose beads, samples were 
washed, eluted and resolved by SDS-PAGE. Bound proteins were detected by 
Western blotting. 
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Fig 4.2. Ad12E1B54K interacts with TIF1γ in infected cells 
Ad12E1B54K was immunoprecipitated from 4 mg of mock-treated and Ad12-
infected HeLa lysate with an anti-XPH9 antibody. After incubation with Protein G-
Sepharose beads, samples were washed, eluted and resolved by SDS-PAGE. Bound 
TIF1γ proteins were detected by Western blotting. 
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Fig 4.3A and B. Ad12- and Ad5E1B55K interact with TIF1β in transformed 
cell lines 
Ad12E1B54K and Ad5E1B55K were immunoprecipitated from 4 mg of HER10 
(anti-XPH9 antibody) and HEK293 (anti-2A6 antibody) cell lysate, respectively. 
After incubation with Protein G-Sepharose beads, samples were washed, eluted and 
resolved by SDS-PAGE. Bound TIF1β proteins were detected by Western blotting. 
 
Ad12E1HER10
Ig
G
X
P
H
9
in
p
u
t
TIF1β
Ad12E1B54K
Ad5E1HEK293
Ig
G
2
A
6
in
p
u
t
TIF1β
Ad5E1B55K
IP
WB
IP
WB
A 
B 
~ 134 ~ 
 
TIF1β was also identified as a possible Ad12E1B54K-binding protein. To investigate this 
further Ad12E1B54K and Ad5E1B55K were immunoprecipitated from HER10 and HEK293 
cell lysates, respectively, and analysed for co-immunoprecipitation with TIF1β as described 
above. Western blot analysis revealed an association between TIF1β and both Ad5 and Ad12 
large E1B viral proteins (Fig 4.3A and B). These data support the mass spectrometry results, 
and identify TIF1g and TIF1b as novel Ad5 and Ad12 large E1B-binding proteins. 
 
4.3.3 Ad12E1B54K/E4ORF6-mediated substrate degradation is not affected by TIF1γ 
depletion  
As discussed in Chapter 1 and Chapter 3, E1B55K and E4ORF6 hijack CRL complexes and 
utilise them to ubiquitylate and degrade key members of the DDR pathway (e.g. Mre11 and 
p53). These cellular E3 ubiquitin ligase complexes are reported to be CUL2- or CUL5-based 
and contain an RBX1 domain and Elongins B and C (Querido et al., 2001, Harada et al., 
2002, Blackford et al., 2010). Given recent evidence contesting the involvement of CUL2 or 
CUL5 in the degradation of Mre11, it is possible that another E3 ubiquitin ligase may be 
responsible for the degradation of cellular proteins during Ad infection (Forrester et al., 2011, 
and Chapter 5 of this thesis). As TIF1γ functions as an E3 ubiquitin ligase in the TGF-β 
signalling pathway (Dupont et al., 2005, Morsut et al., 2010), it is possible that it might also 
participate in the ubiquitin-mediated degradation of Mre11 during Ad infection. 
To investigate this possibility HeLa cells were treated with control non-silencing siRNA and 
siRNA targeting TIF1γ and cultured for 24 hours, after which time they were either mock-
treated or infected with Ad12. Samples were harvested over a period of 72 hours and 
examined by SDS-PAGE and Western blotting. Results indicated that even though TIF1γ 
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protein levels were reduced significantly by RNAi, this depletion had no effect on Mre11 
degradation which was still evident 24 hours post-Ad12 infection (Fig 4.4). Interestingly, this 
experiment also revealed that Ad infection resulted in a loss of TIF1gprotein expression from 
cells treated with either non-silencing, or TIF1g siRNA (Fig 4.4). 
 
4.3.4 TIF1γ protein levels are reduced following Ad infection 
As results presented in Figures 4.2 and Fig 4.3 suggest that TIF1γ protein levels might be 
reduced during Ad12 infection, this observation was examined in more detail. Thus, HeLa 
cells were mock-treated or infected with Ad12 and harvested over a 72 hour period before 
being subjected to Western blotting. As expected, Ad12 infection depleted DNA ligase IV 
protein levels, but interestingly and consistent with earlier findings, TIF1γ protein levels were 
also reduced (Fig 4.5A).  
To expand upon this observation, cells were infected with Ad3, Ad5, Ad7, Ad11 and Ad12, 
harvested, and analysed by Western blotting to determine the protein levels of all TIF1 family 
members during infection. Levels of TIF1β displayed no variation during infection with all 
serotypes, confirming results from Chapter 3 (Fig 3.11). This was also the case for TIF1α 
protein levels; however there was some variation between samples at late time points 
following Ad3, Ad5 and Ad7 infection (Fig 4.5B). It was evident however, that infection with 
all serotypes tested resulted in the loss of TIF1g expression (Fig 4.5B). Ad12 and Ad5 
resulted in a decrease in TIF1γ protein levels by 24 hours post-infection, while TIF1γ 
depletion was not evident until 48 hours post-Ad3, -Ad7 and -Ad11 infection (Fig 4.5B). 
During all infections however, TIF1γ depletion was marked with virtually no protein present 
after 72 hours. A Western blot of Nbs1 was included as a control for this experiment, and its  
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Fig 4.4. Effect of TIF1γ depletion on Mre11 protein degradation during Ad12 
infection 
HeLa cells were treated with non-silencing siRNA or siRNA targeting TIF1γ 
before being infected with Ad12. Cells were then harvested at the indicated time 
points and examined by Western blotting using antibodies against Mre11, TIF1γ, 
Ad12E1B54K and β-actin as a loading control. 
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Fig 4.5A and B. Members of the TIF1 family of proteins are degraded during 
adenovirus infection 
HeLa cells were mock-treated, infected with Ad12 (A) or infected with Ad3, Ad4, 
Ad5, Ad7, Ad9, Ad11 and Ad12 serotypes (B). Cells were harvested at the 
indicated time points and examined by Western blotting using antibodies against 
TIF1γ, TIF1β, TIF1α, DNA ligase IV, Ad12E1B54K and β-actin as a loading 
control. 
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level was appropriately reduced during Ad5 and Ad12 infections with no change seen during 
Ad3, Ad7 and Ad11 infection (Fig. 4.5B). These data indicate that TIF1γ expression is 
commonly reduced following infection with a number of different Ad serotypes. 
 
4.3.5 Endogenous TIF1γ and TIF1α are relocalized into PML-containing nuclear tracks 
during Ad5 and Ad12 infection 
E4ORF3 acts to reorganise the tumour suppressors PML and p53 into “track-like” structures 
throughout the nucleus during Ad infection (Evans and Hearing, 2003). Therefore, the 
localization of the TIF1γ protein was also examined as it is likely that TIF1γ may be 
regulated in a similar manner. To follow the localization of endogenous TIF1γ during 
infection immunofluorescence was performed. HeLa cells were seeded onto glass slides 
before being mock-treated or infected with Ad5 or Ad12. 18 hours post-infection cells were 
harvested by treatment with a pre-extraction buffer and fixation in 4% PFA. Cells were then 
stained for TIF1γ, RPA32 and PML and mounted in a DAPI-containing mounting medium to 
stain the DNA; RPA32 and PML were used as surrogate markers for VRCs and nuclear 
tracks, respectively. Images were analysed using a LSM 510 META confocal laser scanning 
microscope (Carl Zeiss). Results clearly illustrate that TIF1γ relocalizes from a pan-nuclear 
state before infection, into PML-containing nuclear tracks during both Ad5 and Ad12 
infection (Fig 4.6A). This was confirmed by the lack of TIF1γ-RPA32 colocalization, 
suggesting that TIF1γ is not relocalized to sites of viral replication (Fig 4.6B). TIF1α was 
also relocalized into nuclear tracks 18 hours post-Ad5 and -Ad12 infection (Fig 4.7). 
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Fig 4.6A and B. Localization of TIF1γ following adenovirus infection 
HeLa cells were mock-treated or infected with Ad5 and Ad12 and harvested at the 
indicated time points. Cells were treated with a pre-extraction buffer and fixed in 
4% paraformaldehyde before being stained for TIF1γ (red), PML (green; A), 
RPA32 (green; B) and DAPI (blue) and visualised by confocal microscopy. 
Colocalization of proteins is evident in the right-hand merge column (yellow). 
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Fig 4.7. Localization of TIF1α following adenovirus infection 
HeLa cells were mock-treated and infected with Ad5 and Ad12 and harvested at 
the times shown. Cells were treated with a pre-extraction buffer and fixed in 4% 
paraformaldehyde before being stained for TIF1α (red), PML (green) and DAPI 
(blue) and visualised by confocal microscopy. Colocalization of proteins is evident 
in the right-hand merge column (yellow). 
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Fig 4.8A and B. Localization of TIF1β and phospho-TIF1β (Ser842) following 
adenovirus infection 
HeLa cells were mock-treated and infected with Ad5 and Ad12 and harvested at 
the indicated time points. Cells were treated with a pre-extraction buffer and fixed 
in 4% paraformaldehyde before being stained for TIF1β (red; A), phospo-TIF1β 
(red; B), PML (green) and DAPI (blue) and visualised by confocal microscopy. 
Colocalization of proteins is evident in the right-hand merge column (yellow). 
 
 
~ 142 ~ 
 
4.3.6 TIF1β and phospho-TIF1β are not relocalized during Ad5 and Ad12 infection 
Since both TIF1α and TIF1γ were relocalized into nuclear tracks upon Ad infection, the fate 
of TIF1β was also examined by immunofluorescence using the same method as described for 
Fig 4.6. In contrast to TIF1α and TIF1γ, TIF1β was not relocalized during Ad infection and 
instead remained pan-nuclear up to 18 hours post-Ad5 and -Ad12 infection (Fig 4.8A). To 
confirm this, a phospho-specific TIF1β antibody was used to stain HeLa cells since TIF1β is 
phosphorylated on serine 842 following Ad infection (presumably by ATM; see Chapter 3). 
Immunofluorescence revealed that while this modified protein was undetectable during mock 
infection, it was upregulated during Ad5 and Ad12 infection supporting the Western blot data 
from Chapter 3 (Fig 4.8B). However, despite this upregulation, phospho-TIF1β failed to 
colocalize with PML during infection and instead exhibited a granular, yet generally uniform 
staining pattern throughout the nucleus (Fig 4.8B). Taken together these data suggest that 
TIF1a, TIF1b and TIF1g are differentially regulated in response to Ad infection. 
 
4.3.7 Exogenous mutated TIF1γ exhibits restricted relocalization during Ad infection 
During Ad5 infection E4ORF3 directly binds to the conserved N-terminal TRIM domain of 
TIF1α which possesses E3 ubiquitin ligase activity (Yondola and Hearing, 2007). 
Furthermore, the TRIM domain was found to be necessary and sufficient for Ad5E4ORF3 to 
relocalize TIF1α into PML-containing nuclear tracks. In order to determine if the same 
scenario was true for TIF1γ a transfection/infection approach was used.  
HeLa cells were initially transfected with Flag-tagged expression vectors containing either 
full-length TIF1γ, or TIF1γ in which two cysteines at positions 125 and 128 were mutated to  
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Fig 4.9A and B. Localization of exogenous wt TIF1γ and TIF1γC>A following 
adenovirus infection 
HeLa cells were transfected with wt Flag-TIF1γ or Flag-TIF1γC>A plasmid DNA 
48 hours prior to Ad5 (A) and Ad12 (B) infection. After a further 48 hours, cells 
were harvested and treated with a pre-extraction buffer before being fixed in 4% 
paraformaldehyde and stained for Flag (green), PML (red) and DAPI (blue). 
Images were visualised by confocal microscopy and colocalization of proteins is 
evident in the right-hand merge column (yellow). 
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alanines (TIF1γC>A). This point mutant bears an additional SfiI restriction site across the 
mutated cysteines which confers a loss of E3 ubiquitin ligase activity from the deletion of 37 
N-terminal amino acids (Dupont et al., 2005). Forty-eight hours post-transfection cells were 
seeded onto glass slides for infection with Ad5 or Ad12, and after a further 48 hours they 
were harvested by treatment with a pre-extraction buffer and fixation in 4% PFA. Fixed cells 
were then stained for Flag, PML and DAPI and visualised by confocal microscopy. This 
experiment revealed that full-length TIF1γ formed clear nuclear tracks that colocalized with 
PML during Ad5 and Ad12 infection (Fig 4.9A and B). Interestingly however, the TIF1γC>A 
mutant was only partially relocalized following infection as the majority of TIF1γC>A 
remained in a pan nuclear state (Fig 4.9A and B). This defect was especially prominent 
following Ad12 infection where most of the nuclear tracks containing PML had no 
TIF1γC>A protein present. 
 
4.3.8 E4ORF3 is required for Ad5- and Ad12-mediated TIF1γ degradation and 
relocalization 
The requirement of specific Ad proteins for the relocalization and degradation of proteins 
varies depending on the serotype and the substrate. During Ad5 infection, Mre11, p53 and 
TIF1α are relocalized into nuclear tracks in an E4ORF3-dependent manner, and Mre11 and 
p53 are targeted for degradation through the action of E1B55K and E4ORF6 (Stracker et al., 
2002, Evans and Hearing, 2005, Yondola and Hearing, 2007). In contrast, during Ad12 
infection TOPBP1 is relocalized instead to VRCs and is then degraded in an E1B54K-
independent E4ORF6-dependent manner (Blackford et al., 2010).  
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Given that TIF1γ relocalization during Ad infection is regulated in a similar manner to 
TIF1α, the role of E4ORF3 in Ad-mediated TIF1γ degradation and relocalization was 
investigated. This was explored, in the first instance, using a panel of Ad5 and Ad12 mutant 
viruses lacking distinct viral genes.  
HeLa cells were thus mock-treated, infected with wt Ad5, or infected with the mutant Ad5 
viruses dl1520 (ΔE1B55K), dl355 (ΔE4ORF6) or H5pm4155 (ΔE4ORF3/E4ORF6). After 24 
and 48 hours cells were harvested and analysed by Western blotting. Infection with dl1520 
and dl355 led to TIF1γ degradation in a manner indistinguishable from that seen with wt Ad5, 
although DNA ligase IV degradation was delayed (Fig 4.10A). Infection with H5pm4155 
however, significantly inhibited the degradation of TIF1γ and DNA ligase IV degradation in 
comparison to the wt infection (Fig 4.10A). To investigate the effect of Ad5 protein 
expression on TIF1g relocalization to nuclear tracks, HeLa cells were transfected with HA-
tagged expression vectors containing Ad5E1B55K, Ad5E4ORF6 and Ad5E4ORF3. Cells 
were harvested after 48 hours post-transfection, processed for immunofluorescence as 
described above, and stained for TIF1γ, Ad5E1B55K (2A6), Ad5E4ORF6 (RSA3), 
Ad5E4ORF3 (6A11) and DAPI. Visualization by confocal microscopy revealed that 
expression of Ad5E1B55K or Ad5E4ORF6 alone was not sufficient to relocalize TIF1γ (Fig 
4.10B). However, in cells expressing Ad5E4ORF3 alone, TIF1γ was found to colocalize with 
E4ORF3 in nuclear tracks (Fig 4.10B). 
To further study the role of viral proteins in TIF1γ degradation, HeLa cells were transfected 
with E1B55K and/or E4ORF3/E4ORF6 Ad5 expression vectors. Cells were subsequently 
harvested and TIF1γ was analysed by Western blotting and immunofluorescence. Twenty-
four hours post-cotransfection with Ad5E1B55K and Ad5E4ORF3, immunofluorescence 
revealed that TIF1γ was relocalized into nuclear track structures, and that by 48 hours TIF1g 
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levels were completely depleted (Fig 4.11B). Furthermore, Western blot analysis revealed 
that TIF1g levels were reduced 24 hours post-transfection with Ad5E4ORF3, but were not 
reduced following transfection with either Ad5E1B55K or Ad5E4ORF6 (Fig 4.11A). 
Cotransfection with Ad5E4ORF3 and Ad5E4ORF6 also had the capacity to relocalize TIF1γ 
into nuclear tracks (Fig 4.11B), however Western blotting revealed that TIF1γ protein levels 
were not affected by the coexpression of Ad5E1B55K and Ad5E4ORF6 (Fig 4.11A). 
Given these findings, the consequence of Ad12 protein expression on TIF1γ degradation and 
relocalization was also examined by the use of mutant viruses and transfection of viral genes. 
Initially, HeLa cells were infected with wt Ad12 or two mutant Ad12 viruses, dl620 and 
hr703, neither of which express the E1B54K gene product. Levels of Ad substrates were 
analysed over a 48 hour time course by Western blotting, and results revealed that dl620 and 
hr703 retained the ability to degrade TIF1γ to the same extent seen during wt Ad12 infection 
(Fig 4.12A). Mre11, DNA ligase IV and p53 were used as positive controls, and as expected 
in the absence of E1B54K, p53 protein expression was increased and Mre11 and DNA ligase 
IV proteins were stabilized. To examine the requirements for Ad12E4ORF3 in TIF1γ 
degradation and relocalization during infection, HA-tagged expression vectors were 
transfected in to HeLa cells and subsequently analysed by Western blotting and 
immunofluorescence. Both Western blot analysis and confocal microscopy revealed that 
upon Ad12E4ORF3 expression, TIF1γ levels were reduced after 24 hours (Fig 4.12B and 
4.12C). Confocal microscopy also revealed a more substantial reduction in TIF1g protein 
levels 48 hours post-Ad12E4ORF3 transfection, whilst Ad12E1B54K expression had no 
effect (Fig 4.12C). Unlike the Ad5 transfections however, it is ambiguous as to whether 
TIF1γ colocalized with Ad12E4ORF3, or formed nuclear tracks, during transfection; 
although there was some evidence of this (Fig 4.12C). Akin to the Ad5 studies, expression of 
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Fig 4.10A and B. E4ORF3 is required for Ad5-mediated TIF1γ degradation 
and relocalization 
(A) HeLa cells were mock-treated, infected with wt Ad5 or infected with mutant 
Ad5 viruses (dl1520, dl355 and H5pm4155) and harvested at the indicated time 
points. Levels of protein expression was subsequently analysed by Western 
blotting. (B) HeLa cells were transfected with Ad5 HA-tagged E1B55K, E4ORF6 
or E4ORF3 plasmid DNA and harvested after 48 hours. Cells were then treated 
with a pre-extraction buffer before being fixed in 4% paraformaldehyde and stained 
for TIF1γ (red), E1B55K(anti-2A6), E4ORF6 (anti-RSA3), E4ORF3 (anti-6A11; 
all green) and DAPI (blue). Images were visualised by confocal microscopy and 
colocalization of proteins is evident in the right-hand merge column (yellow). 
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Fig 4.11A and B. Ad5-mediated TIF1γ degradation and relocalization is 
independent of E1B55K and E4ORF6 
(A) HeLa cells were transfected or cotransfected with the indicated Ad5 HA-tagged 
E1B55K, E4ORF6 or E4ORF3 plasmid DNA and harvested after 24 hours. Levels 
of protein expression was analysed by SDS-PAGE and Western blotting. 
Transfection of pcDNA3 was used as a negative control. (B) Localization of these 
proteins was also studied by immunofluorescence. Cells were treated with a pre-
extraction buffer before being fixed in 4% paraformaldehyde and stained for TIF1γ 
(red), 2A6 (E1B55K), RSA1 (E4ORF6) and 6A11 (E4ORF3 [all green]) and DAPI 
(blue). Images were visualised by confocal microscopy and colocalization of 
proteins is evident in the right-hand merge column (yellow). 
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Fig 4.12A - C. E4ORF3 is required for Ad12-mediated TIF1γ degradation and 
relocalization 
(A) HeLa cells were mock-treated, infected with wt Ad12 or infected with Ad12 
mutants (dl620 and hr703) and harvested at the indicated times. Levels of protein 
expression was subsequently analysed by Western blotting. (B) HeLa cells were 
transfected or cotransfected with the indicated Ad12 HA-E1B55K, -E4ORF6 and –
E4ORF3 plasmid DNA and harvested after 24 hours. Levels of protein expression 
was analysed by SDS-PAGE and Western blotting. Transfection of pcDNA3 was 
used as a negative control (C) HeLa cells were transfected with Ad12 HA-E1B54K 
and –E4ORF3 plasmid DNA and harvested after 24 hours. Cells were then treated 
with a pre-extraction buffer before being fixed in 4% paraformaldehyde and stained 
for TIF1γ (red), HA and XPH9 (E1B55K [both green]) and DAPI (blue). Images 
were visualised by confocal microscopy and colocalization of proteins is evident in 
the right-hand merge column (yellow). 
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Ad12E1B54K and Ad12E4ORF6 either alone or in combination, had no effect upon TIF1g 
protein levels, despite the ability of E1B54K/E4ORF6 to target p53 for degradation (Fig 
4.12B). Taken together these data suggest that E4ORF3 is solely required to promote 
TIF1gdegradation during Ad5 and Ad12 infection. 
 
4.3.9 Mass spectrometric determination of TIF1γ immunoprecipitates  
In order to idenitify novel TIF1γ-binding proteins which may associate with the protein 
during Ad infection, further mass spectrometric analysis was carried out. To this end, HeLa 
cells were mock-treated or infected with Ad12 and harvested 24 hours post-infection before 
being immunoprecipitated with an antibody against TIF1γ. Immunoprecipitates were then 
incubated with Protein G-Sepharose beads, eluted by boiling in SDS sample buffer and 
separated by SDS-PAGE. Proteins were visualised and processed as described above. As a 
control, an anti-TIF1γ antibody was incubated in lysis buffer alone minus cell lysate. Also the 
proteasomal inhibitor MG132 was added to a separate Ad12 infection after 12 hours, with the 
hypothesis that by preventing TIF1γ degradation any protein-protein complexes formed 
would remain intact. The resulting Coomassie Brilliant Blue G-250-stained gel indicated the 
presence of several specific proteins not found in control lanes (Fig 4.13). The proteins 
identified in this experiment were grouped into four categories and are summarized in Table 
4.2, along with the number of peptides detected. Firstly, the presence of the three TIF1 family 
members in both mock-treated and Ad12-infected cells supports the efficacy of the 
experiment. Interestingly, several samples also identified a putative serine-proline (S/P) 
phosphorylation site in the TIF1γ peptide sequence QSGLSSLVNGKS*PIR.  This was only  
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Fig 4.13. Separation of TIF1γ immunoprecipitates by SDS-PAGE 
HeLa cells were mock-treated or infected with Ad12. After 12 hours the 
proteasomal inhibitor MG132 was added to indicated cells, and after a further 12 
hours all samples were harvested in NETN lysis buffer. TIF1γ was 
immunoprecipitated from 5mg of cell lysate and bound proteins were incubated 
with Protein G-Sepharose beads which were subsequently washed and eluted.  
Eluted proteins were resolved by SDS-PAGE and stained with Coomassie blue 
G125. Some identified proteins are indicated by arrows and HC donates the 
antibody heavy chain. 
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Protein
MW 
(kDa)
Number of peptides
Mock Ad12
Ad12
+MG132
TIF1 family members
TIF1γ 122 29 22 27
TIF1α 117 19 14 16
TIF1β 89 - 4 -
Known adenovirus substrates
p53 53 - 3 -
PML 70 - 3 -
DNA ligase IV 96 - 2 -
Ubiquitin pathways components
CUL3 89 - 2 -
CUL9 281 - 4 -
USP9 289 4 3 -
DNA damage response proteins
ATR 303 - 6 14
Chk1 54 - 3 -
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2. Summary of TIF1γ interacting proteins identified by mass 
spectrometric analysis 
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Fig 4.14A and B. ETD-mass spectrometric determination of TIF1γ and 
phospho-TIF1γ peptides isolated from TIF1γ immunoprecipitates 
(A) Fifteen TIF1γ peptides (red) and one putative phosho-TIF1γ peptide (green) 
were identified by mass spectrometry from TIF1γ immunoprecipitates (putative 
glycosylation sites are highlighted in yellow). (B) A mass spectrogram illustrating 
the ions identified from the phospho-TIF1γ peptide QSGLSSLVNGKS#PIR. This 
peptide generated a Mascot score of 38.76 (* indicates the specific putative 
phosphorylated residue). 
 
 
 
B 
A 
* 
~ 156 ~ 
 
identified in Ad12-infected HeLa cells treated with or without MG132, and not in mock-
treated cells. One example of this from Ad12-infected cells is shown in Figure 4.14A, where 
15 TIF1γ peptides (highlighted in red) were identified including the putative S/P 
phosphorylation site (highlighted in green), which gave a significant Mascot score of 38.76 
(Fig 4.14A). The mass spectrogram of this individual phospho-peptide can be seen in Figure 
4.15B where the putative phosphorylation site is marked with an asterisk. 
The second group of peptides identified belong to proteins already confirmed to interact with 
Ad proteins, further implicating a role for TIF1γ during infection. These proteins included 
p53, DNA ligase IV and PML. Thirdly, three proteins involved in ubiquitylation pathways 
were identified. These were CUL3 and CUL9 which are cullin proteins that nucleate CRLs, 
and the USP9 DUB which was also identified as a potential Ad12E1B54K-interacting protein 
(Table 4.1). 
The final group of proteins identified from TIF1γ immunoprecipitates are involved in the 
DDR. Six peptides from the ATR kinase were identified during Ad12 infection, while 
interestingly three peptides from its substrate Chk1 were also identified. This is in addition to 
p53, PML and DNA ligase IV which also function in DDR pathways. 
 
4.3.10 TIF1γ interacts with ATR 
One of the most interesting findings from this mass spectrometric analysis was the putative 
association between TIF1γ and ATR during Ad infection. In order to confirm this interaction, 
TIF1γ was immunoprecipitated from mock-treated and Ad12-infected HeLa cells and 
immunoprecipitates were analysed for ATR binding using a specific anti-ATR antibody. 
Results  indicated  that  TIF1γ  interacts  with ATR  in  both mock-treated and  Ad12-infected  
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Fig 4.15A and B. TIF1γ interacts with ATR in Ad12-infected and uninfected cells 
TIF1γ was immunoprecipitated from 4mg of mock and Ad12-infected HeLa lysate. 
After incubation with Protein G-Sepharose beads, samples were washed, eluted and 
resolved by SDS-PAGE. ATR co-immunoprecipitates were detected by Western 
blotting (A). Mock and Ad12-infected HeLa lysates from (A) were also analysed by 
Western blotting for the expression of Ad12E1B54K and β-actin as a loading control 
(B). 
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cells, with perhaps a slightly greater avidity during infection (Fig 4.15A). Western blots for 
Ad12E1B54K were also carried out to demonstrate infection (Fig 4.15B).  
 
4.3.11 TIF1γ expression is unaffected by UVA-irradiation 
Given the novel interaction revealed between TIF1γ and ATR, the potential role of TIF1γ in 
the DDR was explored. Thus, HeLa cells were mock-treated or treated with 25 J/m
2 
of UVA-
irradiation to activate ATR kinase activity through the generation of ssDNA. Over a period of 
8 hours cells were harvested and analysed by Western blotting. Results revealed that although 
Chk1 became phosphorylated at serine residue 345 one hour post-UVA treatment as 
expected, TIF1γ protein expression remained unaffected by UVA exposure (Fig 4.16). 
Proteins involved in the DDR are often relocalized into discrete nuclear foci following the 
induction of DNA damage. In order to determine if TIF1γ is similarly relocalized during 
DNA damage, DNA breaks were experimentally introduced into HeLa cells by laser 
microirradiation. Briefly, cells seeded in specialised chambered coverglass dishes were 
sensitized with a minor groove DNA-binding dye to facilitate the introduction of DNA 
breaks. They were then placed into a heated chamber mounted on a LSM 510 META 
confocal microscope and irradiated using a 364 nm UVA laser. Following DNA damage 
induction, immunofluorescence was carried out and cells were visualised by confocal 
microscopy. H2AX phosphorylation was used as a positive indicator for the presence of DNA 
breaks, and as such γH2AX appeared in distinct “stripes” caused by the UVA laser (Figure 
4.17). TIF1γ failed to colocalize with γH2AX in UVA-treated cells and was instead 
distributed in its customary pan-nuclear fashion. 
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Fig 4.16. TIF1γ protein expression is not altered following UVA treatment 
HeLa cells were either mock-treated or treated with 25 J/m
2
 UVA and harvested at 
the indicated times. TIF1γ expression was analysed by Western blotting along with 
antibodies against Chk1-pS345 and Chk1 as controls. 
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Fig 4.17. TIF1γ is not relocalized to DNA damage sites following UVA laser 
microirradiation 
HeLa cells were microirradiated with a 364 nm UVA laser before being treated 
with a pre-extraction buffer and fixed in 4% paraformaldehyde. 
Immunofluorescence was carried out using antibodies against γH2AX (green) and 
TIF1γ (red). DAPI (blue) was used to stain DNA, and cells were visualised by 
confocal microscopy. 
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4.4 DISCUSSION 
The application of mass spectrometry has previously identified the Ad substrate integrin 
alpha 3 as well as CUL5, RBX1 and Elongins B and C proteins which are involved in the 
ubiquitin-proteasome pathways utilised by Ad (Querido et al., 2001, Harada et al., 2002, 
Dallaire et al., 2009a). Data presented in this Chapter describe the successful use of 
proteomics as a method to identify novel Ad12E1B54K- and TIF1γ-interacting proteins. The 
initial mass spectrometry experiment to identify Ad12E1B54K-interacting proteins was given 
credence as an appropriate technique following the identification of known Ad12E1B54K-
interacting proteins, and the subsequent validation of novel interacting proteins, such as 
TIF1g and TIF1b by co-immunoprecipitation (Fig 4.1-4.3). Since three out of the four known 
TIF1 family members were identified in this single screen it was reasonable to speculate that 
they function within the same pathway during Ad infection, although further evidence 
questioned this possibility. Indeed, confocal microscopy revealed that while TIF1γ and TIF1α 
were relocalized into PML-containing nuclear tracks, and TIF1γ was degraded during Ad 
infection, TIF1β protein levels and distribution remained unaffected (Fig 4.5-4.8). Moreover, 
despite their overall structural relatedness, and the fact that TIF1α, TIF1β and TIF1γ act as 
transcriptional repressors when tethered to DNA, these proteins have previously 
demonstrated significant functional diversity (Le Douarin et al., 1996, Venturini et al., 1999). 
A previous study demonstrated that Ad5E4ORF3 binds and reorganizes TIF1α during 
infection, but reported unpublished data to show that TIF1α protein levels were unaffected 
(Yondola and Hearing, 2007). Consistent with these findings, work presented in this Chapter 
demonstrates that TIF1α is relocalized by E4ORF3 into nuclear tracks during Ad5 and Ad12 
infection. Amongst other things, this relocalization is suggested to facilitate the ability of 
TIF1α to transactivate the glucocorticoid receptor (Teyssier et al., 2006, Yondola and 
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Hearing, 2007). This hormone signalling pathway may be beneficial to adenoviruses since 
E4ORF3 has been shown to activate the glucocorticoid-responsive promoter (Wienzek and 
Dobbelstein, 2001).  
In addition to TIF1α, these data strongly imply that TIF1γ is relocalized during Ad5 and 
Ad12 infection, and is likely to be targeted for degradation during infection with Ad3, Ad5, 
Ad7, Ad11 and Ad12 serotypes, which represent four out of the seven Ad groups. Although 
the precise mechanism of TIF1γ depletion has not been addressed in this Chapter it is feasible 
that, like with other Ad substrates, it is driven by ubiquitin-mediated proteasome-dependent 
degradation. Mass spectrometry data from Ad12E1B54K (where TIF1γ was initially 
detected) and TIF1γ immunoprecipitates identified the E3 ubiquitin ligase complex scaffold 
proteins CUL3, CUL7 and CUL9 as potential interactors (Table 4.1 and 4.2). Members of the 
cullin family have previously been implicated in the degradation of Ad substrates, for 
example CUL2- and CUL5-based E3 ubiquitin ligases are hijacked to induce p53 degradation 
by Ad12 and Ad5 E1B55K/E4ORF6 complexes, respectively (Querido et al., 2001, 
Blackford et al., 2010). Data presented in Chapter 5 will further examine the roles of CRLs in 
the degradation of TIF1γ during Ad infection.  
The use of mutant viruses in this study has helped decipher the mechanism behind Ad-
mediated TIF1γ regulation. During infection with Ad5E1B55K, Ad5E4ORF6 and 
Ad12E1B54K deletion mutants, TIF1γ was degraded at the same rate seen with the wt viruses 
(Fig 4.10A and Fig 4.12A). Although a mutant Ad12 virus lacking the E4ORF3 protein has 
yet to be generated, infection with H5pm4155 (Ad5ΔE4ORF3/E4ORF6) lead to a significant 
stabilization of TIF1γ, suggesting a direct role for Ad5E4ORF3 in promoting the degradation 
of TIF1g. Data from Chapter 3 demonstrate that H5pm4155 infection results in the formation 
of multimeric Ad DNA. This is presumably due to the persistence of Mre11 nuclease activity 
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and it is unlikely that TIF1γ contributes to concatemer formation (Stracker et al., 2002). 
Transfection studies with Ad5 and Ad12 DNA expression vectors also confirmed that the 
presence of E4ORF3 was sufficient to promote the loss of TIF1γ 24 hours post-transfection, 
while in the same experiment the presence of E1B55K and E4ORF6 did not affect TIF1γ 
degradation (Fig 4.11A and 4.12B). Futhermore, E1B55K/E4ORF6 cotransfections had a 
negligible affect on TIF1γ protein levels confirming that TIF1γ regulation by adenoviruses is 
distinct from that of other substrates (Querido et al., 2001, Stracker et al., 2002, Baker et al., 
2007, Dallaire et al., 2009b, Blackford et al., 2010, Orazio et al., 2011). 
TIF1γ localization during Ad infection was determined by studying both the endogenous and 
exogenously expressed protein (Fig 4.6 and 4.9). Confocal microscopy revealed clear 
colocalization of TIF1γ and TIF1α proteins with PML in nuclear tracks, and this was 
conserved during Ad5 and Ad12 infection. On close inspection it can be noticed that the 
overlap between TIF1γ and TIF1α with PML staining is incomplete and probably arises 
because, like Mre11, their redistribution are separable events (Stracker et al., 2005). The 
significance of relocalizing proteins into nuclear tracks during Ad infection remains 
ambiguous (Geoffroy and Chelbi-Alix, 2011, Greer et al., 2011). Is it simply a mechanism by 
which proteins are sequestered away from sites of viral replication? Or do these structures 
harbour the ubiquitin-proteasome machinery necessary for substrate degradation? 
Multifaceted proteins such as TIF1γ could even perform important pro- or antiviral functions 
in these tracks such as transcriptional repression of cellular genes, activation of viral late gene 
expression or ubiquitylation. 
Further analysis of cells transfected with viral DNA revealed that TIF1γ relocalization into 
nuclear tracks was also dependent on E4ORF3 expression (Fig 4.10-4.12). Indeed, during 
both Ad infection and viral gene expression studies, E4ORF3 was independently sufficient 
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and necessary to relocalize TIF1γ. Taken together, these data indicate that during Ad 
infection E4ORF3 uniquely functions to promote the degradation and relocalization of TIF1γ, 
however given the mass spectrometry and co-immunoprecipitation data, E1B55K may also 
have a non-essential role (Figs 4.1 and 4.2). E1B55K and E4ORF3 have previously been 
shown to functionally associate with each other within a small cellular pool separate from 
E1B55K/E4ORF6 complexes (Leppard and Everett, 1999). If this were the case it is likely 
that E4ORF3 and E1B55K interact with TIF1γ independently and have distinct roles in 
regulating TIF1γ, for instance E1B55K binding may modulate its transcriptional activity 
while E4ORF3 may solely be responsible for inducing its degradation. In addition to inducing 
the relocalization of cellular substrates E4ORF3 is also implicated in viral DNA replication, 
late mRNA splicing and late gene expression. Therefore studying these processes may 
provide clues as to the importance of TIF1γ degradation. 
Ad5E4ORF3 has previously been shown to specifically target the N-terminal TRIM domain 
of TIF1α, which is conserved among TRIM family members (Yondola and Hearing, 2007). 
The importance of the TRIM domain in TIF1γ relocalization was studied here using a 
TIF1γC>A mutant construct which is catalytically inactive and unable to induce the 
formation of ubiquitin-conjugated products of SMAD4 (Dupont et al., 2005). Figure 4.10 
demonstrates that this TIF1γ mutant was also partially defective in localizing to nuclear 
tracks during Ad12 (and to a lesser extent Ad5) infection when compared to the wt virus, 
indicating that E4ORF3 may interact with the TRIM domain of TIF1γ (Fig 4.9). The 
difference between Ad5 and Ad12 may reflect differences in E4ORF3 coding sequences, and 
it is possible that as with other Ad substrates these serotypes regulate TIF1γ in distinct 
fashions. 
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Mass spectrometric analysis was also carried out on TIF1γ co-immunoprecipitates from 
Ad12-infected cells, and a number of potential interacting proteins were identified (Table 
4.2). Interestingly, p53, DNA ligase IV and PML were all identified giving credibility to this 
study since they are all relocalized along with TIF1γ into nuclear tracks by E4ORF3. Peptides 
from the protein USP9 were also detected in this screen, both before and during infection. 
This DUB opposes the activity of TIF1γ in the TGF-β signalling pathway which plays 
essential roles in growth and development (Dupont et al., 2009). Since these USP9 peptides 
were identified both before and after Ad12 infection, and no complementing experiments 
were carried out, it is difficult to speculate whether this is of consequence to the virus 
however it was also detected in immunocomplexes with Ad12E1B54K.  
Other peptides of interest belonged to ATR and Chk1 proteins, which are principal players in 
the cellular response to DNA damage (Table 4.2). ATR is a PIKK which responds primarily 
to ssDNA breaks and is crucial for maintaining stability during S phase of the cell cycle (Zou, 
2007, Cimprich and Cortez, 2008). Following activation, ATR phosphorylates Chk1 which 
acts as a transducer to trigger cell cycle arrest (Zhao and Piwnica-Worms, 2001). 
Interestingly ATR, along with its cofactor protein ATRIP, relocalize to VRCs during Ad5 
and Ad12 infection, although this does not initiate a DDR with regards to Chk1 
phosphorylation (Blackford et al., 2008, Carson et al., 2009). Results from Chapter 3 
demonstrate that other serotypes (Ad3, Ad4, Ad7 and Ad11) are capable of inducing Chk1 
phosphorylation and suggest that it is not detrimental to their replication. However, ATR 
regulation and ATR and Chk1 localization during these infections is currently unknown.  
Ad proteins have previously been shown to impede cellular responses to DNA damaging 
reagents (Carson et al., 2009). Indeed, in comparison to control cells, cells expressing 
Ad5E4ORF3 which were microirradiated with a UVA laser showed a reduced localization of 
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Nbs1 to sites of DNA damage, and the protein was instead immobilized in nuclear tracks 
(Carson et al., 2009). A similar occurrence was seen in Ad5E4ORF3 expressing cells treated 
with HU where ATR signalling was found to be abrogated (Carson et al., 2009). In the 
current study co-immunoprecipitations revealed that TIF1γ and ATR interact with each other 
in vivo, and interestingly, this association was detected in both infected and non-infected cells 
(Fig 4.15). Combined with the mass spectrometry results summarized in Tables 4.1 and 4.2, 
this suggests a possible role for TIF1γ in the DDR. Contrary to this hypothesis however, 
TIF1γ protein expression was not affected by UVA damage, nor was it relocalized to sites of 
DNA damage following UVA microirradiation (Fig 4.16 and 4.17). Despite these results it is 
still plausible that TIF1γ may have an as yet unidentified role in the DDR.  
Results from Chapter 3 revealed that the DDR protein TIF1β is phosphorylated during 
infection with all serotypes studied, presumably as a consequence of ATM kinase activity. In 
this Chapter, data indicate that TIF1β is unlikely to be an Ad substrate, although recent 
research has implicated it in controlling the switch from viral latency to lytic replication 
during KSHV infection (Cheng et al., 2009). 
Several other TRIM family members that display antiviral activities have previously been 
identified, including TRIM1, TRIM5α, TRIM19 (PML), TRIM22 and TRIM30 (Nisole et al., 
2005). The most studied member of this family, PML, interferes with the replicative cycle of 
many DNA and RNA viruses, and similar to the disruption of PODs by E4ORF3, its integrity 
is also affected by viral proteins from HCMV and EBV DNA viruses (Adamson and Kenney, 
2001, Kang et al., 2006, Salsman et al., 2011). Retroviruses are also limited by TRIM 
proteins, for example human TRIM5α restricts MLV by targeting the capsid and other viral 
components for proteasomal degradation (Yap et al., 2004, Maillard et al., 2010). Along with 
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other publications this suggests that TRIM family members are a widespread class of proteins 
involved in the cellular antiviral response (Nisole et al., 2005). 
In addition to identifying novel interacting proteins, the AmaZon ion trap mass spectrometer 
is able to preserve post-translational modifications such as the addition of phosphate groups 
to an amino acid side chain (Sobott et al., 2009). This technology enabled an advanced 
analysis of Ad12-infected TIF1γ immunoprecipitates and lead to the identification of a 
putative S/P phosphorylation site in the TIF1γ peptide sequence QSGLSSLVNGKS*PIR (Fig 
4.14). Located at Ser862, this residue lies between the N-terminal TRIM domain and the C-
terminal PHD finger, in an unconserved region previously known to encompass protein 
binding sites for SMAD2 and SMAD3 (He et al., 2006). Furthermore, the S/P site is just 28 
residues away from the PHD domain which, although has an unknown function for TIF1γ, is 
required for TIF1β SUMOylation (Mascle et al., 2007). The likelihood of this site being 
phosphorylated during Ad infection is supported by a TIF1γ band shift seen during Ad12 
infection (Fig 4.5A), suggesting that the slower migrating protein is post-translationally 
modified (although other modifications besides phosphorylation cannot be ruled out).  
This specific Ser862 residue has previously been identified, but not studied, during a 
widespread screen examining proteins whose phosphorylation status is cell cycle-regulated 
(Dephoure et al., 2008). This publication identified the putative S/P phosphorylation site in 
cells arrested in G1 and mitotic phases of the cell cycle, although cells arrested in other phases 
were not analysed. Recent work in our laboratory using bromodeoxyuridine (BrdU) 
incorporation and confocal microscopy, suggests that RNAi of the TIF1γ gene arrests HeLa 
cells in S and M phases of the cell cycle (Sedgwick and Turnell, unpublished observations). 
Therefore if TIF1γ has a role in cell cycle regulation adenoviruses may exploit this by 
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promoting its degradation in a phosphorylation-dependent manner. On the other hand, TIF1γ 
phosphorylation may just be a result of the Ad-induced S phase. 
Although it was beyond the scope of this study, it will be interesting to validate this S/P 
phosphorylation site. Multiple serine kinases are activated during the cell cycle and by DNA 
damaging events, thus if Ser862 is confirmed as a bona fide phosphorylation site there would 
be many protein kinase candidates. Considering the similarity in peptide sequence, one likely 
candidate would be a CDK which are known to target [ST]PX[RK] canonical motifs 
(Songyang et al., 1994, Holmes and Soloman, 1996). Furthermore, E1A has previously been 
shown to associate with CDK complexes through interactions with the pRB family of 
proteins (Herrmann et al., 1991, Faha et al., 1993). KSHV viral protein kinases have been 
shown to phosphorylate TIF1 proteins during infection, therefore novel Ad protein kinases 
cannot be discounted (Cheng et al., 2009). Finally, TIF1 family members are often described 
as atypical protein kinases due to the ability of TIF1α and TIF1β to phosphorylate 
themselves, and other substrates, through an undefined kinase domain (Fraser et al., 1998, 
Nielsen et al., 1999). Due to the high degree of sequence conservation within the TIF1 
family, TIF1γ is also suspected to possess intrinsic protein kinase activity, so it is possible 
that Ad infection induces TIF1γ autophosphorylation of Ser862. 
Results described in this Chapter suggest that TIF1γ protein stability and localization is 
affected by Ad E4ORF3 expression in a distinct manner from other substrates, although the 
purpose and functional relevance of this regulation remains elusive. Its conserved nature may 
reflect the importance of targeting TIF1γ and indicates a potential role for this protein in the 
cellular antiviral response. Although data presented in Figure 4.5 suggest that TIF1γ 
depletion by RNAi does not affect the ability of Ad12 to degrade Mre11, future experiments 
could analyse other Ad substrates and functions since TIF1γ has the potential to act as an E3 
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ubiquitin ligase. In addition, further analysis of the TIF1γC>A mutant, and possibly the 
generation of a mutant encompassing the putative S/P phosphorylation site, may shed light on 
the significance of TIF1γ degradation and its possible function during Ad infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~ 170 ~ 
 
 
 
CHAPTER 5 
 
 
 
 
REGULATION OF TIF1γ AND MRE11 BY E3 
UBIQUITIN LIGASE COMPLEXES DURING 
ADENOVIRUS INFECTION 
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5.1 INTRODUCTION 
Post-translational ubiquitin modifications mediate a multitude of cellular regulatory pathways 
including cell cycle progression, cellular differentiation, apoptosis and the DDR (Welchman 
et al., 2005). In this regard ubiquitylation regulates protein function through proteolytic and 
non-proteolytic mechanisms (Wilkinson et al., 2000, Glickman and Ciechanover, 2002).  
The ubiquitylation process involves at least three types of enzyme: initially, an E1 enzyme 
interacts with, and activates, free ubiquitin in an ATP-dependent process; secondly, an E2 
enzyme conjugates to the ubiquitin; and finally an E3 ubiquitin ligase enzyme catalyses the 
transfer of ubiquitin from the E2 to the protein substrate (Hershko et al., 1983, Welchman et 
al., 2005). Two main classes of E3 ubiquitin ligase have been identified based on the 
presence of either a HECT or RING domain (Al-Hakim et al., 2010). CRLs are large multi-
subunit RING ligase complexes characterized by the presence of a central globular cullin 
subunit which acts as a scaffold and linker protein (Zheng et al., 2002). There are seven bona 
fide members of the highly conserved cullin family (CUL1, 2, 3, 4A, 4B, 5 and 7; Petroski 
and Deshaies, 2005), as well as several proteins which contain a cullin-homology domain 
(APC2 and CUL9; Yu et al., 1998, Skaar et al., 2007). 
During Ad infection it is well established that E1B55K and E4ORF6 assemble into a complex 
that targets cellular proteins for degradation via the 26S proteasome (Querido et al., 2001). It 
has been determined, in part, that adenoviruses utilise CUL2- or CUL5-based E3 ubiquitin 
ligase complexes to promote the degradation of substrates; CUL2- and CUL5-based 
complexes assemble in a similar fashion to one another and comprise RBX1 RING domains 
and Elongins B and C, which determine substrate specificity at the N-terminus (Querido et 
al., 2001, Harada et al., 2002, Baker et al., 2007, Mahrour et al., 2008, Blackford et al., 
2010). In most instances it accepted that E1B55K serves as the substrate recognition 
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component, while E4ORF6 recruits the cellular CRL via a direct interaction between 
Elongins B and C and one of its three BC boxes (Harada et al., 2002, Blanchette et al., 2004, 
Cheng et al., 2007, Luo et al., 2007). As with all cullin-based E3 ubiquitin ligases, the 
activity of these complexes is regulated through the covalent attachment of the ubiquitin-like 
polypeptide NEDD8 in a process known as neddylation (Pintard et al., 2003). This 
modification facilitates conformational changes within the cullin and RBX1 domains which 
are required to promote ubiquitylation, although little is known of how adenoviruses control 
this process (Duda et al., 2008). 
Based on several reports, there seems to be a degree of heterogeneity in the composition of 
E1B55K/E4ORF6-containing CRLs between both virus serotypes and substrates, such that 
CUL2- and CUL5-based complexes are utilised to degrade p53 by Ad12 and Ad5 viruses, 
respectively (Querido et al., 2001, Blackford et al., 2010, Cheng et al., 2011). In addition to 
the diversity seen with p53, the Ad12-induced degradation of TOPBP1 utilises a CUL2-based 
E3 ubiquitin ligase complex where E4ORF6 probably acts as the adaptor protein by binding 
to substrates in the absence of E1B55K (Blackford et al., 2010). Previous reports also suggest 
that Mre11 and DNA ligase IV are degraded via a CUL5-based E3 ubiquitin ligase during 
Ad5 infection (Querido et al., 2001, Baker et al., 2007, Dallaire et al., 2009b), however 
preliminary data from our laboratory suggest that this is not the case (Forrester et al., 2011). 
Given these findings, and the identification of potentially novel E1B55K- and TIF1γ-
interacting proteins as discussed in Chapter 4, it is possible that other E3 ubiquitin ligase 
complexes may be important for the degradation of Ad substrates. 
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5.2 AIMS 
The specific aims of this Chapter were to further investigate the regulation of TIF1γ during 
Ad infection and to determine the underlying mechanisms involved in targeting known and 
novel Ad substrates for degradation by: 
a) Verifying TIF1γ as a bona fide Ad substrate. 
b) Exploring potential roles of cullin-based E3 ubiquitin ligases during Ad infection. 
c) Investigating the roles of other E3 ubiquitin ligases during Ad infection. 
d) Analysing the importance of ATR and CDK kinase activity in the degradation of Ad 
substrates. 
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5.3 RESULTS 
5.3.1 TIF1γ is degraded in a proteasome-dependent manner during Ad5 and Ad12 
infection 
Results described in Chapter 4 demonstrate that the protein levels of the cellular 
transcriptional regulator TIF1γ are reduced following infection with a panel of Ad serotypes. 
To ascertain if this depletion is due to ubiquitin-mediated proteasome-dependent degradation, 
experiments were carried out using the potent cell-permeable proteasome inhibitor MG132. 
MG132 is a peptide aldehyde that can enter mammalian cells and block the proteolytic 
activity of the 26S proteasome by binding to the active sites of its 20S catalytic component 
(Zhang et al., 2009). 
Thus, HeLa cells were first infected with Ad5 or Ad12 before being treated after 2 hours with 
either MG132 (10 μM in DSMO) or DMSO alone which served as a negative control. Cells 
were then harvested and analysed by Western blotting. Results indicate that while TIF1γ and 
DNA ligase IV protein levels were reduced 24 hours post Ad5- and Ad12-infection in cells 
treated with DMSO alone, both proteins were stabilized in the presence of MG132 (Fig 5.1A 
and B). This confirms that TIF1γ, like other cellular substrates including DNA ligase IV, 
Mre11 and p53, is targeted for ubiquitin-mediated proteasome-dependent degradation during 
Ad5 and Ad12 infection. 
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A 
B 
Fig 5.1 A and B. TIF1γ is degraded in a proteasome-dependent manner by 
Ad5 and Ad12 
HeLa cells were infected with Ad5 (A) or Ad12 (B) in the presence or absence of 
10 μM MG132 made up in DMSO which was added 2 hours after infection. Cells 
were harvested at the indicated time points and analysed by Western blotting using 
DNA ligase IV as a positive control and ß-actin as a loading control. 
h.p.i. Ad12      0    12   24    0    12  24
β-actin
DNA ligase IV
Ad12E1B54K
TIF1γ
+DMSO         +MG132
β-actin
DNA ligase IV
Ad5E1B55K
TIF1γ
+ DMSO         +MG132
h.p.i. Ad5      0    12   24     0    12  24
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5.3.2 CUL2- and CUL5-based E3 ubiquitin ligase complexes are not required for TIF1γ, 
Mre11 or DNA ligase IV degradation during Ad5 or Ad12 infection 
As discussed in the introduction to this Chapter, Ad proteins can hijack CRLs to target 
cellular proteins for proteasomal degradation (Querido et al., 2001, Harada et al., 2002, 
Blanchette et al., 2004, Blackford et al., 2010). To determine if adenoviruses similarly utilise 
CUL2 or CUL5 to promote the degradation of TIF1γ during Ad infection a series of RNAi 
experiments were carried out to silence their gene expression.  
HeLa cells were therefore transfected with specific CUL2 and CUL5 siRNA oligonucleotides 
to specifically knockdown the expression of CUL2 and CUL5 proteins, or alternatively 
treated with a non-silencing siRNA to serve as a control. Twenty-four hours post-
transfection, cells were infected with Ad5 or Ad12 viruses and harvested at the appropriate 
time points. Consistent with other studies, depletion of CUL5 during Ad infection inhibited 
p53 degradation, however it had no effect on TIF1γ, DNA ligase IV or Mre11 degradation 
(Fig 5.2A). CUL2 knockdown had no effect the degradation of any substrates during Ad5 
infection, however during Ad12 infection it appropriately stabilized p53 and TOPBP1 protein 
expression (Fig 5.2; Blackford et al., 2010). CUL5 knockdowns also failed to inhibit the 
degradation of TIF1γ, DNA ligase IV or Mre11 during Ad12 infection (Fig 5.2B). Taken 
together these data suggest that adenoviruses do not utilise CUL2- or CUL5-based E3 
ubiquitin ligase complexes in order to promote the degradation of TIF1γ, DNA ligase IV or 
Mre11 during infection.  
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Ad12E1B54K
TIF1γ
CUL2
DNA ligase IV
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CUL5
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Fig 5.2 A and B. Degradation of TIF1γ, Mre11 and DNA ligase IV during Ad5 
and Ad12 infection is CUL2- and CUL5-independent  
HeLa cells were transfected with non-silencing siRNA or siRNA targeting CUL2 
or CUL5 before being infected after 24 hours with Ad5 (A) and Ad12 (B). Cells 
were harvested and prepared for Western blotting at the indicated time points post-
infection. 
A 
B 
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5.3.3 CUL1- and CUL3-based E3 ubiquitin ligase complexes are not required for Mre11 
degradation during Ad5 infection 
In order to ascertain whether other CRLs are required for the degradation of these substrates, 
systematic siRNA knockdowns of individual cullin family members were carried out and the 
stability of these proteins following Ad infection were subsequently assessed. Given that 
CUL1 is known to interact with E1A (Isobe et al., 2009), and that CUL3 was identified as a 
putative TIF1γ-interacting protein in Chapter 4, initially the possible usage of these cullins in 
Ad-substrate degradation were determined. The impact of CUL1 and CUL3 depletion on the 
Ad5-induced degradation of Mre11 was analysed in H1299 CUL5 knockdown, and H1299 
control (pcDNA3) cells which were transfected with specific CUL1 or CUL3 siRNA 
oligonucleotides. H1299 CUL5 knockdown cells were utilised to rule out any functional 
redundancies that may exist between CUL1/CUL3 and CUL5. Western blotting revealed that 
although CUL1 and CUL3 knockdown was achieved, this had no effect on Mre11 
degradation at 24 or 48 hours post-Ad5 infection (Fig 5.3). In addition to eliminating a role 
for CUL1 and CUL3 in Ad-mediated degradation of target substrates these data also support 
the notion that CUL5 is dispensable for Mre11 degradation. 
 
5.3.4 CUL4A- and CUL4B-based E3 ubiquitin ligase complexes are not required for 
TIF1γ or Mre11 degradation during Ad5 infection 
Next, the possible usage of CUL4A- or CUL4B-based E3 ubiquitin ligase complexes in Ad-
substrate degradation was investigated. CUL4A has been implicated in the degradation of 
substrates from other viruses besides Ad such as HIV-1 and hepatitis B (Transey and 
Margottin-Goguet, 2009, Ahn et al., 2010, Belzile et al., 2010, Li et al., 2010). To determine  
~ 179 ~ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.3. Degradation of Mre11 during Ad5 infection is CUL1-, CUL3- and 
CUL5-independent  
H1299 CUL5 knockdown cells and H1299 control cells (pcDNA3) were 
transfected with non-silencing siRNA or siRNA targeting CUL1 or CUL3 before 
being infected after 24 hours with Ad5. Cells were harvested and prepared for 
Western blotting at the indicated time points post-infection. 
h.p.i. Ad5    0  24 48  0 24 48  0 24 48 24 48 24 48   
siRNA control    control CUL1 CUL3    
cells        pcDNA3                   CUL5 KD
CUL1 
CUL5 
CUL3  
β-actin
Mre11 
Ad5E1B55K 
Ad5E1A  
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Fig 5.4. Degradation of TIF1γ and Mre11 during Ad5 and Ad12 infection is 
CUL4A- and CUL4B-independent  
HeLa cells were transfected with non-silencing siRNA or siRNA targeting CUL4A 
and/or CUL4B before being infected after 24 hours with Ad5. Cells were harvested 
and prepared for Western blotting at the indicated time points post-infection. 
 
 
h.p.i. Ad5      0  24 48 72  0  24  48 72   0 24 48 72  0  24 48 72 
siRNA non-sil.        CUL4A        CUL4B      CUL4A/B
CUL4A
CUL4B
Ad5E1B55K
Mre11
β-actin
TIF1γ
~ 181 ~ 
 
if CUL4A, or its closely related ancestor CUL4B, is involved in the degradation of Ad 
substrates, transfections were carried out using CUL4A- and CUL4B-specific siRNA. 
Following the transfection of CUL4A and/or CUL4B siRNA oligonucleotides, HeLa cells 
were infected with Ad5 and harvested over a period of 72 hours. Western blotting revealed 
that the depletion of these cullins was unable to inhibit, or delay, the degradation of TIF1γ or 
Mre11 during Ad5 infection (Fig 5.4). To allow for any functional redundancies between the 
CUL4A and CUL4B proteins, cotransfections were also carried out with CUL4A and CUL4B 
siRNAs; however this co-depletion also had no effect on TIF1γ or Mre11 degradation during 
Ad5 infection (Fig 5.4). 
 
5.3.5 CUL7-based E3 ubiquitin ligase complexes are not required for TIF1γ or Mre11 
degradation during Ad4, Ad5 or Ad12 infection 
The final member of the cullin family to be considered for inducing Ad-mediated substrate 
degradation was CUL7 which was identified, along with TIF1γ, in immunocomplexes with 
Ad12E1B54K in Chapter 4. Thus, HeLa cells were initially transfected with CUL7-specific 
siRNA before being infected with Ad4, Ad5 and Ad12 serotypes. Western blotting revealed 
that CUL7 knockdown had no effect on TIF1γ or Mre11 degradation which was evident 24 
hours post-Ad4, -Ad5 and -Ad12 infection (Fig 5.5A-C). 
Taken in their entirety, these data suggest that adenoviruses do not rely solely upon CRLs in 
order to promote substrate degradation during infection. 
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Fig 5.5A-C. Degradation of TIF1γ and Mre11 during Ad4, Ad5 and Ad12 
infection is CUL7-independent  
HeLa cells were transfected with non-silencing siRNA or siRNA targeting CUL7 
before being infected after 24 hours with Ad4 (A), Ad5 (B) or Ad12 (C). Cells 
were harvested and prepared for Western blotting at the indicated time points post-
infection. 
 
h.p.i. Ad12     0   6  12 24 48  0  6  12  24 48
TIF1γ
Mre11
CUL7
Ad12E1B54K
β-actin
siRNA non-sil.            CUL7
TIF1γ
Mre11
CUL7
Ad5E1B55K
β-actin
h.p.i. Ad5    0   6  12 24 48  0  6  12  24 48
siRNA non-sil.            CUL7
TIF1γ
Mre11
CUL7
Ad4E1B55K
β-actin
h.p.i. Ad4     0   6  12 24 48  0  6  12  24 48
siRNA non-sil.            CUL7
A
B
C
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5.3.6 TIF1α is not required for TIF1γ degradation during Ad5 or Ad12 infection 
Given that the data so far presented in this Chapter suggests that Ad-mediated TIF1γ 
degradation is not driven by CRLs containing CUL1-7 proteins, the potential requirement of 
non-cullin-based E3 ubiquitin complexes was investigated. One potential candidate was 
TIF1α which has a close relationship with TIF1γ and was also identified in Chapter 4 as 
putative Ad12E1B54K-interacting protein.  
To examine this further, HeLa cells were transfected with TIF1α-specific siRNA before being 
infected with Ad5 or Ad12 and harvested. Western blot analysis demonstrated that TIF1α 
knockdown had no effect on TIF1γ degradation during Ad5 infection (Fig 5.6A), or TIF1γ or 
Mre11 degradation during Ad12 infection (Fig 5.6B). 
 
5.3.7 TIF1γ degradation during Ad5 and Ad12 infection is independent of ATR kinase 
activity 
ETD mass spectrometric analysis of TIF1γ immunoprecipitates described in Chapter 4 
identified a putative S/P phosphorylation site within the central unconserved region of the 
TIF1γ protein that was phosphorylated in response to Ad infection. The same screen also 
identified the serine/threonine-protein kinase ATR which was shown to interact with TIF1γ in 
vivo. ATR is activated in response to DNA damage (and during infection with certain Ad 
serotypes), however its catalytic activity can be inhibited by the radiosensitizing agent 
caffeine (Hall-Jackson et al., 1999, Sarkaria et al., 1999).  
In some instances phosphorylation events are known to stimulate ubiquitin-mediated 
degradation (Koepp et al., 2001, Lin et al., 2006); therefore to determine if ATR kinase 
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activity has a role in TIF1γ degradation during Ad infection, HeLa cells were first infected 
with Ad5 or Ad12 and subsequently incubated with caffeine (5 mM in DMSO), or DMSO 
alone as a negative control. Western blotting revealed that TIF1γ was still degraded during 
Ad5 and Ad12 infection in cells treated with caffeine, whereas H2AX was appropriately 
phosphorylated to a lesser extent confirming that ATR kinase activity was inhibited (Fig 5.7A 
and B). Noticeably, TIF1γ protein levels were generally reduced in the presence of the drug, 
even in mock treated cells, suggesting that ATR, or another caffeine-sensitive kinase, may 
stabilize TIF1γ protein levels (Fig 5.7A and B).  
 
5.3.8 TIF1γ degradation during Ad5 infection is independent of CDK kinase activity 
Interestingly, the putative S/P TIF1γ phosphorylation site identified in Chapter 4 was flanked 
by similar residues to those found in canonical CDK-target motifs (Songyang et al., 1994, 
Holmes and Soloman, 1996). Therefore the significance of CDK activity on Ad5-induced 
TIF1γ degradation was examined using the purine analogue roscovitine, which is a potent and 
selective inhibitor of CDK phosphorylation (Meijer et al., 2007).  
HeLa cells were first infected with Ad5 and subsequently incubated with roscovitine (20 μM 
in DMSO) to inhibit CDK kinase activity, or DMSO alone as a negative control. Western blot 
analysis revealed that TIF1γ degradation was not inhibited in the presence of roscovitine 
during Ad5 infection (Fig 5.8). Due to the effect of Ad infection on cell cycle progression, a 
suitable positive control was not able to be included in this experiment. Taken together these 
data suggest that ATR and CDKs do not promote TIF1γ degradation during Ad infection. 
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siRNA non-sil.          TIF1α
virus    mock     Ad12    mock      Ad12
h.p.i.  24 48   24  48  24  48   24  48
Ad12E1B54K
TIF1α
TIF1γ
Mre11
β-actin
A 
B 
Fig 5.6A and B. Degradation of TIF1γ during Ad5 and Ad12 infection is 
TIF1α-independent  
HeLa cells were transfected with non-silencing siRNA or siRNA targeting TIF1α 
before being infected after 24 hours with Ad5 or Ad12. Cells were harvested and 
prepared for Western blotting at the indicated time points post-infection. 
 
h.p.i.      0   24  48  72   0   24  48  72    0   24  48  72   0   24  48  72 
siRNA non-sil.                                      TIF1α
virus             mock                 Ad5                 mock Ad5
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β-actin
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Ad12E1B55K
TIF1γ
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.7 A and B. Degradation of TIF1γ during Ad5 and Ad12 infection is 
independent of putative ATR phosphorylation 
HeLa cells were infected with Ad5 (A) or Ad12 (B) in the presence or absence of 5 
mM caffeine made up in DMSO which was added 2 hours after infection. Cells 
were harvested after 24 and 48 hours and prepared for Western blotting. H2AX 
phosphorylation was used as a positive control. 
β-actin
γH2AX
Ad5E1B55K
TIF1γ
h.p.i. Ad5     24 48 24 48 24  48   24 48
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β-actin
RB
Ad5E1B55K
TIF1γ
h.p.i. Ad5     24 48 24 48 24  48   24 48
virus     mock      Ad5   mock  Ad5
+ DMSO         + roscovitine
Fig 5.8. Degradation of TIF1γ during Ad5 infection is independent of putative 
CDK phosphorylation 
HeLa cells were infected with Ad5 in the presence or absence of 20 μM roscovitine 
made up in DMSO which was added 2 hours after infection. Cells were harvested 
after 24 and 48 hours and prepared for Western blotting. 
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5.4 DISCUSSION 
In conjunction with observations described in Chapter 4, data presented in this Chapter 
support the notion that TIF1γ is targeted for ubiquitin-mediated proteasome-dependent 
degradation during Ad infection (Fig 5.1). Based on these findings, putative TIF1γ 
ubiquitylation and phosphorylation modification events were investigated during Ad 
infection. The role of CRLs in TIF1γ degradation were considered since CUL2 and CUL5 
have previously been implicated in Ad-dependent substrate proteolysis (Querido et al., 2001, 
Harada et al., 2002, Baker et al., 2007, Blackford et al., 2010).  
RNAi was utilised to interfere with the gene expression of most cullin proteins, and Western 
blotting demonstrated a significant level of knockdown was achieved in all the experiments 
reported here. However results revealed that during both Ad5 and Ad12 infection, CUL2 and 
CUL5 depletion had no effect on Mre11, DNA ligase IV or TIF1γ degradation, which 
progressed unabated (Fig 5.2); indeed, Mre11 was also degraded during Ad5 infection in 
H1299 CUL5 knockdown cells (Fig 5.3). As anticipated, p53 was not degraded during Ad5 
and Ad12 infection when cells were transfected with CUL5 and CUL2 siRNA, respectively. 
These data contradict current assumptions that Mre11 is degraded by a CUL5-based E3 
ubiquitin ligase complex; however even in these previous investigations the evidence is 
questionable. For example, Mre11 and integrin alpha 3 are only slightly stabilized in Ad5-
infected H1299 CUL5 knockdown cells, and E1B55K/E4ORF6 protein expression levels 
varied appreciably from control samples (Querido et al., 2001, Dallaire et al., 2009b). 
A recent publication also suggests that adenoviruses exclusively utilise CUL2- or CUL5-
based E3 ubiquitin ligase complexes to degrade substrate proteins, which is in contrast to data 
presented here (Cheng et al., 2011). Cheng and colleagues reported that tagged E4ORF6 
plasmid constructs for Ad4, Ad5, Ad9 and Ad34 co-immunoprecipitated with CUL5, while 
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constructs for Ad12, Ad16 and Ad40 co-immunoprecipitated with CUL2. Degradation assays 
using plasmid DNA also showed that in the presence of Ad5 and Ad12 E1B55K/E4ORF6 
proteins, H1299 CUL5 and CUL2 knockdown cells, respectively, were unable to degrade 
Mre11 (although the expression of Ad5E1B55K was significantly less than in control cells; 
Cheng et al., 2011). Several discrepancies from this study have already been reported in 
Chapter 3 regarding substrate specificities. Reasons for these differences remain unknown at 
present, although in contrast to previous reports, the work described here utilised HeLa cells 
in the context of a full infection, and it is possible that the presence of other viral gene 
products may be significant. It should also be noted that the expression of a dominant-
negative CUL5 mutant protein has been shown to inhibit the degradation of DNA ligase IV 
during Ad5 infection (Baker et al., 2007), however, in the current study Ad5- and Ad12-
mediated degradation of DNA ligase IV was not inhibited when CUL5 or CUL2 protein 
expression was depleted by siRNA (Fig 5.2). 
CUL2- and CUL5-based E3 ubiquitin ligase complexes are functionally redundant for 
oogenesis and activation of the mitogen-activated protein (MAP) kinase, MPK-1, in 
Caenorhabditis elegans (Sasagawa et al., 2007). Therefore to accommodate this possibility 
during Ad-mediated proteolysis of Mre11, DNA ligase IV and TIF1γ, future experiments 
could be carried out where cells are cotransfected with siRNAs targeting both CUL2 and 
CUL5.  
There are two possible shortcomings in the current data which must be considered, as there 
can often be limitations and weaknesses in experimental procedures. Firstly, all gene 
depletions carried out on cullin and TIF1α proteins in this Chapter were achieved though 
siRNA-mediated knockdown which, unlike stable conditional “knockout” models, may not 
completely silence gene expression in 100% of the cell population. Therefore, despite the 
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strong overall reduction gained from RNAi, residual expression of these proteins may 
account for the degradation of Mre11 and TIF1γ seen during Ad infection. With siRNA there 
is also the possibility that it will generate “off-target” effects within the cell (Jackson and 
Linsley, 2010). Secondly, it must be considered that E3 ubiquitin ligase complexes may have 
different affinities for different substrates. For example, while siRNA knockdown of CUL2 
was sufficient to stabilize p53 and TOPBP1 protein expression during Ad12 infection, 
residual levels of functioning CUL2 complexes may have higher affinities for other proteins 
such as Mre11 and TIF1γ causing them to be preferentially targeted for degradation.  
This study also investigated the role of CUL1-, CUL3-, CUL4A-, CUL4B- and CUL7-based 
E3 ubiquitin ligase complexes in Ad-mediated degradation of target substrates. Some of these 
scaffold proteins are already reported to be exploited by a range of viruses known to interact 
with the ubiquitin-proteasome system to promote viral replication and circumvent immune 
responses. It is often suggested that the hijack of such complexes is achieved by viral proteins 
mimicking cellular adaptors. Indeed, the EBV encoded protein BPLF1 has recently been 
found to bind directly to and deneddylate CUL1 and CUL4A (Gastaldello et al., 2010). This 
inactivation leads to the stabilization of CDT1 (chromatin licensing and DNA replication 
factor 1) which induces a deregulated S phase-like environment that is permissive for viral 
DNA replication (Gastaldello et al., 2010). Cellular transformation by SV40 TAg is also 
dependent on TAg binding to a cellular CUL7-based E3 ubiquitin ligase complex, while this 
same complex aids viral replication by inducing the proteolysis of MRN to manipulate the 
cellular DDR (Ali et al., 2004, Zhao et al., 2008). Recently, cullins have also been implicated 
in HIV-1 cell cycle regulation. In this instance, the HIV-1 Vpr protein manipulates DDB1-
CUL4A E3 ubiquitin ligase complex activity to induce G2/M arrest and degrade its cellular 
substrates (Transey and Margottin-Goguet, 2009, Ahn et al., 2010, Belzile et al., 2010). 
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CUL4-contining E3 ubiquitin ligase complexes are also hijacked by other viral proteins such 
as paramyxovirus SV5, hepatitis B virus X (HBX) protein and woodchuck hepatitis B virus X 
(WHX) protein to facilitate viral replication (Li et al., 2010).  
In contrast, viruses can also interfere with CRLs to reduce the degradation of target proteins. 
Indeed, to aid unregulated proliferation, Ad E1A directly binds CUL1 to attenuate the 
function of the SCF
Fbw7
 E3 ubiquitin ligase complex (Isobe et al., 2009). It was therefore 
unlikely that CUL1 complexes would be utilised by Ad E1B55K/E4ORF6 proteins to 
ubiquitylate cellular substrates, and this was the conclusion drawn from knockdown 
experiments examining Mre11 degradation during Ad5 infection (Fig 5.3). Mre11 and TIF1γ 
degradation during Ad infection was also unaffected by the siRNA-mediated knockdown of 
CUL3, CUL4A, CUL4B or CUL7 (Fig 5.3-5.5).  
Cullin activity is regulated through the covalent attachment of the ubiquitin-like polypeptide, 
NEDD8, and neddylated versions of these proteins can be detected as slower migrating bands 
during SDS-PAGE and Western blotting (Pintard et al., 2003, Duda et al., 2008). Thus it was 
seen that CUL5 and CUL2 proteins became neddylated during Ad5 and Ad12 infection, 
respectively (Fig 5.2), presumably for the degradation of p53 and TOPBP1 (Blackford et al., 
2010). However for all the other cullin proteins examined, banding patterns were relatively 
uniform during Ad infection suggesting a lack of activation (Fig 5.3-5.5). Taken together 
these data suggest that Mre11 and TIF1γ are not targeted by CRLs during Ad5 or Ad12 
infection. 
Another candidate for directing E3 ubiquitin ligase activity towards cellular Ad substrates 
was TIF1α. This protein contains an N-terminal RING-finger motif and was identified in 
Chapter 4 as a binding partner of Ad12E1B54K. In addition, TIF1α is relocalized into PML-
containing nuclear tracks by E4ORF3 during Ad infection where its function remains 
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unknown, although it is not targeted for degradation like its close relative TIF1γ (Chapter 4; 
Yondola and Hearing, 2007). Despite these features, siRNA-mediated knockdown of TIF1α 
failed to rescue Mre11 or TIF1γ degradation which was still apparent 24 hours post-Ad5 and 
-Ad12 infection (Fig 5.6). 
Given that TIF1γ is a bona fide E3 ubiquitin ligase itself, it may also be capable of 
autoubiquitylating itself to regulate its own degradation during Ad infection. Indeed, this has 
recently been reported for the first time where PHD/BRD-dependent TIF1γ histone binding 
induced autoubiquitylation of its TRIM domain, in the presence or absence of TGF-β 
signalling (Agricola et al., 2011). Data from Chapter 4 suggest that Ad-mediated TIF1γ 
relocalization, and possibly degradation, is dependent the interaction between its TRIM 
domain and E4ORF3. Therefore if TIF1γ does undergo autoubiquitylation, this may explain 
why the TIF1γC>A point mutant with no E3 ubiquitin ligase activity is less readily 
relocalized into E4ORF3-containing nuclear tracks during Ad12 infection (Fig 4.9B), and 
suggest that E4ORF3 may activate this putative TIF1γ ligase activity. It will therefore be 
interesting to investigate whether the TIF1γC>A mutant is able to be degraded during Ad 
infection, however as E4ORF3 is likely to interact with the TRIM domain of TIF1γ it will be 
difficult to discriminate between E4ORF3 recruiting TIF1γ to nuclear tracks, and cellular E3 
ubiquitin ligase complexes and E4ORF3 functioning to directly activate intrinsic E3 ubiquitin 
ligase activity. 
Results from Chapter 4 suggested that TIF1γ is phosphorylated during Ad infection at 
Ser862. Phosphorylation events are also known to promote the destruction of proteins via the 
ubiquitin-proteasome pathway (Koepp et al., 2001, Lin et al., 2006), therefore in the current 
Chapter the potential role of two classes of protein kinases were investigated; ATR, a 
serine/threonine kinase activated in response to DNA damage, and CDKs which are central 
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regulators of the cell cycle. CDKs phosphorylate their substrates on serine or threonine 
residues which are followed by a proline at position +1 and an arginine or lysine at position 
+3 (Songyang et al., 1994). This arrangement is analogous to the S*PIR sequence identified 
in Chapter 4. Unfortunately, both ATR and CDK chemical inhibitors failed to significantly 
inhibit TIF1γ degradation in Ad-infected cells (Fig 5.7 and 5.8). This suggests that either 
phosphorylation is inconsequential for TIF1γ degradation, or that Ser862 is phosphorylated 
by another cellular kinase. The future development of a phospho-specific antibody or the 
mutagenesis of Ser862 may help to determine the importance of this putative modification. 
Data presented in Chapter 4 revealed that TIF1γ degradation is conserved amongst a selection 
of Ad serotypes from species A, B1, B2 and C. Out of these viruses, Ad3, Ad7 and Ad11 
(unlike Ad5 and Ad12) have been shown to activate ATR kinase activity towards Chk1 
during infection (Chapter 3), therefore it will also be interesting to investigate the effect 
caffeine has on the ability of these viruses to degrade TIF1γ. 
In addition to the E3 ubiquitin ligases mentioned here, several other proteins with known or 
putative ligase activity were also examined. These included CUL9, UBR5, CtIP, CBP, p300 
and APC3; however siRNA-mediated knockdown of all of these genes failed to impede 
Mre11 degradation during Ad infection (data not shown). 
Given the diversity of p53 regulation seen between adenoviruses, it is likely that Mre11, 
DNA ligase IV and TIF1γ are differentially regulated during infection by other Ad serotypes. 
To our knowledge, the only similarity between adenoviruses and cullin specificity is that both 
Ad4 and Ad5 utilise a CUL5-based E3 ubiquitin ligase to target p53 for degradation (Fig 
5.2A and data not shown). At present, it is not understood how CRL selection occurs by 
E4ORF6 since E4ORF6 sequences do not contain the CUL2- or CUL5-consensus motifs that 
are used by cellular proteins (Luo et al., 2007, Mahrour et al., 2008). This suggests that CRLs 
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are hijacked by viral proteins during Ad5 and Ad12 infection via a non-canonical process or 
binding sequence. 
Data from Chapter 4 strongly imply that TIF1γ protein stability is affected by Ad E4ORF3 
expression in a manner distinct from other substrates, therefore it is likely that TIF1γ and 
Mre11 are differentially regulated during Ad infection. This is supported by the fact that, 
while all serotypes studied were capable of degrading TIF1γ (and DNA ligase IV), only some 
degraded Mre11. Although the present study failed to identify the specific E3 ubiquitin ligase 
complex required for degrading these proteins, there are many more candidates yet to be 
investigated, some of which were identified by mass spectrometry in Chapter 4. It should also 
be noted that ubiquitylation has not actually been demonstrated on any of the MRN 
components, and since the absence of one member is sufficient to destabilize the entire 
complex the direct target is still yet to be determined. 
In conclusion, it appears that the Ad-mediated degradation of target substrates is more 
complex than first described, and that more work is needed to fully determine the relationship 
between adenoviruses and the ubiquitin-proteasome pathway. 
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6.1 FUTURE PERSPECTIVES OF SEROTYPE-SPECIFIC INACTIVATION OF THE 
DDR 
Previously, it had been generally assumed that the relationship between adenoviruses and the 
DDR was, with some exceptions, broadly similar amongst different serotypes (Stracker et al., 
2005, Cheng et al., 2011). However, recent observations from our laboratory showing that 
Ad5 and Ad12 differentially inactivate ATR (Blackford et al., 2010) prompted the current 
study into how adenoviruses from other Ad species interact with the cellular DDR.  
Data presented in Chapter 3 revealed that representative Ad serotypes from species A to E are 
all capable of activating a subset of the DDR, but there was considerable diversity regarding 
how these serotypes abrogated signal transduction pathways in order to prevent checkpoint 
activation and apoptosis. Interestingly, out the four cellular Ad substrates examined, only 
DNA ligase IV protein levels were reduced following infection with all viral serotypes tested. 
Presumably DNA ligase IV degradation prevents the illegitimate repair of viral genomes by 
NHEJ, as previously reported (Baker et al., 2007, Jayaram et al., 2008). It will be interesting 
to ascertain by immunofluorescence if DNA ligase IV is relocalized into nuclear tracks prior 
to its degradation though the development a suitable antibody, or by using a tagged construct 
to detect it exogenously. Relocalization is the fate for most Ad substrates, therefore this will 
be especially interesting to determine for the species B serotypes, Ad3, Ad7 and Ad11, which 
are unable to degrade or relocalize Mre11, p53 or TOPBP1.  
In addition to DNA ligase IV degradation, it is also possible that species B serotypes have 
evolved novel mechanisms to circumvent the DDR, especially since the E4ORF6 BC boxes 
from these viruses are highly homologous to those of Ad5 and Ad12 and may therefore have 
the ability to interact with cellular proteins (Cheng et al., 2007). The development of mutant 
viruses and antibodies against these less studied serotypes may help to decipher these 
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theories, and to determine whether their E1B55K and E4ORF6 proteins are responsible for 
inducing the ubiquitin-mediated proteasome-dependent degradation of DNA ligase IV. 
The levels of p53 following infection were also examined in Chapter 3 and it was discovered 
that during Ad3, Ad7, Ad9 and Ad11 infection p53 protein levels were increased 
substantially (presumably through the action of E1A); however in this instance p53 was 
transcriptionally inactive. As p53 regulation is extremely complex, and MDM2 protein levels 
were reduced during these infections, further studies are needed to determine the mechanism 
behind p53-MDM2 inactivation and its significance to the virus. One possibility is that this 
transcriptional inactivation is caused by an epigenetic mechanism that occurs irrespective of 
protein degradation. Indeed, a recent study revealed that during Ad5 infection E4ORF3 
induces de novo H3K9me3 methylated heterochromatin formation at p53 target promoters in 
order to prevent p53 binding to promoter sites (Soria et al., 2010).  
In agreement with previous reports, the studies presented in Chapter 3 of this thesis 
determined that Chk1 was not activated during Ad5 or Ad12 infection, however, during Ad3, 
Ad7 and Ad11 infection Chk1 was phosphorylated. This correlates with the inability of 
species B viruses to degrade or relocalize the MRN complex, and suggests that a degree of 
ATR activation is tolerated by these viruses as no indication of apoptosis was seen. As Chk1 
regulates the S phase checkpoint through CDC25A degradation, and since E1A has been 
shown to increase CDC25A phosphatase activity, it will be interesting in future studies to 
take a closer look at Chk1/CDC25A pathway components in cells infected with species B 
viruses (Spitkovsky et al., 1996, Grand et al., 1998, Xiao et al., 2003). Furthermore, 
phospho-specific antibodies could be utilised to determine the localization of activated Chk1 
during Ad3, Ad7 and Ad11 infection, as sequestration by viral proteins may impede signal 
transduction. It is also possible that Chk1 activation by species B adenoviruses could be akin 
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to HIV-1 and SV40 infections where activated DDR pathways are utilised to promote viral 
genome replication (Lai et al., 2005, Boichuk et al., 2010, Rohaly et al., 2010). Indeed, 
previous reports have suggested that certain undefined aspects of the species B Ad life cycle 
differ from canonical pathways utilised by other serotypes (Hall et al., 2010). These include 
virus disassembly, virus release, replication efficiency and utilising the human membrane 
cofactor CD46 receptor rather than the CAR receptor for cellular attachment (Kawakami et 
al., 2003, Sirena et al., 2004, Hall et al., 2010). 
Immunofluorescence and Western blotting techniques employed in Chapter 3 further 
investigated the relationship between protein relocalization and degradation. For Mre11, 
these data indicate that there is not always an obvious correlation between these events since 
during Ad12 infection Mre11 is degraded but resides in VRCs, while during Ad9 infection it 
is relocalized into nuclear tracks but not degraded. At present the purpose of protein 
relocalization during Ad infection is not fully understood and more work is needed to 
understand why adenoviruses have different effects on the cellular DDR. 
 
6.2 A ROLE FOR TIF1γ IN THE CELLULAR DEFENCE TO AD INFECTION 
This study endeavoured to identify novel Ad-interacting proteins via mass spectrometric 
analysis of anti-Ad12E1B54K immunoprecipitates. Using this approach, the transcriptional 
regulator TIF1γ was identified as a bona fide E1B55K-interacting protein which is targeted 
for ubiquitin-mediated proteasome-dependent degradation during Ad3, Ad5, Ad7, Ad11 and 
Ad12 infection.  
The most interesting aspect of this interaction is the unique mechanism by which TIF1γ is 
degraded by adenoviruses. Indeed, unlike other Ad substrates TIF1γ is both degraded and 
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relocalized in an E1B55K/E4ORF6-independent E4ORF3-dependent manner representing a 
novel way in which adenoviruses manipulate the cellular environment. Although the 
relationship is yet to be completely defined, future co-immunoprecipitation and in vitro GST 
(glutathione S-transferase)-pulldown binding assays, should help to decipher the nature of the 
TIF1γ-E4ORF3 interaction. Ad infections could also be carried out in cells transfected with 
the E3 ubiquitin ligase dead TIF1γC>A mutant to determine if, along with restricted 
relocalization, this mutant protein is unable to be degraded by E4ORF3. This could also be 
addressed by transfecting cells with a TIF1γ mutant expressing only the N-terminal TRIM 
domain and seeing if this is sufficient for E4ORF3 to target the protein; data indicate that 
Ad5E4ORF3 interacts with TIF1α through its TRIM domain (Yondola and Hearing, 2007). 
In addition to proteolytic degradation, TIF1γ (akin to p53) function might be modulated by 
E4ORF3-dependent methylation of TIF1g-target promoters (Soria et al., 2010). Therefore, it 
would be interesting to study whether E4ORF3 expression alters the methylation status at 
promoter regions of TIF1g/SMAD-regulated genes. Similarly, the possibility that TIF1γ is 
SUMOylated should be investigated since E1B55K-mediated SUMOylation has been found 
to inhibit p53 transcriptional activity (Muller and Dobner, 2008, Pennella et al., 2010).  
While data presented in Chapter 5 was unsuccessful in identifying the E3 ubiquitin ligase 
accountable for Ad-induced TIF1γ degradation, conventional CRLs were ruled out. This may 
not be surprising since E4ORF3 lacks the BC box motif necessary to mediate an interaction 
with these complexes. There is however an abundance of other proteins that may be 
responsible, and as mentioned in Chapter 5 the possibility that TIF1γ targets itself for 
proteolytic destruction via autoubiquitylation cannot be discounted. As is common for many 
cellular Ad substrates, TIF1γ was also relocalized into nuclear tracks during Ad5 and Ad12 
infection in an E4ORF3-depndent manner. The ability of Ad3, Ad7 and Ad11 to relocalize 
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TIF1γ will also be interesting to determine since nuclear track formation is not a prerequisite 
for proteolytic degradation, and these serotypes are unable to divert p53, Mre11 or TOPBP1 
away from VRCs. 
Further studies are needed to determine the significance of TIF1γ inactivation by 
adenoviruses, especially since its conserved nature may reflect its importance to viral 
persistence. It is reasonable to suggest that TIF1γ abrogation prevents some unknown 
function of the protein that would otherwise be detrimental for the virus. TIF1γ is known to 
have tumour suppressive properties in CMML and PDAC, and hence could initiate 
programmed cell death and cell cycle arrest in infected cells (Vincent et al., 2009, Aucagne et 
al., 2011). Furthermore, recent data from our laboratory suggest that TIF1γ is required for M 
and S phase progression (Sedgwick and Turnell, unpublished observations); therefore 
adenoviruses could exploit TIF1γ degradation as an additional means of inducing, or 
sustaining, an S phase-like environment in host cells to promote viral replication. This theory 
could be examined through the stable over-expression of TIF1γ in Ad infected cells and by 
using flow cytometry to assess cell cycle distribution. 
Over-expression studies could also be used to investigate the impact of TIF1γ on E4ORF3 
function. E4ORF3 mutants are defective for certain aspects of Ad infection. For example, the 
E4ORF3-null virus dl341 is unable to promote viral DNA replication, late viral mRNA 
accumulation, and late viral gene expression in the absence of E1B55K (Shepard and 
Ornelles, 2004). Over-expression of TIF1γ could impede the wt functions of E4ORF3, or in 
contrast, the transcriptional nature of TIF1γ suggests that it could assist in the activation of 
late viral gene expression and/or cellular gene expression. Therefore, it will be interesting to 
establish if cells lacking TIF1γ through siRNA-mediated knockdown, or cells transfected 
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with the ligase-dead TIF1γC>A mutant, are able to rescue the phenotype of E4ORF3 
mutants. 
The ability of TIF1γ to function as a transcriptional repressor and de-repressor indicates that 
there are many other possible roles for TIF1γ during Ad infection. Indeed, adenoviruses are 
well known to transcriptionally inactivate the tumour suppressive properties of p53 and pRB 
either directly or indirectly. It would be interesting to utilise ChIP analysis to determine if 
TIF1γ can directly associate with p53 or pRB-responsive promoters. If proven, further studies 
could be carried out using RT-QPCR to determine the status of TIF1γ transcriptional targets 
in infected cells over-expressing TIF1γ, or cells infected with an E4ORF3 mutant virus. 
Although in the latter case it would be difficult to separate TIF1γ function from p53 
relocalization and transcriptional regulation by wt E4ORF3 (Soria et al., 2010). 
Given that mass spectrometric analysis identified USP9 and SMURF2, in addition to TIF1g, 
as potential Ad12E1B54K-interacting proteins, it will be interesting to explore the impact Ad 
infection has on the TGF-β signalling pathway. This pathway arrests cells in G1
 
to inhibit 
proliferation and promote apoptosis, and previous data has demonstrated that species C E1A 
and E1B55K proteins overcome TGF-β growth inhibition (Datto et al., 1997, Ravitz and 
Wenner, 1997, Tarakanova and Wold, 2003, Tarakanova and Wold, 2010). This antiviral 
defence mechanism is attributed to the transcriptional inhibition of SMAD-containing 
complexes and interference of mitochondrial activation. While the role of TIF1γ needs 
exploring, it is interesting that another Ad substrate, Daxx, is also known to regulate 
SMAD4-mediated TGF-β signalling (Chang et al., 2005, Schreiner et al., 2010). Ad-
mediated degradation of Daxx is suspected to inhibit its transcriptional co-repressor 
properties such as its ability to enhance p53 activity (Schreiner et al., 2010), but prior to its 
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degradation it could also be involved in the regulation of TGF-β signalling pathways by early 
Ad proteins. 
Finally, the possibility that TIF1γ is phosphorylated (or autophosphorylated) during Ad 
infection could be verified by further phosphoproteomic profiling, combined with 
phosphopeptide enrichment using a TiO2 affinity purification column. If this were confirmed, 
it would be interesting to carry out in vitro kinase assays to determine the specific protein 
kinase responsible, and the development of phospho-specific TIF1γ antibodies or site-
directed mutagenesis of the TIF1γ motif could help to study the modified protein’s biological 
function. Furthermore, mutational analysis could also help to establish whether 
phosphorylation of TIF1g during Ad infection is required to promote TIF1gdegradation.  
 
6.3 A ROLE FOR TIF1γ IN THE DDR 
While investigating the relationship between adenoviruses and TIF1γ, a secondary thread of 
research developed when TIF1γ was found to interact with the DDR kinase ATR. This 
interaction was confirmed by in vivo protein-binding assays, however TIF1γ protein 
expression remained unaffected by UVA damage, and the protein was not relocalized to sites 
of DNA damage during UVA microirradiation. In spite of this, there are many other avenues 
that need to be investigated to decipher the role, if any, TIF1γ has in the DDR. 
Firstly, IR radiation could be used to study the effect a different DNA lesion has on TIF1γ 
protein expression and cellular localization; although it should be noted that some DDR 
proteins, such as Chk2, do not concentrate at sites of DNA damage and are instead distributed 
throughout the nucleus to enhance signal transduction (Lukas et al., 2003). While the ability 
of ATR to interact with TIF1γ was identical in mock- and Ad12-infected cells, it will be 
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interesting to determine by co-immunoprecipitation if this association is enhanced or reduced 
by DNA damage. In a similar manner, protein-binding assays could be carried out between 
TIF1γ and other members of the DDR, particularly the ATR-regulatory protein ATRIP and 
those identified in the mass spectrometric analysis of TIF1γ immunoprecipitates (Chk1, p53 
and DNA ligase IV). These results may provide further clues regarding the putative 
significance of TIF1γ function in the DDR. 
In addition to the putative phosphorylation site identified in Chapter 4, TIF1γ also has two 
SQ/TQ motifs located within its BRD and coiled-coil domains. These domains are associated 
with protein binding and transcriptional repression, and E3 ubiquitin ligase activity in the 
case of BRD, therefore it will be interesting to determine whether these SQ/TQ motifs are 
ATR or ATM targets by in vitro kinase assays (Reymond et al., 2001, Meroni and Diez-
Roux, 2005, Liu et al., 2006, Agricola et al., 2011). This could lead to the development of 
phospho-specific TIF1γ antibodies to help determine the function of this modified protein. 
It would be invaluable to use TIF1γ-specific siRNA to investigate the requirement of this 
protein in DNA damage-induced signalling events and relocalization of DDR proteins. 
Moreover, colony survival assays could be employed to measure the sensitivity of TIF1γ-
knockdown cells to IR and UVA irradiation. In the event of TIF1γ having a confirmed role in 
the DDR in vivo studies could also be carried out. While knockout of TIF1γ in mice causes 
embryonic lethality from excessive Nodal signalling, conditional knockout mice have 
previously been generated using the Cre-Lox recombination system (Kim and Kaartinen, 
2008, Vincent et al., 2009). Treatment of these mice with DNA damaging agents, or 
inhibitors of DNA replication, could be used to determine if they are radiosensitive or 
defective for checkpoint signalling, and help identify a role for TIF1γ. 
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The hypothesis that TIF1γ functions in the DDR is given some credibility by the fact that 
TGF-β is rapidly activated in response to IR in order to induce p53-dependent apoptosis 
(Ewan et al., 2002). This is supported by two recent publications; one which provides 
evidence that BRCA1 interacts with SMAD3 to modulate TGF-β signalling and growth 
inhibition in response to oxidative stress, and another which suggests that the synthetic 3-
indole compound induces cell cycle arrest partly through the contribution of SMAD3 
pathways (Li et al., 2009, Huang et al., 2011). Therefore, the function of TIF1γ as a negative 
regulator of TGF-β signalling could implicate it as a molecular switch that either allows 
apoptosis, or obstructs it to encourage DNA repair. Furthermore, the TIF1 family member 
TIF1β is already known to function in the DDR, whereby activated ATM phosphorylates 
TIF1β to de-repress the expression of genes involved in promoting cell cycle control and 
apoptosis (White et al., 2006, Li et al., 2007). 
As an alternative to radiation-induced DNA breaks, it may also be worth investigating the 
implication of TIF1γ in DNA replication fidelity as ATR is fundamental for its maintenance 
(Bakkenist and Kastan, 2004, Petermann and Caldecott, 2006). Exposure of cells to chemical 
agents which cause faults in origin activation and fork progression, such as HU and 
aphidicolin (APH), could be useful in studying the involvement of TIF1γ in DNA replication. 
Correspondingly, the possibility that ATR interacts with TIF1γ in a non-DDR capacity 
cannot be disregarded, although so far reports on TIF1γ function are scarce. 
While the function of TIF1γ in the DDR remains unknown, its ability to regulate 
transcription, associate with chromatin, function as an E3 ubiquitin ligase and putatively 
function as a protein kinase renders it a credible candidate DDR protein, and it will be 
worthwhile to investigate the above hypotheses. 
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